<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES
EXCHANGE ACT OF 1934 (AMENDMENT NO. )
Filed by the Registrant [X]
Filed by a Party other than the Registrant [_]
Check the appropriate box:
[X] Preliminary Proxy Statement [_] Confidential, For Use of the
[_] Definitive Proxy Statement Commission Only (as permitted by
[_] Definitive Additional Materials Rule 14a-6(e)(2))
[_] Soliciting Material Pursuant to Exchange Act Rule 240.14a-11 or 14a-12
NATIONAL MEDIA CORPORATION
- --------------------------------------------------------------------------------
(NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
- --------------------------------------------------------------------------------
(NAME OF PERSON(S) FILING PROXY STATEMENT, IF OTHER THAN THE REGISTRANT)
Payment of Filing Fee (Check the appropriate box):
[X] No Fee Required
[_] Fee computed on table below per Exchange Act Rules 14(a)-6(i)(1) and 0-11.
(1) Title of each class of securities to which investment applies:
------------------------------------------------------------------------
(2) Aggregate number of securities to which investment applies:
------------------------------------------------------------------------
(3) Per unit price or other underlying value of investment computed
pursuant to Exchange Act Rule 0-11: (set forth the amount on which the
filing fee is calculated and state how it was determined.)
------------------------------------------------------------------------
(4) Proposed maximum aggregate value of investment:
------------------------------------------------------------------------
(5) Total Fee paid:
------------------------------------------------------------------------
[_] Fee paid previously with preliminary materials.
[_] Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number, or
the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
------------------------------------------------------------------------
(2) Form, Schedule or Registration Statement No.:
------------------------------------------------------------------------
(3) Filing Party:
------------------------------------------------------------------------
(4) Date Filed:
------------------------------------------------------------------------
<PAGE>
NATIONAL MEDIA CORPORATION
ELEVEN PENN CENTER
SUITE 1100
1835 MARKET STREET
PHILADELPHIA, PA 19103
September , 1998
DEAR FELLOW STOCKHOLDER:
You are cordially invited to attend the special meeting of stockholders (the
"Stockholders' Meeting") of National Media Corporation ("National Media") to
be held on , October , 1998, at [10:00 A.M., LOCAL TIME, AT THE UNION
LEAGUE, 140 SOUTH BROAD STREET, PHILADELPHIA, PENNSYLVANIA 19102].
At the Stockholders' Meeting, stockholders will vote upon a proposal related
to the transactions contemplated by a Stock Purchase Agreement between
National Media and an investor group led by Stephen C. Lehman pursuant to
which the investor group will purchase $20,000,000 to $22,000,000 of newly-
issued shares of National Media's Series E Convertible Preferred Stock from
the Company. Simultaneously with the execution of the Stock Purchase
Agreement, the investor group consummated the purchase of $10,000,000 of
National Media's Series D Convertible Preferred Stock from the original
holders thereof. At the Stockholders' Meeting, you will also be asked to
consider and vote upon the election of nine members of the Board of Directors,
certain of whom have agreed to resign in the event of consummation of the
transactions contemplated by the Stock Purchase Agreement in order to create
sufficient vacancies on the Board of Directors for the appointment of three
additional Directors by the investor group. You will also be asked to consider
and approve an amendment to the Company's 1991 Stock Option Plan increasing
the number of shares of Common Stock available for awards thereunder by
800,000 shares. Last, you will be asked to consider and approve Ernst & Young
LLP as National Media's independent certified public accountants for the
fiscal year ending March 31, 1999. Our Annual Report on Form 10-K to
Stockholders for the fiscal year ended March 31, 1998 accompanies this Proxy
Statement.
We look forward to seeing you at the Stockholders' Meeting and we strongly
urge your favorable vote on the transactions contemplated by the Stock
Purchase Agreement and the other proposals in the Proxy Statement. Whether or
not you are planning to attend, we urge you to return the enclosed proxy at
your earliest convenience.
Sincerely,
Frederick S. Hammer
Chairman of the Board of Directors
<PAGE>
NATIONAL MEDIA CORPORATION
ELEVEN PENN CENTER
SUITE 1100
1835 MARKET STREET
PHILADELPHIA, PA 19103
----------------
NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
TO BE HELD ON OCTOBER , 1998
To the Stockholders of National Media Corporation ("National Media" or the
"Company"):
A special meeting of stockholders (the "Stockholders' Meeting") of National
Media will be held on October , 1998, at [10:00 a.m., at The Union League,
140 South Broad Street, Philadelphia, Pennsylvania 19102], for the following
purposes:
. To consider and vote upon a proposal to approve the consummation of the
transactions (the "Transactions") contemplated by that certain stock
purchase agreement (the "Stock Purchase Agreement"), dated as of August
11, 1998, by and between National Media and NM Acquisition Co., LLC
("ACO"), including among other things, (i) the issuance of a minimum of
20,000 and, at the option of the Company, a maximum of 22,000 shares of
the Company's Series E Convertible Preferred Stock; (ii) the amendment
of National Media's Certificate of Incorporation increasing the
authorized number of shares of common stock of the Company ("Common
Stock") to 150,000,000 shares; (iii) an agreement with ValueVision
International, Inc. ("ValueVision") amending, among other things,
certain terms of a $10,000,000 promissory note payable to ValueVision
and certain warrants of the Company held by ValueVision; and (iv) the
grant to Temporary Media Co., LLC ("TMC"), an affiliate of ACO, of
options to purchase up to 212,500 shares of Common Stock and warrants to
purchase up to 3,762,500 shares of Common Stock, 2,612,500 of which may
be exercised by TMC or its affiliates.
. To consider and vote upon the election of nine members of the Board of
Directors, certain of whom have agreed to resign upon consummation of
the Transactions contemplated by the Stock Purchase Agreement, if the
proposal regarding the Transactions is approved at the Stockholders'
Meeting, in order to create sufficient vacancies on the Board of
Directors for the appointment of three ACO nominees by the Company's
Board of Directors;
. To consider and vote upon a proposal to amend the Company's 1991 Stock
Option Plan to increase the number of shares of Common Stock available
for awards thereunder by 800,000 shares;
. To consider and vote upon a proposal to ratify the appointment of Ernst
& Young LLP as the Company's independent certified public accountants
for the fiscal year ending March 31, 1999; and
. To transact such other business as may properly come before the
Stockholders' Meeting and any or all adjournments or postponements
thereof.
THE NATIONAL MEDIA BOARD OF DIRECTORS HAS APPROVED THE TRANSACTIONS AND
RECOMMENDS THAT STOCKHOLDERS VOTE FOR APPROVAL AND ADOPTION OF THE
TRANSACTIONS. THE NATIONAL MEDIA BOARD OF DIRECTORS ALSO RECOMMENDS THAT
STOCKHOLDERS VOTE FOR THE DIRECTORS NOMINATED HEREIN, FOR APPROVAL OF THE
AMENDMENT TO THE COMPANY'S 1991 STOCK OPTION PLAN, AND FOR RATIFICATION OF
ERNST & YOUNG LLP AS NATIONAL MEDIA'S INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS
FOR THE FISCAL YEAR ENDING MARCH 31, 1999.
The Stock Purchase Agreement and other important matters are explained in
the accompanying Proxy Statement, which you are urged to read carefully. A
copy of the Stock Purchase Agreement is attached as Annex A to the Proxy
Statement and copies of additional agreements and instruments related to the
Stock Purchase Agreement have been filed as exhibits to the Company's Current
Report on Form 8-K dated August 13, 1998 and are incorporated by reference in
the Proxy Statement. In addition, a copy of the Fairness Opinion of Janney
<PAGE>
Montgomery Scott Inc. dated August 28, 1998 is attached as Annex B to the
Proxy Statement and a copy of the Company's 1991 Stock Option Plan is attached
as Annex C to the Proxy Statement.
The National Media Board of Directors has fixed the close of business on
September 18, 1998 as the record date for determining the stockholders
entitled to receive notice of and to vote at the Stockholders' Meeting and at
any and all adjournments or postponements thereof.
Management welcomes your attendance at the Stockholders' Meeting. Whether or
not you expect to attend the Stockholders' Meeting in person, you are
requested to complete, sign, date and promptly return the enclosed proxy in
the accompanying postage-paid envelope. The prompt return of your proxy will
save expenses involved in further communication. Your proxy will not affect
your right to vote in person if you attend the Stockholders' Meeting. FAILURE
TO RETURN A PROPERLY EXECUTED PROXY CARD OR FAILURE TO VOTE IN PERSON AT THE
STOCKHOLDERS' MEETING WILL HAVE THE SAME EFFECT AS A VOTE AGAINST THE
TRANSACTIONS AND THE OTHER PROPOSALS SET FORTH IN THE PROXY STATEMENT.
Brian J. Sisko
Senior Vice President,
General Counsel and Secretary
Philadelphia, Pennsylvania
September , 1998
YOUR VOTE IS IMPORTANT.
TO VOTE YOUR SHARES, PLEASE SIGN, DATE AND COMPLETE THE ENCLOSED PROXY
AND MAIL IT PROMPTLY IN THE ENCLOSED, POSTAGE PAID RETURN ENVELOPE.
<PAGE>
TABLE OF CONTENTS
<TABLE>
<S> <C>
VOTING AT THE SPECIAL MEETING; REVOCATION OF PROXIES....................... 1
INCORPORATION BY REFERENCE................................................. 2
ADDITIONAL INFORMATION..................................................... 3
SOLICITATION OF PROXIES.................................................... 3
PROPOSAL I
APPROVAL OF THE TRANSACTIONS............................................. 4
PROPOSAL II
ELECTION OF DIRECTORS.................................................... 24
Meetings of the Board of Directors and its Committees.................... 27
PROPOSAL III
APPROVAL OF AMENDMENT TO THE COMPANY'S 1991 STOCK OPTION PLAN............ 30
PROPOSAL IV
RATIFICATION OF APPOINTMENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS.. 33
SECURITY OWNERSHIP OF MANAGEMENT........................................... 34
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS............................ 36
EXECUTIVE COMPENSATION..................................................... 38
Summary Compensation Table............................................... 38
Employment Contracts, Termination of Employment and Change-in-Control
Arrangements............................................................ 40
Stock Options Granted During Fiscal 1998................................. 43
Aggregated Option Exercises in Last Fiscal Year and Fiscal Year End
Option Values........................................................... 44
10-Year Option Repricings................................................ 44
Compensation of Directors................................................ 45
Options.................................................................. 45
COMPENSATION COMMITTEE REPORT.............................................. 46
COMPARATIVE STOCK PERFORMANCE GRAPH........................................ 49
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS....................... 50
OTHER STOCKHOLDER MATTERS.................................................. 51
Stockholder Proposals and Nominations of Directors for the Company's Next
Annual Meeting of Stockholders.......................................... 51
Other Business........................................................... 52
Section 16(a) Beneficial Ownership Reporting Compliance.................. 52
Independent Certified Public Accountants................................. 52
Annual Report to Stockholders............................................ 52
Annex A: Stock Purchase Agreement.......................................... A-1
Annex B: Fairness Opinion of Janney Montgomery Scott Inc................... B-1
Annex C: 1991 Stock Option Plan............................................ C-1
</TABLE>
<PAGE>
NATIONAL MEDIA CORPORATION
ELEVEN PENN CENTER
SUITE 1100
1835 MARKET STREET
PHILADELPHIA, PENNSYLVANIA 19103
----------------
PROXY STATEMENT
----------------
The enclosed proxy is solicited by the Board of Directors of National Media
Corporation ("National Media" or the "Company"), a Delaware corporation, for
use at the special meeting of stockholders of the Company (the "Stockholders'
Meeting") to be held on , October , 1998, at [THE UNION LEAGUE, 140 SOUTH
BROAD STREET, PHILADELPHIA, PENNSYLVANIA 19102, AT 10:00 A.M., LOCAL TIME,] or
any adjournments or postponements thereof. This Proxy Statement and
accompanying proxy are first being mailed to the Company's stockholders on or
about September , 1998.
VOTING AT THE SPECIAL MEETING; REVOCATION OF PROXIES
The Company's Board of Directors has fixed the close of business on
September 18, 1998 as the record date (the "Record Date") for determining the
stockholders entitled to notice of and to vote at the Stockholders' Meeting.
As of the Record Date there were [25,453,752] shares of common stock, par
value $.01 per share ("Common Stock") issued and outstanding, each of which is
entitled to one vote as to all matters to be acted upon at the Stockholders'
Meeting; and 81,250 shares of its Series B Convertible Preferred Stock, par
value $.01 per share (the "Series B Preferred Stock") issued and outstanding,
each of which is entitled to ten votes per share as to all matters to be voted
upon at the Stockholders' Meeting, except the election of the nine Directors,
as to which the holders of the Series B Preferred Stock shall have no voting
rights. The presence, in person or by properly executed proxy, of the holders
of a majority of the Common Stock and the Series B Preferred Stock entitled to
vote at the Stockholders' Meeting is necessary to constitute a quorum at the
Stockholders' Meeting. Only stockholders of record at the close of business on
the Record Date will be entitled to vote at the Stockholders' Meeting or any
adjournments or postponements thereof.
Shares of Common Stock and Series B Preferred Stock represented at the
Stockholders' Meeting in person or by proxy will be counted for the purposes
of determining whether a quorum is present at the Stockholders' Meeting.
Shares which abstain from voting as to a particular matter will be treated as
shares that are present and entitled to vote at the Stockholders' Meeting for
purposes of determining whether a quorum exists, but will not be counted as
votes cast on such matter. If a broker or nominee holding stock in "street
name" indicates on a proxy that it does not have discretionary authority to
vote as to a particular matter ("broker non-votes"), those shares will be
treated as present and entitled to vote at the Stockholders' Meeting for
purposes of determining whether a quorum exists, but will not be counted as
votes cast on such matter. Further, abstentions (but not broker non-votes)
will have the same effect as votes against approval of the Stock Purchase
Agreement and the other proposals set forth in this Proxy Statement.
Except with respect to the election of Directors, on all matters presented
to the Company's stockholders for a vote at the Stockholders' Meeting, the
Common Stock and the Series B Preferred Stock will vote as a single class. The
holders of Common Stock do not have cumulative voting rights in connection
with the election of Directors. All shares of Common Stock and Series B
Preferred Stock which are entitled to vote and are represented at the
Stockholders' Meeting by properly executed proxies received prior to or at the
Stockholders' Meeting, and not revoked, will be voted at the Stockholders'
Meeting in accordance with the instructions indicated on such proxies. If no
instructions are indicated (other than in the case of broker non-votes), such
proxies will be voted for approval and adoption of the proposals set forth in
this Proxy Statement.
1
<PAGE>
Paragraph 312.03(c) of the New York Stock Exchange Listed Company Manual
requires stockholder approval as a condition to list shares of Common Stock
for trading on the New York Stock Exchange (the "NYSE") in connection with the
issuance by the Company of securities convertible into or exercisable for
shares of Common Stock if the number of shares of Common Stock to be issued
has, or will have upon issuance, voting power greater than or equal to 20% of
the total voting power of the shares of Common Stock outstanding before the
issuance of such stock or other securities. As of September 18, 1998, the
Company has [25,453,752] shares of Common Stock outstanding. The Company is
required to obtain stockholder approval regarding the issuance of securities
convertible and/or exercisable into shares of Common Stock in excess of the
20% limitation on account of the Transactions. In the event that stockholders
do not approve Proposal I, the Company will not be able to consummate the
Transactions without violating the rules of the NYSE.
Each member of the Board of Directors as of the date immediately prior to
the execution of the Stock Purchase Agreement entered into a Stockholders
Voting Agreement pursuant to which such Directors agreed to vote their shares
of Common Stock in favor of the Transactions. Parties to the Stockholders
Voting Agreement, other than ACO, will represent approximately 2.5% of the
shares of Common Stock eligible to vote on Proposal I at the Stockholders'
Meeting. As of the Record Date, ACO was the record holder of % of the shares
of Common Stock eligible to vote on Proposal I at the Stockholders' Meeting.
The Board of Directors does not intend to bring any matter before the
Stockholders' Meeting other than the matters specifically referred to in the
notice of the Stockholders' Meeting, nor does the Board of Directors know of
any other matter which anyone else proposes to present for action at the
Stockholders' Meeting. However, if any other matter is properly brought before
the Stockholders' Meeting, the persons named in the accompanying proxy or
their duly constituted substitutes acting at the Stockholders' Meeting will be
deemed authorized to vote or otherwise act thereon in accordance with their
judgment on such matter. Proxies indicating a vote against the proposals
contained herein may not be voted by the persons marked in the accompanying
proxy or their duly constituted substitutes for adjournment of the
Stockholders' Meeting for the purpose of giving management additional time to
solicit votes to approve such proposals.
Any proxy given pursuant to this solicitation may be revoked by the person
giving it at any time before it is voted. Proxies may be revoked by (i) filing
with the Secretary of the Company, at or before the taking of a vote at the
Stockholders' Meeting, a written notice of revocation bearing a later date
than the proxy, (ii) duly executing a later dated proxy relating to the same
shares and delivering it to the Secretary of the Company before the taking of
a vote at the Stockholders' Meeting or (iii) attending the Stockholders'
Meeting and voting in person (although attendance at the Stockholders' Meeting
will not in and of itself constitute a revocation of a proxy). Any written
notice of revocation or subsequent proxy should be sent to National Media
Corporation, Eleven Penn Center, Suite 1100, 1835 Market Street, Philadelphia,
Pennsylvania 19103, Attention: Secretary, or hand delivered to the Secretary
of National Media at or before the taking of the vote at the Stockholders'
Meeting.
Enclosed herewith are WHITE proxy card(s) for use by holders of the
Company's Common Stock and/or WHITE proxy card(s) with a BLUE STRIPE for use
by the holders of the Series B Preferred Stock. Properly executed proxies will
be voted in accordance with the instructions therein. In the absence of
instruction, the shares of Common Stock represented at the Stockholders'
Meeting by the enclosed proxy will be voted FOR each of the proposals set
forth herein.
INCORPORATION BY REFERENCE
The Company's Annual Report, the Company's Quarterly Report on Form 10-Q for
the quarter ended June 30, 1998 (the "June 30, 1998 10-Q") and the Company's
Current Report on Form 8-K dated August 13, 1998 (the "Transactions Form 8-K")
are hereby incorporated by reference into this Proxy Statement.
2
<PAGE>
ADDITIONAL INFORMATION
A copy of the Company's Annual Report on Form 10-K for the fiscal year ended
March 31, 1998 accompanies this Proxy Statement and the Company will furnish
without charge to any stockholder, upon written or oral request, any other
documents filed by the Company pursuant to the Securities Exchange Act of 1934
(the "Exchange Act"). Requests for such documents should be addressed to John
J. Sullivan, Senior Vice President and Chief Financial Officer of National
Media Corporation, Eleven Penn Center, Suite 1100, 1835 Market Street,
Philadelphia, Pennsylvania 19103, telephone number (215) 988-4600. Documents
filed by the Company pursuant to the Exchange Act may be reviewed and/or
obtained through the Securities and Exchange Commission's (the "SEC")
Electronic Data Gathering Analysis and Retrieval System, which is publicly
available through the SEC's web site (http://www.sec.gov).
SOLICITATION OF PROXIES
All expenses of the Company's solicitation of proxies for the Stockholders'
Meeting will be borne by the Company. In addition to solicitation by use of
the mails, proxies may be solicited from National Media stockholders by
directors, officers and employees of National Media in person or by telephone,
telegram or other means of communication. Such directors, officers and
employees will not be additionally compensated, but may be reimbursed for
reasonable out-of-pocket expenses in connection with such solicitation. The
Company reserves the right to retain a proxy solicitation firm for assistance
in connection with the solicitation of proxies for the Stockholders' Meeting,
should the Board of Directors deem such action prudent. Arrangements will also
be made with brokerage houses, custodians, nominees and fiduciaries for
forwarding of proxy solicitation materials to beneficial owners of shares held
of record by such brokerage houses, custodians, nominees and fiduciaries, and
the Company will reimburse such brokerage houses, custodians, nominees and
fiduciaries for their reasonable expenses incurred in connection therewith.
3
<PAGE>
PROPOSAL I
APPROVAL OF THE TRANSACTIONS
This section of the Proxy Statement describes certain aspects of the Stock
Purchase Agreement and other agreements entered into in connection therewith
and the transactions contemplated thereby (the "Transactions"). The following
description does not purport to be complete and is qualified in its entirety
by reference to the Stock Purchase Agreement which is attached as Annex A to
this Proxy Statement and to the exhibits thereto, each of which is attached as
an exhibit to the Company's Current Report on Form 8-K, dated August 13, 1998.
ALL STOCKHOLDERS ARE URGED TO READ THE STOCK PURCHASE AGREEMENT IN ITS
ENTIRETY.
OVERVIEW
On August 11, 1998, National Media Corporation ("National Media" or the
"Company") executed definitive agreements with NM Acquisition Co., LLC
("ACO"), a new Delaware limited liability company formed for the purpose of
the transactions described herein, and certain other persons, relating to a
transaction pursuant to which an investor group (the "Investor Group") acting
through ACO agreed to acquire a substantial equity interest in and operational
control of the Company through the purchase (the "Series D Purchase") from the
original holders thereof (the "Series D Holders") of $10,000,000 of the
Company's Series D Convertible Preferred Stock, par value of $.01 per share
(the "Series D Preferred Stock") and 992,942 warrants issued in connection
therewith, and the purchase from the Company of a minimum $20,000,000 and a
maximum of $22,000,000 of the Company's newly-created Series E Convertible
Preferred Stock, par value $.01 per share (the "Series E Preferred Stock")
(together with the other transactions contemplated thereby, other than the
Series D Purchase, the "Transactions").
At the time of the execution of the definitive agreements regarding the
Transactions, the Investor Group consummated the Series D Purchase, consisting
of the acquisition of 10,000 shares of the Company's outstanding Series D
Preferred Stock, along with warrants to purchase 992,942 shares of Common
Stock which had previously been issued to the Series D Holders (the "Series D
Warrants," and together with the Series D Preferred Stock, the "Series D
Securities"), for an aggregate of $10,000,000. Upon consummation of the Series
D Purchase, the Investor Group, the Series D Holders and the Company
eliminated the floating conversion price feature of the Series D Preferred
Stock, fixing the conversion price at $1.073125 per share of Common Stock, and
agreed to certain limitations regarding sales of the Series D Securities and
the Common Stock issuable upon conversion and/or exercise of the Series D
Securities. In the event the Transactions are not consummated, or upon the
occurrence of certain events, including a subsequent "change in control" of
the Company, the agreements related to the elimination of the floating
conversion price feature of the Series D Preferred Stock, the sales
limitations with respect to the Series D Securities and the Common Stock
issuable upon conversion and/or exercise of the Series D Securities and
certain other covenants with respect to sales of the Series D Securities and
the Common Stock issuable upon conversion and/or exercise of the Series D
Securities will terminate. See "Description of Related Agreements and
Transactions--The Series D Agreement."
In addition to the Series D Purchase, ACO entered into a stock purchase
agreement (the "Stock Purchase Agreement") with the Company pursuant to which
the Investor Group agreed to invest a minimum of $20,000,000 and a maximum of
$22,000,000 directly into the Company in exchange for shares of the Company's
newly-created Series E Preferred Stock. The Series E Preferred Stock will be
convertible into shares of Common Stock at a fixed conversion price of $1.50
per share (subject to adjustment for certain anti-dilution events).
Upon execution of the definitive agreements regarding the Transactions,
Stephen C. Lehman was named Acting Chief Executive Officer of the Company. Mr.
Lehman, Eric R. Weiss and Andrew M. Schuon were also named to the Company's
Board of Directors as designees of ACO. The Company also entered into a
consulting agreement (the "Consulting Agreement") with Temporary Media Co.,
LLC ("TMC"), a newly-formed Delaware limited liability company controlled by
Mr. Lehman, Mr. Weiss and Daniel M. Yukelson, pursuant to
4
<PAGE>
which TMC is presently providing executive management consulting services to
the Company pending consummation of the Transactions. In connection with the
Consulting Agreement, the Company granted to TMC (i) a five-year option (the
"TMC Options") to purchase up to 212,500 shares of Common Stock, subject to
certain vesting requirements, at an exercise price of $1.32 per share and (ii)
contingent warrants (the "TMC Warrants"), which will only become effective
following consummation of the Transactions, to purchase up to 3,762,500 shares
of Common Stock, at exercise prices ranging from $1.32 per share to $3.00 per
share. See "The TMC Options and TMC Warrants." In the event that the Company's
stockholders do not approve the Transactions, all TMC Warrants and all non-
vested TMC Options will be canceled. Additionally, if TMC materially breaches
its duties and obligations under the Consulting Agreement and such breach
remains uncured for 30 days, all TMC Warrants and all non-vested TMC Options
will be cancelled. 1,000,000 of the TMC Warrants may not be exercised by TMC
or any employee of TMC and may only be transferred to any officer, Director,
employee or consultant of the Company other than Messrs. Lehman, Weiss,
Yukelson or any employee of TMC. TMC expects to use such 1,000,000 TMC
Warrants to retain and attract highly qualified executive personnel and other
persons associated with the Company's programming to the Company and that such
1,000,000 TMC Warrants will have additional terms which provide for the
vesting of the TMC Warrants over a three to five year period.
As a result of negotiations initiated by the Company and ACO, the Company
also executed agreements with First Union National Bank ("First Union") and
ValueVision International, Inc. ("ValueVision") providing for modifications to
the Company's two primary credit facilities. First Union agreed to waive all
outstanding financial covenant violations and to modify certain financial
covenants pending consummation of the Transactions in consideration of the
receipt of a $190,000 fee. First Union also agreed to accept payment of 75% of
all outstanding principal obligations in full satisfaction of the Company's
indebtedness, provided such payment is made to First Union by November 15,
1998 and all other outstanding fees and accrued interest are paid in full.
As a result of negotiations initiated by the Company and ACO, ValueVision
has agreed to waive its right to accelerate repayment of its $10,000,000
demand note (the "ValueVision Note") pending Closing of the Transactions,
other than in the event of an acceleration of the First Union facility or any
failure by the Company to make any required interest payment to ValueVision.
ValueVision also agreed to certain standstill provisions and certain
limitations regarding the Company's payment of the ValueVision Note prior to
January 1, 1999. In consideration thereof, the Company agreed to re-price
500,000 warrants held by ValueVision to $2.74 per share. The Company retained
its right to repay the ValueVision Note upon maturity in cash or shares of
Common Stock (valued at $1.073125 per share), at the Company's option.
ACO has advised the Company that, following the consummation of the
Transactions, ACO will distribute its interests in the Company to the members
of ACO.
BACKGROUND OF THE TRANSACTIONS
During the past fiscal year, the Company has engaged in discussions with a
number of third parties regarding the possibility of entering into investment
and/or strategic transactions. The Company, having experienced severe cash
flow and liquidity problems, has sought to find a strategic partner with the
financial strength to support the cyclical nature of the Company's business
and which could provide the Company with more cost effective operational and
fulfillment capabilities or investors who would provide the necessary funds to
pay down the Company's existing long-term debt and who would help to attract
or provide executive management personnel for the Company's future capable of
maximizing the Company's future growth opportunities.
The Company incurred a pre-tax loss for the fiscal year ended March 31, 1997
of approximately $45,000,000. The Company was also in technical default of its
bank loan. In connection with the audit of the
5
<PAGE>
Company's fiscal 1997 annual financial statements, the Company's auditors
issued an opinion questioning the Company's ability to continue as a "going
concern."
In August 1997, the Company announced the execution of an agreement pursuant
to which it would receive $20,000,000 in equity financing from the Series D
Holders. That transaction was consummated in September 1997. At the same time,
the Company's principal credit facility was extended through December 31,
1998.
Throughout the Summer and Fall of 1997, the Company made and received
inquiries regarding potential strategic and investment transactions, including
business combinations, and asset-based financing transactions with third
parties. Discussions were held with a number of third parties, including
ValueVision. None of such discussions resulted in any strategic or financing
transactions being agreed upon except as discussed in this Proxy Statement.
On August 18, 1997, the Company and ValueVision entered into a
confidentiality agreement in order to exchange certain financial and other
information. After extensive due diligence, and lengthy negotiations, in
January 1998, the Company and ValueVision executed a merger agreement which
was subject to the approval of the shareholders of both the Company and
ValueVision. Subsequent to the execution of the ValueVision merger agreement,
the companies began a joint search for a new chief executive officer to manage
the combined company. One of the persons who indicated an interest in such a
position was Stephen C. Lehman, who, at the time, was President, Chief
Executive Officer and Chairman of the Board of Premiere Radio Networks, Inc.
During the proxy solicitation process leading up to the shareholder meetings
to be held to approve the proposed ValueVision merger, ValueVision was
notified by its largest shareholder that such shareholder intended to exercise
its right under Minnesota law to dissent from the intended merger and seek an
appraisal of its holdings. Based on the receipt of the dissenters' rights
notice, the exercise of which would have violated a condition to closing under
the ValueVision merger agreement, the companies agreed to postpone the
upcoming shareholders' meetings to approve the proposed merger and attempted
to renegotiate the terms of the proposed merger. During such period, the
Company received several inquiries from third parties regarding the Company
and certain confidentiality agreements were executed to facilitate the flow of
due diligence information to such third parties. One of the parties executing
a confidentiality agreement was an entity affiliated with Messrs. Lehman,
Weiss and Yukelson. The Company and ValueVision were unable to reach terms
upon which the ValueVision merger agreement would be amended and the Company's
discussions with ValueVision terminated. The Board of Directors considered all
inquiries from third parties, none of which led to a bona fide offer being
made to the Company.
Following the termination of the ValueVision merger agreement, Mr. Lehman
expressed his interest in making an investment in the Company and becoming the
Chief Executive Officer of the Company. The discussions which ensued resulted
in Mr. Lehman retaining BT Alex. Brown Inc. to assist with assembling an
investor group and making a proposal to the Company. On June 23, 1998, Messrs.
Lehman, Weiss and Yukelson, along with representatives from BT Alex. Brown
Inc., made a presentation to the Company's Board of Directors concerning their
interest in the Company. Following such meeting, Messrs. Lehman, Weiss and
Yukelson, at the suggestion of the Company, met with representatives of the
Series D Holders, First Union and ValueVision to address complexities arising
due to the nature of such entities' interests in the Company.
In early July 1998, the Company announced that it had incurred a loss for
the fiscal year ended March 31, 1998 of approximately $56,700,000, that it was
in technical default of its bank loan and that the Company's auditors had
issued an opinion questioning the Company's ability to continue as a going
concern in connection with the audit of the Company's fiscal 1998 annual
financial statements.
Following discussions with the Series D Holders, First Union and ValueVision
and negotiation between the Company and ACO, a letter of intent was executed
between the Company and ACO on July 10, 1998. The letter of intent was entered
into on July 10, 1998 and was amended on July 15, 1998. The effectiveness of
the letter of
6
<PAGE>
intent was conditioned upon the execution of agreements with First Union, the
Series D Holders and ValueVision, each of which was executed on July 15, 1998.
During the weeks following the execution of the letter of intent, ACO and
its representatives conducted a further due diligence review of the Company.
On August 11, 1998 the Company's Board of Directors met and approved the Stock
Purchase Agreement and such agreement was executed late that evening.
INFORMATION REGARDING THE INVESTOR GROUP
The Investor Group is led by Stephen C. Lehman, former President, Chief
Executive Officer and Chairman of the Board of Premiere Radio Networks, Inc.,
a subsidiary of Jacor Communications, Inc. Other members of the Investor Group
include Jacor Communications, Inc., Gruber/McBain Management, Mark Cuban and
Todd Wagner, Chief Executive Officer and President, respectively, of
Broadcast.com, David E. Salzman, Executive Producer of "Mad TV," and Andrew M.
Schuon, Executive Vice President and General Manager of Warner Bros. Records.
ACO, the limited liability company through which the Investor Group has
entered into the Stock Purchase Agreement, was formed for the purposes of the
Transactions. Messrs. Yukelson and Schuon and entities controlled by Messrs.
Lehman and Weiss are members of ACO, and own beneficial interests in ACO of
1.28%, less than 1%, 12.81% and 4.34%, respectively. John W. Kirby, President
and a Director of the Company, and Bruce M. Goodman, a Senior Vice President
of the Company, are also members of the Investor Group and have invested
$300,000 and $150,000 in and have 1.20% and .53% membership interests of ACO,
respectively. See "Interests of Certain Persons in the Transactions." TMC was
formed for the purposes of the Consulting Agreement. TMC is the Manager of
ACO. Mr. Lehman, Mr. Weiss (through an entity controlled by Mr. Weiss) and Mr.
Yukelson are the managing members of TMC, and own beneficial interests of
43.36%, 35.66% and 20.98%, respectively, of TMC. For further information about
the members of the Investor Group who have agreed to serve on the Company's
Board of Directors, see "Proposal II, Election of Directors."
REASONS FOR THE TRANSACTIONS
The Board of Directors of the Company (the "Board of Directors"), by
unanimous vote of those Directors present, with the exception of John W.
Kirby, who abstained from the discussion and vote regarding the Transactions
due to Mr. Kirby's minority interest in ACO, has approved the Transactions and
believes that the Transactions are in the best interest of the Company and its
stockholders. In reaching its decision to approve the terms of the
Transactions, the Board of Directors considered, among other matters, the
following factors:
(a) The Board of Directors believes that the Company's severe cash needs
have required management, since the beginning of the 1997 calendar year, to
focus nearly exclusively on short-term financial strategies because of its
tight cash position. The Transactions should provide the Company with
improved financial strength and stability. The Transactions will result in
the Company's principal debt facility being replaced with equity capital.
As a result of the Transactions, the Company should have the ability to
address longer-term opportunities as follows:
(i) Flexibility to negotiate and secure longer-term credit facilities
with improved terms and conditions.
(ii) Additional management skills contributed by Messrs. Lehman,
Weiss and Yukelson and other affiliates of the Investor Group who are
expected to focus on stabilization and expansion of the Company's
businesses.
(iii) Stability to address opportunities to improve operations, such
as exploiting alternate sales media for the Company's products,
reducing overhead cost structures, developing enhanced delivery
systems, and updating information technology capabilities.
(iv) Target capital resources and management time to market share
growth in the United States and internationally, and strategic
integration of its United States and international operations with
expanded business development efforts.
7
<PAGE>
(v) Greater access to capital and management resources in
implementing long-term growth initiatives, including technology and
training, and expansion of the Company's business lines, including
sales through new media such as the Internet.
(b) Due to the Company's recent financial performance and its financial
condition, without a capital infusion of the magnitude which will occur as
part of the Transactions, the Company did not believe that it would be able
to repay its First Union debt facilities and/or the ValueVision debt
facility when due (or upon default). The Transactions will result in the
full satisfaction of the First Union facilities and should provide a basis
for the Company to make arrangements to repay ValueVision on or before
maturity.
(c) The Board of Directors believes that there are material potential
advantages to the Company and its stockholders from the Company's
association with the Investor Group. The Board of Directors believes that
the Company will benefit from direct association with members of the
Investor Group, particularly with respect to the expertise and contacts of
the Investor Group's affiliates in industries related to Internet
marketing, television and radio. It will be in the interests of the
Investor Group, as the Company's largest stockholder, to make available to
the Company the resources and expertise of the Investor Group personnel.
(d) The Company's financial advisor, Janney Montgomery Scott Inc., has
given its opinion to the effect that, as of the date of such opinion, and
based on and subject to the assumptions, limitations and qualifications set
forth in such opinion, the aggregate consideration to be received by the
Company in connection with the Transactions is fair to the holders of
Common Stock from a financial point of view. See "Opinion of Financial
Advisor" attached hereto as Annex B.
(e) Based upon the Company's lengthy exploration of strategic and
recapitalization alternatives, the Board of Directors believes that there
is no alternative equity infusion transaction available to it which would
be more advantageous to stockholders than the proposed Transactions.
(f) The Transactions are structured to provide that stockholders of the
Company will generally benefit as the Investor Group benefits from the
Transactions.
(g) Three of the principals of the Investor Group have begun providing
services to the Company pursuant to the Consulting Agreement. This has
allowed the Investor Group to begin to implement plans to restore the
Company to profitability.
(h) The new Directors appointed in connection with the Transactions have
strong and successful backgrounds in business and as investors. With the
representatives of the Investor Group, it is expected that such persons
will provide strong and cohesive leadership for the Company.
(i) Unsatisfactory results of operations of the Company have created a
need for positive changes in the Company's management and governance, which
will be facilitated by the Transactions.
(j) The Board of Directors considered its knowledge of the management,
business operations, properties, assets, financial condition, operating
results and prospects of the Company, including the Company's liquidity
issues and its long-term strategic plan and believes that the Company will
benefit from the Transactions.
(k) The Board of Directors considered the financial and strategic
benefits which would be derived from the Transactions by the Company,
including the substantial increase in the Company's available cash to
immediately address the Company's debt obligations and believes that the
Company will benefit from the Transactions.
(l) The Board of Directors considered the various reports from the
Company's management and financial and legal advisors and believes that the
Company will benefit from the Transactions.
(m) The Board of Directors considered the level of interest of parties
expressing an interest in receiving further information regarding the
Company (including the Investor Group) and the results of discussions with
such parties. The Board of Directors concluded that the terms of the
Investor Group's proposal were more favorable than those of the alternative
courses of action available to the Company. The Board of Directors also
considered the fact that the Investor Group's proposal was a fully
developed,
8
<PAGE>
definitive proposal which was not subject to any unusual conditions. In
particular, the Board of Directors took note of the absence of any
financing contingencies.
(n) Additionally, the Board of Directors considered the fact that all of
the Company's existing stockholders would retain their entire equity
interest in the Company and that although their interest would be diluted,
all of the Company's existing common stockholders would be able to
participate in any future improvement in the Company's operating
performance that might occur following the consummation of the
Transactions.
(o) The Board of Directors considered the benefits to the Company that
would be derived from having representatives of the Investor Group control
the Board of Directors and assist the Board of Directors in planning the
Company's strategic course and making other important decisions facing the
Board of Directors.
(p) The Board of Directors considered the implications of having a
stockholder group own approximately 52% of the Company's outstanding Common
Stock (on a fully-diluted basis but without giving effect to conversions
and/or exercises of securities held by persons other than ACO or TMC) and
the conflicts of interest that might arise and the potential deterrent
effect on other transactions that might result from such share holding.
(q) The Board of Directors considered that certain persons affiliated
with the Company would have interests in the Transactions which were in
addition to those of holders of Common Stock generally. See "Interests of
Certain Persons in the Transactions."
(r) The Board of Directors considered the purchase price for the Series E
Preferred Stock, the number of TMC Options and TMC Warrants granted,
including the exercise prices and vesting schedules thereof, to be issued
to the Investor Group, and the relationship of such prices to the current
and historical market prices of the Common Stock and the prices of the
Common Stock at the time the Company entered into the letter of intent with
the Investor Group establishing the basic economic terms of the
Transactions.
(s) The Board of Directors took into account that the Company's
stockholders will have the opportunity to review and approve the
Transactions and that such stockholder approval is a condition to the
consummation of the Transactions.
Based upon all of the factors mentioned above, and the Board of Directors'
evaluation of the Company's prospects as an ongoing business without the
Transactions, the Board of Directors concluded that the prospects for
enhancing stockholder value will be materially increased by the Transactions.
In view of the variety of factors considered by the Board of Directors in
connection with this evaluation of the Transactions, the Board of Directors
did not assign relative weights to the individual factors considered in
reaching its determination and recommendations set forth herein.
OPINION OF FINANCIAL ADVISOR
The Board of Directors retained Janney Montgomery Scott Inc. ("Janney
Montgomery") as its financial advisor to review the Transactions and to render
an opinion as to the fairness, from a financial point of view, of the
Transactions to the holders of the Common Stock. As described herein, Janney
Montgomery's opinion, dated August 28, 1998, together with the related
presentation to the Board of Directors, was only one of many factors taken
into consideration by the Board of Directors in making its determination to
approve the Transactions.
On August 28, 1998, Janney Montgomery delivered its opinion to the Board of
Directors to the effect that, as of such date, and based upon and subject to
certain matters stated therein, the Transactions were fair, from a financial
point of view, to the holders of the Common Stock.
THE FULL TEXT OF JANNEY MONTGOMERY'S WRITTEN OPINION, DATED AUGUST 28, 1998,
WHICH SETS FORTH THE ASSUMPTIONS MADE, MATTERS CONSIDERED AND LIMITATIONS ON
REVIEW UNDERTAKEN, IS ATTACHED TO THIS PROXY STATEMENT AS ANNEX B AND IS
INCORPORATED HEREIN BY REFERENCE. JANNEY MONTGOMERY'S OPINION IS DIRECTED TO
9
<PAGE>
THE BOARD OF DIRECTORS OF THE COMPANY AND ADDRESSES THE FAIRNESS OF THE
TRANSACTIONS TO THE HOLDERS OF THE COMMON STOCK OF THE COMPANY FROM A
FINANCIAL POINT OF VIEW. JANNEY MONTGOMERY'S OPINION DOES NOT ADDRESS THE
UNDERLYING DECISION OF THE COMPANY TO ENGAGE IN THE TRANSACTIONS AND DOES NOT
CONSTITUTE A RECOMMENDATION TO ANY STOCKHOLDER AS TO HOW SUCH STOCKHOLDER
SHOULD VOTE OR AS TO ANY OTHER ACTION SUCH STOCKHOLDER SHOULD TAKE IN
CONNECTION WITH THE TRANSACTIONS. THE SUMMARY OF THE OPINION OF JANNEY
MONTGOMERY SET FORTH IN THIS PROXY STATEMENT IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO THE FULL TEXT OF SUCH OPINION.
In connection with its opinion, Janney Montgomery reviewed: 1) certain
publicly available business and financial information relating to the Company
that Janney Montgomery deemed relevant; 2) certain information, including
financial forecasts, relating to the business and prospects of the Company; 3)
selected financial and stock market data for certain other publicly traded
companies that Janney Montgomery deemed relevant; 4) the financial terms of
certain other business combinations that Janney Montgomery deemed relevant; 5)
the recent trading history of the Common Stock; 6) various agreements,
including, among others, the Series D Stock Purchase Agreement, the Series E
Stock Purchase Agreement, the Consulting Agreement, the First Union Agreement
and the ValueVision Agreement; and 7) other financial studies and analyses as
Janney Montgomery deemed necessary. In addition, Janney Montgomery held
discussions with members of management of the Company regarding the Company's
business, financial condition and prospects.
In preparing its opinion, Janney Montgomery assumed and relied on the
accuracy and completeness of all information supplied or otherwise made
available to it, discussed with or reviewed by or for it, or publicly
available, and Janney Montgomery has not assumed any responsibility for
independently verifying such information or undertaken any independent
evaluation or appraisal of any of the assets or liabilities of the Company or
been furnished with any such evaluation or appraisal. In addition, Janney
Montgomery has not assumed any obligation to conduct any physical inspection
of the properties or facilities of the Company. With respect to the financial
forecast information furnished to or discussed with it by the Company, Janney
Montgomery has assumed that it has been reasonably prepared and reflects the
best currently available estimates and judgment of the Company's management as
to the expected future financial performance of the Company. Janney
Montgomery's opinion expresses no view with respect to the obtainability of
such projections or the assumptions on which they were based. Further, Janney
Montgomery has relied upon the assurances of management of the Company that
they are not aware of any facts or circumstances that would make such
information inaccurate or misleading. Janney Montgomery's opinion is
necessarily based upon market, economic and other conditions as they exist and
can be evaluated on, and on the information made available to it as of August
28, 1998.
In arriving at its opinion as described herein, Janney Montgomery did not
ascribe a specific range of values to the Company, but made its determination
as to the fairness, from a financial point of view, of the Transactions to the
holders of the Common Stock on the basis of a variety of financial and
comparative analyses, including those described below. The summary of analyses
performed by Janney Montgomery as set forth below does not purport to be a
complete description of the analyses underlying Janney Montgomery's opinion.
The presentation of a fairness opinion is a complex analytic process involving
various determinations as to the most appropriate and relevant methods of
financial analyses and the application of those methods to the particular
circumstances and, therefore, such an opinion is not readily susceptible to
partial or summary description. No company or transactions used in such
analyses as a comparison is identical to the Company or the Transactions, nor
is an evaluation of the results of such analyses entirely mathematical;
rather, it involves complex considerations and judgments concerning financial
and operating characteristics and other factors that could affect the
acquisition, public trading or other values of the companies or transactions
being analyzed. The estimates contained in such analyses and the ranges of
valuations resulting from any particular analysis are not necessarily
indicative of actual values or predictive of future results or values, which
may be significantly more or less favorable than those suggested by such
analyses. In addition, analyses relating to the value of the business or
securities do not
10
<PAGE>
purport to be appraisals or to reflect the prices at which businesses,
companies or securities actually may be sold. Accordingly, such analyses and
estimates are inherently subject to substantial uncertainty. In arriving at
this opinion, Janney Montgomery made qualitative judgments as to the
significance and relevance of each analysis and factor considered by it.
Accordingly, Janney Montgomery believes that its analyses must be considered
as a whole and that selecting portions of its analyses and factors, without
considering all analyses and factors, could create an incomplete view of the
processes underlying such analyses and its opinion.
The following is a summary of the material analyses performed by Janney
Montgomery and presented to the Board of Directors at a meeting on August 28,
1998.
HISTORICAL OPERATING RESULTS AND FINANCIAL CONDITION
In rendering its opinion, Janney Montgomery reviewed and analyzed the
historical and current operating results and financial condition of the
Company which included (i) an assessment of the Company's recent financial
statements and (ii) an analysis of the Company's revenue, growth and operating
performance trends.
PROJECTIONS
Janney Montgomery analyzed the Company's projections in support of its
fairness opinion. The projections were not reviewed by independent auditors
and were not prepared in accordance with generally accepted accounting
principles. Such projections were based on numerous estimates and other
assumptions and are inherently subject to significant uncertainties and
contingencies. There is no assurance that the projections will be achieved and
the use thereof by Janney Montgomery should not be regarded as an indication
that the Company or any other person considers such estimates an accurate
prediction of future events.
HISTORICAL STOCK PRICE PERFORMANCE
Janney Montgomery reviewed and analyzed the reported daily closing market
prices and trading volume of the Common Stock for the three year period ended
August 27, 1998. The Common Stock closed at a three year high of $21.50 per
share on January 3, 1996, and at a three year low of $1.06 per share on June
24, 1998. For the fifty trading days prior to July 10, 1998 (April 29 through
July 9), the date the Company and ACO executed a letter of intent regarding
the Transactions, the Common Stock closed at a price from between $1.06 per
share to $1.25 per share on 14 days; from between $1.26 per share to $1.50 per
share on 26 days; and from between $1.51 per share to $1.75 per share on 10
days. The historical stock performance review was performed to provide
background information and to add context to the other analyses performed by
Janney Montgomery, as described below.
ANALYSIS OF SELECTED PUBLICLY TRADED COMPARABLE COMPANIES
Using publicly available information, Janney Montgomery compared the
financial performance and stock market valuation for the Company with
respective corresponding data and ratios of certain similar publicly traded
companies. Janney Montgomery selected these companies from the universe of
possible companies based upon Janney Montgomery's view as to the comparability
of financial and operating characteristics of these companies to the Company.
With respect to each such analysis, Janney Montgomery made such comparisons
among the following companies: Catalina Marketing Corporation, DAMARK
International Inc., DM Management Company, Fingerhut Companies Inc., Genesis
Direct Inc., Harte-Hanks Inc., Reader's Digest Association Inc., Shop at Home
Inc., Sport Supply Group Inc., and ValueVision International Inc. (the
"Comparable Companies").
Among other multiples calculated and reviewed by Janney Montgomery were the
Comparable Companies' (a) stock price multiples to historical and estimated
net income and (b) enterprise value (total stock market value adjusted for
debt and cash) multiples to latest twelve months ("LTM") revenues, earnings
before interest and taxes ("EBIT") and earnings before interest, taxes,
depreciation and amortization ("EBITDA").
11
<PAGE>
Because the Company's EBIT, EBITDA and net income for the LTM period is
negative, and because the Company projects a net loss for the fiscal year
ending March 31, 1999, any comparison with multiples thereof would not be
meaningful. Janney Montgomery also indicated that, due to the differences
between the operations, profitability and financial condition of the Company
relative to the Comparable Companies, a comparison of enterprise value based
on revenue multiples was of limited value. Janney Montgomery further noted
that the stock prices of the Comparable Companies as multiples of projected
net income for the year ending December 31, 1999 ranged from 11.6 times to
23.9 times, with a mean value of 17.1 times. Applying these multiples to the
Company's projected net income of $0.14 per share for the fiscal year ending
March 31, 2000 results in low, high and mean per share values of $1.63, $3.35
and $2.39, respectively. Applying the same multiples to the Company's
projected net income of $0.14 per share for its fiscal year ending March 31,
2000, and assuming conversion of the Company's Series B Preferred Stock and
Series D Preferred Stock (thereby increasing shares outstanding by the 19.4
million shares into which they are collectively convertible), results in low,
high and mean per share values of $0.92, $1.89 and $1.35, respectively.
Based on the current and projected financial and operating performance of
the Company, including its LTM operating losses and net losses, and its
projected net loss for the fiscal year ending March 31, 1999, Janney
Montgomery believed that it was inappropriate to, and therefore did not, rely
solely on the quantitative results of this analysis.
ANALYSES OF SELECTED COMPARABLE TRANSACTIONS
Janney Montgomery also reviewed publicly available information relating to
certain merger and acquisition transactions in respect of companies primarily
in industries related to the Company's business ("Comparable Transactions").
With respect to the Company, Janney Montgomery examined multiples of the value
of common equity and indebtedness assumed in each of the transactions to,
among other measures, such acquired companies' revenue, EBITDA and EBIT, and
examined multiples of the value of the common equity in each of the
transactions to net income. For each measure, revenue, EBITDA, EBIT and net
income consisted of the latest twelve months of available financial
information on the respective date of each transaction.
Janney Montgomery identified and examined twelve Comparable Transactions
since 1995. However, due to (i) the differences between the operations,
financial condition and/or transaction sizes of the selected Comparable
Transactions and the Transactions and (ii) the Company's lack of LTM EBITDA,
EBIT and net income, Janney Montgomery advised the Board of Directors that
there was insufficient information to evaluate its Transactions based on these
transactions. Consequently, this analysis was deemed to be of limited value.
DISCOUNTED CASH FLOW ANALYSIS
Janney Montgomery prepared a discounted cash flow analysis of the future
unleveraged free cash flows that the Company's operations could be expected to
generate during various periods using projections provided to Janney
Montgomery by the Company. Unleveraged free cash flows of the Company were
projected over a period ending March 31, 2005. A terminal value was calculated
utilizing an exit multiple between 10.0 and 12.0 times projected EBITDA in
fiscal 2005. The estimated future unleveraged free cash flows and the terminal
value were discounted to present values using a range of discount rates from
between 15.0% and 25.0%. After subtracting the present value of payments due
to debtholders, and assuming the conversion of the Company's Series B
Preferred Stock and Series D Preferred Stock, Janney Montgomery arrived at a
range of estimated per share values for the Common Stock of between $0.96 and
$2.15. Based on a midpoint exit multiple of 11.0 times EBITDA in the fiscal
year 2005, and a midpoint discount rate of 20.0%, this analysis produced a
midpoint per share value for the Common Stock of $1.45.
Janney Montgomery is a nationally recognized investment banking firm and, as
part of its investment banking activities, is regularly engaged in the
valuation of businesses and securities in connection with mergers and
acquisitions, negotiated underwritings, secondary distributions of securities,
private placements and valuations for corporate and other purposes.
12
<PAGE>
Pursuant to the terms of Janney Montgomery's engagement, the Company has
agreed to pay Janney Montgomery for its financial advisory services in
connection with the Transactions as follows: (i) a financial advisory fee of
$25,000 payable on the date of the engagement; and (ii) a fee of $150,000 to
be paid on the closing of the Transactions. As of the date hereof, the Company
has paid Janney Montgomery $25,000 of such fees. In addition, the Company has
agreed to reimburse Janney Montgomery for its out-of-pocket expenses, and to
indemnify Janney Montgomery against certain liabilities, or to contribute to
payments Janney Montgomery may be required to make in respect thereof.
USE OF PROCEEDS
Pursuant to the Stock Purchase Agreement, the proceeds received upon
consummation of the Transactions (the "Closing") shall be applied as follows:
(a) approximately $16,200,000 to First Union, in full satisfaction of the
Company's credit facilities with First Union; (b) the payment of all
reasonable fees and disbursements of the Company, ACO and their respective
counsel in connection with the Transactions; and (c) the balance to be used
for working capital and for general corporate purposes.
SPECIAL CONSIDERATIONS IN CONNECTION WITH THE TRANSACTIONS
Completion of the Transactions will result in (i) the addition of a new,
large stockholder group of the Company; and (ii) the dilution of the equity
and voting interests of the Company's existing stockholders. Currently, the
Company is not aware of any other stockholder or stockholder group that holds
in the aggregate more than 12% of the outstanding shares of Common Stock. If
the Company's stockholders approve the Transactions and the Company issues and
sells shares of Series E Preferred Stock to ACO and assuming the purchase of
20,000 shares of Series E Preferred Stock and full conversion of all such
shares of Series E Preferred Stock and the Series D Preferred Stock held by
the Investor Group, and the full exercise of the TMC Options and the TMC
Warrants, the Investor Group would own approximately 52% of the then
outstanding shares of the Common Stock. In addition, consummation of the
Transactions will result in a new management team managing the operations of
the Company, including Stephen Lehman as President and Chief Executive Officer
of the Company. Also, the Investor Group will have the voting power to elect
or appoint the Company's Board of Directors. Accordingly, the Investor Group
will effectively have the ability to control the Company and its policies. The
consummation of the Transactions could have a deterrent effect on anyone
considering attempting to acquire the Company at a later date. The control of
the Company by the Investor Group could delay or prevent a change in control
of the Company or impede a merger, consolidation, takeover or other business
combination involving the Company. In addition, the large number of shares to
be held by the Investor Group could have, if offered or sold as a block, an
adverse impact on the market price for the Common Stock. Although a majority
of the securities owned and to be owned by the Investor Group are or will be
"restricted securities" which cannot be sold publicly for a period of time
without registration under the Securities Act, the Company has granted the
Investor Group certain registration rights pursuant to a Registration Rights
Agreement between the Company and ACO and is obligated to register the re-sale
of such shares of Common Stock following the Closing of the Transactions.
INTERESTS OF CERTAIN PERSONS IN THE TRANSACTIONS
In considering the recommendation of the Board of Directors with respect to
the Transactions, holders of Common Stock should be aware that certain members
of management of the Company have interests in the Transactions that are
different from, or in addition to, the holders of Common Stock generally. The
Board of Directors was fully informed of such interests and considered them,
among other matters, in approving the Stock Purchase Agreement and the
transactions contemplated thereby.
John W. Kirby, President and a Director of the Company, and Bruce D.
Goodman, a Senior Vice President of the Company, and Andrew M. Schuon, a
Director of the Company, through an interest in Alex. Brown NM Partners LLC,
are members of the Investor Group and have invested $300,000, $650,000 and
$50,000 in and have 1.20%, 2.67% and 0.18% membership interests of ACO,
respectively.
13
<PAGE>
In connection with the execution of the Stock Purchase Agreement, Robert N.
Verratti, Director and former Chief Executive Officer of the Company,
Constantinos I. Costalas, Vice Chairman of the Board of Directors and a
Director of the Company and Frederick S. Hammer, Chairman of the Board of
Directors of the Company, each entered into agreements with the Company
pursuant to which such persons waived the applicability of the change-in-
control provisions of such officers' employment agreements which otherwise
would have entitled them to cash payments of $600,000, $975,000 and $200,000,
respectively, if such officers' employment with the Company terminates
following consummation of the Transactions. In consideration thereof, the
Company agreed to reprice 50,000, 125,000 and 450,000 previously issued
options to purchase Common Stock held by Messrs. Costalas, Hammer and
Verratti, respectively, to $2.00 per share. Mr. Costalas also agreed to a
continuing consulting relationship with the Company. See "Certain Waivers" and
"Executive Compensation--Employment Contracts, Termination of Employment and
Change-in-Control Arrangements."
SECTION 203 OF THE DELAWARE GENERAL CORPORATION LAW
The Board of Directors has approved the Transactions so that the provisions
of Section 203 of the Delaware General Corporation Law ("DGCL") will not apply
to the Transactions. Section 203 of the DGCL prohibits a Delaware corporation
from engaging in a "business combination" with an "interested stockholder" for
a period of three years after the date of the transaction in which the person
became an interested stockholder, unless (i) prior to that date, either the
business combination or such transaction is approved by the board of directors
of the corporation; (ii) upon consummation of the transaction which resulted
in the stockholder becoming an interested stockholder, the interested
stockholder owns at least 85% of the corporation's outstanding voting stock;
or (iii) on or after that date, the business combination is approved by the
board of directors and by an affirmative vote of at least 66% of the
outstanding voting stock which is not owned by the interested stockholder.
A "business combination" is defined to include mergers, assets sales, and
other transactions resulting in a financial benefit to the interested
stockholder. An "interested stockholder" is a person who, together with
affiliates and associates, owns 15% or more of the corporation's outstanding
voting stock.
DESCRIPTION OF THE STOCK PURCHASE AGREEMENT
The following is a summary of the material provisions of the Stock Purchase
Agreement, a copy of which is attached hereto as Annex A, and certain other
agreements entered into and instruments issued in connection with the Stock
Purchase Agreement. This summary is not intended to be complete and is subject
to, and qualified in its entirety by reference to, all of the provisions of
the Stock Purchase Agreement. The Company reserves the right to amend or waive
the provisions of the Stock Purchase Agreement and the other documents related
thereto in all respects before or after the approval of the Transactions by
the stockholders. In addition, the Board of Directors reserves its right to
terminate the Stock Purchase Agreement in accordance with its terms
notwithstanding stockholder approval.
GENERAL
Pursuant to the Stock Purchase Agreement, the Company has agreed to sell,
and ACO has agreed to purchase, a minimum of 20,000 newly-created shares of
Series E Preferred Stock at a purchase price of $1,000 per share. In addition,
ACO has agreed to purchase, if requested by the Company, up to an additional
2,000 shares of Series E Preferred Stock, also at a purchase price of $1,000
per share.
RIGHTS AND PREFERENCES OF SERIES E PREFERRED STOCK
The holders of the Series E Preferred Stock will be entitled to vote
together with the holders of Common Stock as a single class of capital stock.
Holders of Series E Preferred Stock shall have that number of votes per share
as is equal to the number of shares of Common Stock into which such shares of
Series E Preferred Stock
14
<PAGE>
are convertible on the record date for such vote. Shares of Series E Preferred
Stock are convertible, at any time at the option of the holder, into shares of
Common Stock at a fixed conversion price of $1.50 per share of Common Stock
(subject to adjustment for certain anti-dilution events). Subject to the
satisfaction of certain conditions, shares of Series E Preferred Stock
outstanding on the third anniversary of the issuance date will be
automatically converted into shares of Common Stock. Holders of Series E
Preferred Stock are entitled to a liquidation preference of $1,000 per share:
(i) before any distribution to the holders of Common Stock and Series A Junior
Participating Preferred Stock, (ii) on parity and ratably with the holders of
Series D Preferred Stock and (iii) after any distributions to the holders of
Series B Preferred Stock.
The holders of the Series E Preferred Stock shall be entitled to receive,
when, as and if declared by the Board of Directors, a premium equal to 4% of
the face amount ($1,000) of each share outstanding on the thirtieth day of the
calendar month during which the one year anniversary of the consummation of
the Transactions occurs. The premium may be paid in cash or in shares of
Common Stock (at then prevailing market prices), at the Company's option. No
premium is payable subsequent to such first anniversary.
REPRESENTATIONS AND WARRANTIES
The Stock Purchase Agreement contains customary representations and
warranties of the Company with respect to the Company and its subsidiaries
relating to, among other things, the following matters: (a) organization,
standing and qualification to do business; (b) equity interest in other
companies; (c) the Company's capital structure; (d) the authorization,
execution, delivery performance and enforceability of the Stock Purchase
Agreement and related documents; (e) absence of conflict with or violation of
the Certificate of Incorporation or By-Laws of the Company or any material
agreements; (f) documents filed by the Company with the SEC, the accuracy of
information contained therein and the absence of undisclosed liabilities; (g)
the absence of certain changes or events since the date of certain financial
statements of the Company, including material adverse changes with respect to
the Company; (h) tax returns and reports; (i) real estate related matters,
including ownership of real property and valid leasehold interests in leased
real property; (j) intellectual property matters; (k) the absence of defaults
or violations under material contracts; (l) pending or threatened material
litigation; (m) environmental matters; (n) benefit plans, employment matters
and other matters relating to the Employee Retirement Income Security Act of
1974, as amended ("ERISA"); (o) compliance with applicable laws; (p)
maintenance of adequate insurance; (q) broker fees; (r) absence of existing
discussions with another party relating to an acquisition proposal; (s) Board
of Directors approval with respect to Section 203 of the DGCL; (t)
recommendation of the Board of Directors for stockholder approval; (u) the
Company Rights Plan; (v) required stockholder vote; and (w) the accuracy and
completeness of disclosures to ACO.
The Stock Purchase Agreement also contains customary representations and
warranties of ACO relating to, among other things, the following matters: (a)
the organization, standing, composition of ACO and TMC, and similar corporate
matters; (b) the authorization, execution, delivery, performance and
enforceability of the Stock Purchase Agreement and related documents; (c)
accredited investor status and investment intent; (d) the absence of public
solicitation; (e) the existence of sufficient funds to consummate the
Transactions; (f) certain restrictions on transfer or disposition of the
Series E Preferred Stock; (g) broker commissions; and (h) the absence of any
untrue statements or omissions of material fact with regard to information
supplied by ACO for inclusion in this Proxy Statement.
COVENANTS OF THE COMPANY
Pursuant to the Stock Purchase Agreement, the Company has agreed, unless ACO
otherwise consents in writing, to comply with certain covenants, including
those described below. The following covenants apply only until the earlier of
the Closing or termination of the Stock Purchase Agreement, except that the
covenant described below under "Provision of Information" applies for so long
as ACO or TMC is the beneficial owner of at least 1,000 shares of Series E
Preferred Stock or 100,000 shares of Common Stock issued upon conversion of
the Series E Preferred Stock or upon exercise of the TMC Options and the TMC
Warrants.
15
<PAGE>
Conduct of Business. The Company has agreed that, unless ACO otherwise
consents in writing, the business of the Company and its subsidiaries will be
conducted in the same general manner as now conducted and so as to implement
the most recent annual operating plan adopted by the Company. The Company has
agreed, among other things: (a) to pay timely all material obligations of the
Company; (b) to maintain the Company's property in good condition; (c) to
maintain adequate insurance; (d) to maintain reserves for potential patent
infringement actions; (e) to maintain proper books and records; (f) to
preserve the corporate existence of the Company's subsidiaries; (g) to comply
with all applicable laws; (h) to make all necessary filings with respect to
the registration of applicable securities; and (i) to comply with its
Certificate of Incorporation and By-Laws.
The Company has also agreed, among other things, that neither it nor its
subsidiaries will, subject to specified exceptions: (a) incur additional
indebtedness; (b) merge or consolidate; (c) make any restricted payments with
respect to any capital stock; (d) make any investments in any other person;
(e) engage in transactions with affiliates; (f) amend its Certificate of
Incorporation or By-Laws; or (g) adopt or amend any employee benefit plan.
No Solicitation of Competing Transactions. Until the earlier of the Closing
or termination of the Stock Purchase Agreement, the Stock Purchase Agreement
provides that, subject to the Board of Directors' fiduciary duties and
obligations, the Company will not take any action to encourage, solicit,
initiate, respond to, continue or engage in discussions or negotiations
concerning any offer or proposal for, or indication of interest in, any
acquisition of or a substantial portion of the assets of the Company or the
acquisition of any equity interest in the Company.
Use of Proceeds. The Company has agreed to apply the proceeds received in
connection with the Transactions as follows: (a) approximately $16,200,000 to
First Union, in full satisfaction of the Company's credit facilities with
First Union; (b) payment of all reasonable fees and disbursements of ACO, the
Company and their respective counsel in connection with the Transactions; and
(c) the balance to be used for working capital and for general corporate
purposes.
Provision of Information. The Company has agreed to deliver certain
financial, operational and legal information relating to the Company and its
subsidiaries to ACO, including financial statements, budgets, forecasts, SEC
filings, audit reports, or any information relating to ERISA matters,
litigation or any defaults pursuant to the Stock Purchase Agreement or other
related agreements.
Consultation with ACO. The Company has agreed that it will not adopt any
budget or other fiscal plan for the Company without the prior written approval
of ACO, that ACO-designated directors will be compensated consistent with
other directors of the Company, that the Company will consult with ACO on all
strategic and material operational matters and that the Company and ACO will
consult with each other regarding any public announcements.
Best Efforts. Both the Company and ACO have agreed to use their reasonable
best efforts to take all actions necessary to consummate the Transactions. The
Company has agreed to use its best efforts to insure that all stock issued
upon conversion of the Series E Preferred Stock or upon the exercise of the
TMC Options or the TMC Warrants is continuously registered with the SEC in
accordance the terms and conditions of the Registration Rights Agreement.
CONDITIONS TO CLOSING
The obligations of each of the parties to the Stock Purchase Agreement are
subject to, among other things, the conditions that: (i) the Company's
stockholders approve the Transactions by the requisite vote; (ii) any waiting
period applicable to the Transactions under the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, as amended, has terminated or expired; (iii) all
other regulatory approvals necessary for the consummation of the Transactions
are obtained; (iv) that there not be in effect any order, decree or ruling or
other action by any governmental entity, restraining, enjoining or otherwise
prohibiting the Transactions; (v) the Company shall have
16
<PAGE>
received on or prior to the date of this Proxy Statement an opinion from an
investment banking firm chosen by the Company and reasonably acceptable to ACO
to the effect that the Transactions are fair to the holders of the Common
Stock from a financial point of view, and such opinion shall be confirmed as
of the date of the Closing; (vi) payment by the Company of the ACO's
reasonable expenses; (vii) performance by the parties in all material respects
of their obligations pursuant to the Stock Purchase Agreement and the absence
of any termination thereof; (viii) execution of the appropriate documents
relating to the Transactions; (ix) the Company's Common Stock shall not have
been delisted by the NYSE; (x) the ACO Board of Directors nominees shall
constitute a majority of the Company's Board of Directors; (xi) Stephen C.
Lehman shall be the Company's Acting Chief Executive Officer; and (xii) John
W. Kirby shall not have been removed, without cause, by the Company as a
Director.
REIMBURSEMENT OF EXPENSES; INDEMNIFICATION
Pursuant to the Stock Purchase Agreement, the Company has agreed to pay all
reasonable fees and disbursements of ACO and ACO's counsel in connection with
the Transactions. The Company has also agreed to indemnify ACO against any
transfer taxes, documentary taxes, assessments or charges made by any
governmental authority by reason of the execution and delivery of the
documents relating to the Stock Purchase Agreement.
TERMINATION; BREAK-UP FEE
The Stock Purchase Agreement may be terminated at any time prior to Closing:
(a) by mutual written consent of the Company and ACO; (b) by either the
Company or ACO if the Transactions have not been consummated by November 15,
1998, or by December 31, 1998 upon the receipt of a letter from the Company to
ACO extending the termination date of the Stock Purchase Agreement because the
Company is awaiting regulatory or shareholder approval; (c) by either the
Company or ACO if a court of competent jurisdiction or other governmental
entity shall have issued a non-appealable final order, decree or ruling, or
taken any other non-appealable final action, having the effect of permanently
restraining, enjoining or otherwise prohibiting the Transactions; (d) by the
Company or ACO if there has been a material breach of the Stock Purchase
Agreement by the other party, which such breach shall not have been cured
within twenty business days; (e) or by the Company, if the Company accepts an
Acquisition Proposal (as defined below) and pays to ACO the Transaction
Initiation Fee (as defined below).
If the Company enters into any agreement or understanding with another party
with respect to the acquisition of any interest in the Company in a
transaction involving any equity interest in or substantial portion of the
assets of the Company or the acquisition of any capital stock of the Company
(an "Acquisition Proposal"), the Company will be obligated to pay to ACO a
transaction initiation fee (the "Transaction Initiation Fee"). The Transaction
Initiation Fee shall be equal to (i) the amount of ACO's reasonable expenses
arising directly out of negotiation of the Stock Purchase Agreement and its
investigations regarding the Company, and its legal and accounting advice with
respect to the Transactions, up to a maximum of $500,000 in the aggregate,
plus (ii) 4.9% of the difference, if any, between the aggregate equity value
attributed to the Company for the purposes of the Acquisition Proposal and the
aggregate equity value attributed to the Company for the purposes of the Stock
Purchase Agreement, up to a total aggregate maximum amount of $2,500,000.
RESTRICTIONS ON TRANSFERS; REGISTRATION RIGHTS
When issued to ACO, neither the Series E Preferred Stock nor the shares of
Common Stock issuable upon conversion thereof will have been registered under
the Securities Act of 1933, as amended (the "Securities Act") and,
accordingly, such shares will not be fully transferable, except as permitted
under various exemptions contained in the Securities Act, or upon satisfaction
of the registration and prospectus delivery requirements of the Securities
Act. In connection with the consummation of the Transactions, the Company and
ACO will enter into a Registration Rights Agreement, pursuant to which the
Company will undertake to effect registration of the resale of the shares of
Common Stock issuable upon conversion of the shares of Series E Preferred
Stock and
17
<PAGE>
upon exercise of the TMC Options and TMC Warrants as soon as practicable after
the consummation of the Transactions and to maintain such registration for a
period of up to two years. Members of the Investor Group will remain subject
to certain sale restrictions pursuant to Rule 144 under the Securities Act for
so long as such parties are deemed "affiliates" of the Company.
AMENDMENT TO THE COMPANY'S CERTIFICATE OF INCORPORATION
INCREASING THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK
TO 150,000,000 SHARES OF COMMON STOCK
On August 11, 1998, in connection with the approval of the Stock Purchase
Agreement, the Board of Directors unanimously adopted a resolution approving
an amendment to the first paragraph of Article Fourth of the Company's
Certificate of Incorporation increasing the number of shares of Common Stock
which the Company is authorized to issue from 75,000,000 to 150,000,000. Such
an amendment is required prior to consummation of the Transactions.
The full text of the introductory paragraph of Article Fourth of the
Company's Certificate of Incorporation, if amended as proposed, will be as
follows:
The aggregate number of shares which the Company shall have the authority
to issue is 160,000,000 of which 10,000,000 shall be Preferred Stock, par
value $.01 per share, and 150,000,000 shall be common stock, par value $.01
per share and the voting powers, designations, preferences and relative,
participating, optional or other special qualifications, limitations or
restrictions thereof are set forth hereinafter:
The amendment will not increase the number of shares of Preferred Stock
authorized. The relative rights and limitations of the Common Stock and
Preferred Stock would remain unchanged under the proposed amendment.
PURPOSES AND EFFECTS OF INCREASING THE NUMBER OF AUTHORIZED SHARES OF COMMON
STOCK
The proposed amendment would increase the number of shares of Common Stock
which the Company is authorized to issue from 75,000,000 shares to 150,000,000
shares. The additional 75,000,000 shares, if and when issued, would have the
same rights and privileges as the shares of Common Stock presently issued and
outstanding. The holders of Common Stock of the Company are not entitled to
preemptive rights or cumulative voting.
On the Record Date, the Company had [25,453,752] shares of Common Stock
issued and outstanding. In addition, as of such date, an aggregate of
approximately 44,000,000 shares of Common Stock were reserved or allocated for
issuance by the Company (i) upon exercise of options granted under the
Company's employee stock option plans and pursuant to certain employment
agreements; (ii) upon exercise of warrants issued in connection with certain
capital-raising and other business transactions completed by the Company;
(iii) upon conversion of issued and outstanding Series B Preferred Stock and
Series D Preferred Stock; (iv) pursuant to the ValueVision Note; and (v) upon
exercise of the TMC Options and the TMC Warrants. The Company will be unable
to consummate the Transactions absent such amendment.
After taking into account the number of currently issued and outstanding
shares of Common Stock together with the shares of Common Stock reserved or
allocated for issuance by the Company, the Company has approximately 5,000,000
shares of Common Stock which remain unreserved for issuance. In order for the
Company to consummate the Transactions as described in this Proposal I, the
Company is required to reserve for issuance an additional 14,666,666 shares of
Common Stock to be issued upon conversion of the Company's Series E Preferred
Stock (assuming the purchase of $22,000,000 of Series E Preferred Stock). In
addition, a significant element of the Company's business strategy is the
continued expansion of the Company's business in existing and in new markets,
and through new media. The ability of the Company to issue Common Stock or
securities convertible into or exchangeable for Common Stock as consideration
in any such transaction is viewed
18
<PAGE>
by management as a key element of such growth strategy. The Board of Directors
recommends the proposed increase in the authorized number of shares of Common
Stock to ensure that an adequate number of authorized and unissued shares is
available principally for (i) the consummation of the Transactions, (ii) the
financing of new growth opportunities for the Company and (iii) the raising of
additional capital for the operations of the Company. Except as described
above, there are currently no plans or arrangements relating to the issuance
of any of the additional shares of Common Stock proposed to be authorized and
such shares would be available for issuance without further action by
stockholders, unless required by the Company's Certificate of Incorporation,
its By-Laws or by applicable law.
The increase in the number of authorized shares of Common Stock has not been
proposed for any anti-takeover-related purpose, and the Board of Directors and
management of the Company have no knowledge of any current effort to obtain
control of the Company or accumulate large amounts of its Common Stock other
than through the Transactions described in this Proxy Statement. However, the
availability of additional shares of Common Stock could make any attempt to
gain control of the Company or of the Board of Directors more difficult.
Shares of authorized but unissued Common Stock could be issued in an effort to
dilute the stock ownership and voting power of any person or entity desiring
to acquire control of the Company, which might have the effect of discouraging
or making less likely such a change of control. Such shares could also be
issued to other persons or entities who support the Board of Directors in
opposing a takeover attempt that the Board of Directors has deemed not to be
in the best interests of the Company and its stockholders.
In evaluating the proposed amendment to the Company's Certificate of
Incorporation, stockholders should consider the effect of certain other
provisions of the Company's Certificate of Incorporation and By-Laws which may
have anti-takeover consequences. These provisions include (a) the
authorization of up to 10,000,000 shares of Preferred Stock, the terms of
which may be fixed by the Board of Directors without further action by
stockholders, (b) a provision that standing Directors may be removed without
cause only by a majority vote of stockholders entitled to vote, (c) a
limitation on the ability of stockholders to call special stockholder
meetings, and (d) a provision that vacancies in, and newly created
directorships resulting from an increase in the authorized number of Directors
on, the Board of Directors may be filled by a majority of the remaining
Directors. The Company also has a Shareholder Rights Agreement in effect which
serves as an anti-takeover mechanism.
EFFECTIVE DATE OF PROPOSED AMENDMENT
If the proposed amendment to Article Fourth of the Company's Certificate of
Incorporation is adopted by the required vote of the Company's stockholders,
such amendment will become effective upon the filing by the Company of a
Certificate of Amendment to the Company's Certificate of Incorporation with
the Secretary of the State of Delaware, which is expected to be accomplished
as soon as practicable after stockholder approval is obtained.
DESCRIPTION OF THE CONSULTING AGREEMENT
Pursuant to the Consulting Agreement, the Company has engaged TMC for a
period commencing August 11, 1998 and continuing until terminated (as
discussed below) to provide executive management consulting services to the
Company. Such services are to include at least an aggregate of 100 hours per
week by Stephen C. Lehman, Eric R. Weiss and Daniel M. Yukelson. A minimum of
40 of such hours are to be devoted by Mr. Lehman. Under the terms of the
Consulting Agreement, effective as of the execution of the Consulting
Agreement on August 11, 1998, Mr. Lehman was designated Acting Chief Executive
Officer of the Company, with the duties, responsibilities and authority
normally associated with that office. As compensation for consulting services,
the Company agreed to pay TMC the sum of $80,000 per month and granted to TMC
(i) a five-year option to purchase up to 212,500 shares of Common Stock,
subject to certain vesting requirements, at an exercise price of $1.32 per
share; and (ii) contingent warrants, which will only become effective
following consummation of the Transactions, to purchase up to 3,762,500 shares
of Common Stock, at exercise prices ranging from $1.32 per share to $3.00 per
share. 1,000,000 of the TMC Warrants, to the extent such warrants
19
<PAGE>
are distributed by TMC, will be utilized to retain and attract personnel to
the Company and such warrants may not be exercised by TMC or its affiliates.
If the Company's stockholders do not approve the Transactions, or if there is
a material breach by TMC of the Consulting Agreement which is not cured, if
curable, within 30 days, all of the TMC Warrants and the non-vested TMC
Options will be cancelled.
The Company has agreed to reimburse TMC for reasonable and actual out-of-
pocket business expenses incurred by TMC in performance of its
responsibilities under the Consulting Agreement. The Company has also agreed
to indemnify TMC against all losses, claims, damages, liabilities and expenses
to which TMC may become liable arising out of TMC's acting for the Company
pursuant to the Consulting Agreement, provided that the Company shall not be
liable to the extent any loss, claimed damage, liability or expense is found
to have resulted from TMC's gross negligence, bad faith, material breach of
the Consulting Agreement, actions outside the scope of the authority granted
to TMC or in contravention of specific instructions from the Board of
Directors. The Consulting Agreement will terminate upon the earliest of: (i)
the expiration of the six-month term; (ii) a negative vote by the Company's
stockholders regarding the Transactions; (iii) the Company becoming obligated
to pay the Transaction Initiation Fee; (iv) the signing of employment
agreements by the Company with each of Messrs. Lehman, Weiss and Yukelson; or
(v) the material breach by TMC of its duties and obligations under the
Consulting Agreement, and the failure of TMC to cure such breach, if curable,
within thirty days.
If the Consulting Agreement is terminated pursuant to the Company's
obligation to pay the Transaction Initiation Fee, the Company is obligated to
pay to TMC a sum equal to the amount which would have been payable to TMC if
the Consulting Agreement had continued for an additional six-month term, up to
a maximum of $720,000. If the Consulting Agreement is terminated because the
Company's stockholders do not approve the Transactions, the Company is
obligated to pay to TMC a sum equal to the amount which would have been
payable to TMC if the Consulting Agreement had remained in full force and
effect for the six-month term.
THE TMC OPTIONS AND TMC WARRANTS
The TMC Options granted pursuant to the Consulting Agreement consist of a
five-year option to purchase up to 212,500 shares of Common Stock at an
exercise price of $1.32 per share. One-sixth of such options are to vest on
each of the 30th, 60th, 90th, 120th, 150th and 180th day following August 11,
1998, the date of the Consulting Agreement, provided that the Consulting
Agreement is in effect on such date and further provided that: (i) all such
options shall immediately vest upon the earlier of the Closing or termination
of the Consulting Agreement pursuant to the Company becoming obligated to pay
the Transaction Initiation Fee; and (ii) all non-vested options shall be
cancelled if the stockholders vote not to approve the Transactions or if there
is a material breach by TMC of the Consulting Agreement, which such breach, if
curable, is not cured within thirty (30) days.
The TMC Warrants granted pursuant to the Consulting Agreement consist of:
(i) a warrant to purchase 2,412,500 shares of Common Stock exercisable on and
from the Closing as to 1,912,500 shares at an exercise price of $1.32 per
share and, upon the price of the Common Stock first trading in excess of $3.00
per share for a period of fifteen consecutive trading days following the date
of the Consulting Agreement (the "Price Threshold"), which Price Threshold has
been met, the remaining 500,00 shares at an exercise price of $3.00 per share;
(ii) a warrant to purchase 150,000 shares at an exercise price of $1.50 per
share, exercisable on and from the Closing, which will be distributed to BT
Alex. Brown Inc., ACO's financial advisor with respect to the Transactions;
(iii) a warrant to purchase 200,000 shares of Common Stock at an exercise
price of $1.50 per share; and (iv) a warrant to purchase 1,000,000 shares of
Common Stock exercisable on and from the Closing at an exercise price of $1.32
per share, which warrants may not be exercised by TMC or any employee of TMC
and may only be transferred to any officer, Director, employee or consultant
of the Company other than Messrs. Lehman, Weiss, Yukelson or any employee of
TMC. TMC intends to transfer such 1,000,000 TMC Warrants, subject to three to
five year vesting schedules, to eligible officers, Directors, employees,
consultants of the Company and other persons associated with the Company's
programming.
The TMC Options and TMC Warrants contain customary anti-dilution
adjustments, including adjustments if the Company issues shares of Common
Stock or securities convertible, exchangeable or exercisable for shares of
Common Stock at a price less than the exercise price then in effect with
respect to such instrument.
20
<PAGE>
DESCRIPTION OF RELATED AGREEMENTS AND TRANSACTIONS
The Series D Agreement. In connection with the Transactions, the Company and
ACO entered into a separate agreement with the Series D Holders (the "Series D
Agreement") and consummated the Series D Purchase. Pursuant to the Series D
Agreement, ACO purchased, pro rata from the Series D Holders, 10,000 shares of
Series D Preferred Stock and 992,942 warrants to purchase Common Stock, for an
aggregate of $10,000,000 in cash. The Series D Agreement provides that the
floating conversion price feature of the Series D Preferred Stock shall no
longer be applicable. The existing maximum conversion price of $1.073125 was
established as the fixed conversion price. The Series D Holders also agreed to
vote any shares of Common Stock held by them in support of proposals
recommended to the Company's stockholders by the Board of Directors for a
period of three years from the Closing and to certain limitations on sales and
short selling restrictions and a right of first refusal for the benefit of the
Company with respect to the sale of shares of Series D Preferred Stock. In the
event the Transactions are not consummated, or upon the occurrence of certain
events, including a subsequent "change in control" of the Company, the
agreements related to the elimination of the floating conversion price feature
of the Series D Preferred Stock, the sales limitations with respect to the
Series D Securities and the Common Stock issuable upon conversion and/or
exercise of the Series D Securities, the right of first refusal, the voting
support agreement and certain other covenants with respect to the Series D
Securities and the Common Stock issuable upon conversion and/or exercise of
the Series D Securities will terminate. One of the Series D Holders, Capital
Ventures International ("CVI"), obtained a right to designate an observer to
attend all Board of Directors' meetings in a non-voting observer capacity for
so long as CVI owns in the aggregate at least 500 shares of Series D Preferred
Stock or at least 500,000 shares of Common Stock acquired upon conversion of
Series D Preferred Stock. The Company agreed to pay an aggregate of $684,000
to the two Series D Holders (pro rata based on their relative holdings of
Series D Preferred Stock on the date of execution of the Series D Agreement)
in consideration of their consent to and participation in the Transactions.
Such payment is due one year from the Closing.
ValueVision Agreement. In connection with the Transactions, ACO, the Company
and ValueVision entered into an agreement (the "ValueVision Agreement") which
amended certain terms of existing agreements between the Company and
ValueVision. On January 5, 1998, in connection with the execution of the then
contemplated merger agreement with ValueVision (the "Merger Agreement") , the
Company executed a note (the "ValueVision Note") in favor of ValueVision,
pursuant to which ValueVision agreed to lend up to $10,000,000 to the Company
for working capital purposes. On such date, the Company received $7,000,000
under the ValueVision Note. In March and April, 1998, the Company received the
remaining $3,000,000 in funding under the ValueVision Note. The ValueVision
Note bears interest at prime plus 1.5%, which is payable quarterly. The
ValueVision Note is due on demand on the earlier of January 1, 1999 or upon
the occurrence of certain triggering events, including but not limited to, the
announcement of a change in control of the Company, a sale of the Company's
assets or a default under the Company's senior credit facility. If the Company
is unable to repay the ValueVision Note when due, the ValueVision Note, as
amended by the ValueVision Agreement, provides that ValueVision may elect to
receive payments in shares of Common Stock at $1.073125 per share. The Company
has the right to repay the ValueVision Note in cash, or shares of Common
Stock, at the Company's option. At a conversion price of $1.073125 per share,
the $10,000,000 in principal outstanding under the ValueVision Note would be
converted into approximately 9,318,579 shares of Common Stock. In addition, in
consideration for providing the working capital loan to the Company, the
Company granted to ValueVision warrants (the "1998 Warrants") to purchase
250,000 shares of the Company's Common Stock at an exercise price equal to
$2.74 per share. In consideration for ValueVision providing its consent to the
Transactions and waiving certain events of default under the ValueVision Note,
pursuant to the ValueVision Agreement, the Company agreed to reduce the
exercise price of 500,000 warrants (the "1995 Warrants") granted to
ValueVision in April 1995 in connection with the execution of a Telemarketing,
Production and Post-Production Agreement to $2.74 per share. In the event of
the conversion of the ValueVision Note and exercise of the 1998 Warrants and
the 1995 Warrants, the Company would be required to issue up to 10,568,579
shares of Common Stock to ValueVision.
21
<PAGE>
Paragraph 312.03(c) of the New York Stock Exchange Listed Company Manual
requires that, as a condition to listing such shares for trading on the NYSE,
stockholder approval in connection with the issuance by the Company of
securities convertible into or exercisable for shares of Common Stock if the
number of shares of Common Stock to be issued has, or will have upon issuance,
voting power greater than or equal to 20% of the total voting power of the
shares of Common Stock outstanding before the issuance of such stock or other
securities. As of September 18, 1998, the Company has [25,453,752] shares of
Common Stock outstanding. Accordingly, while it is not presently anticipated
that any shares of Common Stock will be issued relating to the satisfaction of
the ValueVision Note, it is technically required that the Company obtain
stockholder approval regarding the issuance of shares of Common Stock in
excess of the 20% limitation on account of the ValueVision Note, the 1998
Warrants and the 1995 Warrants. In the event that stockholder approval is not
received for Proposal I, the Company may be unable to satisfy its obligations
under the ValueVision Note, the 1998 Warrants and the 1995 Warrants. Failure
to satisfy such obligations would cause the Company to be in breach of such
instruments, which could have a material adverse effect on the Company's
financial condition.
First Union Agreement. In connection with the Transactions, the Company and
ACO entered into an agreement with First Union pursuant to which First Union
agreed, subject to certain terms and conditions, to accept 75% of the
outstanding principal obligations of the Company and its affiliates under the
Company's credit facilities with First Union in full satisfaction for all such
outstanding indebtedness, provided such payment is made to First Union by
November 15, 1998 and all other outstanding fees and accrued interest are paid
in full. The approximate total indebtedness under such credit facilities is
currently $21,500,000. First Union also agreed to waive outstanding violations
with respect to certain financial covenant ratios by amending certain of the
covenants in consideration of a $190,000 fee paid on August 17, 1998.
Amendment to Rights Agreement. In connection with the Transactions, the
Company amended its Rights Agreement with Chase Mellon Shareholder Services,
LLC, as rights agent, to allow the Transactions to be consummated without
triggering a distribution date under the terms of the Rights Agreement.
Stockholders Voting Agreement. In connection with the Transactions, ACO and
certain stockholders of the Company entered into a Stockholders Voting
Agreement obligating each of the signatories thereto to vote their shares of
Common Stock in favor of the Transactions. The parties to the Stockholders
Voting Agreement are ACO and all of the Company's Directors prior to execution
of the documents relating to the Transactions: Constantinos I. Costalas,
Albert R. Dowden, Michael J. Emmi, William M. Goldstein, Frederick S. Hammer,
Robert E. Keith, Jr., John W. Kirby, Ira M. Lubert, Warren V. Musser, Robert
N. Verratti and Jon W. Yoskin, II. Parties to the Stockholders Voting
Agreement, other than ACO, will represent approximately 2.5% of the shares of
Common Stock eligible to vote on Proposal I at the Stockholders' Meeting. As
of the Record Date, ACO was the record holder of % of the shares of Common
Stock eligible to vote on Proposal I at the Stockholders' Meeting.
Registration Rights Agreement. In connection with the consummation of the
Transactions, the Company and ACO will enter into a Registration Rights
Agreement pursuant to which the Company will prepare and file with the SEC a
registration statement with respect to the Common Stock issuable upon
conversion of the Series E Preferred Stock and upon exercise of the TMC
Options and the TMC Warrants. The Company will also agree to use its best
efforts to cause such registration statement to become effective and to keep
such registration statement effective for a period of up to two years.
Certain Waivers. In connection with the Transactions, the Company entered
into Waiver Agreements with three executives of the Company: Constantinos I.
Costalas, Frederick S. Hammer, and Robert N. Verratti. The Waiver Agreements
contain certain amendments to the employment agreements of the executives,
including, among other things, a waiver of the change in control provisions of
such employment agreements. In the event stockholders do not approve this
Proposal I and the Transactions are not consummated, the Waiver Agreements
will be of no force and effect, other than as to the option repricing
provisions thereof.
22
<PAGE>
Under the terms of Mr. Costalas' employment agreement, upon consummation of
the Transactions, Mr. Costalas could have elected to receive a cash payment in
the amount of $975,000. Mr. Costalas agreed to waive the benefit of such
provision. In connection with such waiver, Mr. Costalas agreed to continue to
be employed by the Company under his current employment agreement for a period
of ninety days after Closing, and further agreed to act as a consultant to the
Company for a further period of twenty-one months at an initial rate of
$325,000 per annum, for the first nine months, and at a rate of $200,000 per
annum, for the remaining twelve months. In consideration of this waiver, Mr.
Costalas was also granted a cash bonus of $350,000 to be paid at Closing. Mr.
Costalas will be required to satisfy a promissory note payable to the Company
in the amount of $177,400 within two days after Closing. Options to purchase
50,000 shares of Common Stock at a price of $7.00 per share held by Mr.
Costalas were also repriced to $2.00 per share. Effective upon Closing, the
exercisability of all of Mr. Costalas' 220,000 options will be extended for
one additional year to three years from the date of termination of his
employment/consulting by the Company.
Under the terms of Mr. Hammer's employment agreement, upon consummation of
the Transactions, Mr. Hammer could have elected to receive a cash payment in
the amount of $200,000. Mr. Hammer agreed to waive the benefit of such
provision. In exchange for such waiver and Mr. Hammer's agreement to terminate
his employment with the Company effective upon Closing, 125,000 options to
purchase Common Stock at a price of $5.65 per share held by Mr. Hammer were
repriced to $2.00 per share. Effective upon Closing, the exercisability of all
of Mr. Hammer's 325,000 options will be extended for one additional year to
three years from the date of termination of his employment by the Company.
Under the terms of Mr. Verratti's employment agreement, upon consummation of
the Transactions, Mr. Verratti could have elected to receive a cash payment in
the amount of $600,000. Mr. Verratti agreed to waive the benefit of such
provision and also agreed to relinquish the position of Chief Executive
Officer to Mr. Lehman, pending the consummation of the Transactions. In
exchange for such waiver and Mr. Verratti's agreement to terminate his
employment with the Company effective upon Closing, 450,000 options to
purchase Common Stock at a price of $4.75 per share held by Mr. Verratti were
repriced to $2.00 per share. Effective upon Closing, the exercisability of all
of Mr. Verratti's 700,000 options will be extended for one additional year to
three years from the date of termination of his employment by the Company.
NO APPRAISAL RIGHTS
The holders of shares of Common Stock have no appraisal rights in connection
with the Transactions.
VOTE REQUIRED FOR APPROVAL
Approval of Proposal I requires the affirmative vote of a majority of the
votes cast at the Stockholders' Meeting, provided that the total number of
votes cast on the proposal represents over 50% in interest of all securities
present in person or by proxy and entitled to vote on the proposal.
Abstentions, therefore, will have the practical effect of voting against
Proposal I because the affirmative vote of a majority of the shares present at
the Stockholders' Meeting is required to approve Proposal I. Broker non-votes
will not be voted or have any effect on Proposal I.
Each member of the Board of Directors as of the date immediately prior to
the execution of the Stock Purchase Agreement entered into a Stockholders
Voting Agreement pursuant to which such Directors agreed to vote their shares
of Common Stock in favor of the Transactions. Parties to the Stockholders
Voting Agreement, other than ACO, will represent approximately 2.5% of the
shares of Common Stock eligible to vote on Proposal I at the Stockholders'
Meeting. As of the Record Date, ACO was the record holder of % of the shares
of Common Stock eligible to vote on Proposal I at the Stockholders' Meeting.
THE BOARD OF DIRECTORS BELIEVES THAT THE PROPOSED TRANSACTIONS ARE FAIR TO,
AND IN THE BEST INTERESTS OF, THE COMPANY AND ITS STOCKHOLDERS AND UNANIMOUSLY
RECOMMENDS THAT THE STOCKHOLDERS OF THE COMPANY VOTE "FOR" APPROVAL OF
PROPOSAL I.
23
<PAGE>
PROPOSAL II
ELECTION OF DIRECTORS
ELECTION
The By-Laws of the Company provide that the Board of Directors shall be
composed of three to eleven Directors, with such number to be fixed by the
Board of Directors from time to time. The Board of Directors has currently
fixed the number of Directors of the Company at nine. Therefore, the Company
is nominating nine Directors for election at the Stockholders' Meeting. Each
of the nine Directors to be elected at the Stockholders' Meeting will be
elected by the holders of the Common Stock. Safeguard Scientifics, Inc.
("Safeguard"), in connection with its purchase of Series B Preferred Stock in
Fall 1994, obtained the contractual right to representation on the Board of
Directors. [Safeguard has agreed to waive its right to a representative on the
Company's Board of Directors.]
In connection with the execution of the definitive agreements regarding the
Transactions, three ACO designees were appointed to the Board of Directors. In
addition, the Stock Purchase Agreement requires that, upon Closing, ACO's
nominees to the Board of Directors shall constitute a majority of the
Company's Directors. Therefore, the composition of the Board of Directors
depends on whether Proposal I (relating to the Transactions) is approved by
the Company's stockholders. Until Closing, or until the Company's stockholders
vote in opposition of Proposal I, the Board of Directors will consist of the
following nine Directors: Albert R. Dowden, William M. Goldstein, Frederick S.
Hammer, John W. Kirby, Stephen C. Lehman, Andrew M. Schuon, Robert N.
Verratti, Eric R. Weiss and Jon W. Yoskin, II. Messrs. Lehman, Schuon and
Weiss are the ACO nominees to the Board of Directors who were appointed as
Directors effective upon execution of the Stock Purchase Agreement. If
Proposal I is not approved, Andrew M. Schuon and Eric R. Weiss will resign
from the Board of Directors, Constantinos I. Costalas and Robert E. Keith, Jr.
will be re-appointed to the Board of Directors to fill such vacancies and
Messrs. Costalas and Keith, together with the persons elected pursuant to this
Proposal II (other than Messrs. Schuon and Weiss) shall serve as the Directors
of the Company until their successors have been duly elected to the Board of
Directors and have qualified. If Proposal I is approved, effective upon
Closing, the Board of Directors shall fix the number of Directors of the
Company at seven, Messrs. Dowden, Goldstein, Hammer, Verratti and Yoskin will
resign from their Directorships and the Board of Directors shall appoint
Stuart D. Buchalter, Roberto Crawford and David E. Salzman to the Board of
Directors, each of whom has agreed to serve on the Company's Board of
Directors, as designees of ACO, to join Messrs. Kirby, Lehman, Schuon and
Weiss, who will continue to serve as Directors.
Set forth below is certain information with respect to the persons nominated
for election by the Board of Directors as well as the persons who will be
appointed to the Board of Directors if Proposal I is approved and the
Transactions are consummated. With respect to each such person, such
information includes his age, the period, if any, during which he has served
as a Director of the Company and his principal occupation and employment
during at least the past five years. All nominees are currently Directors of
the Company. Unless otherwise specified on the enclosed proxy card, each proxy
received from the holders of shares of Common Stock will be voted for the
election as Directors of the nine nominees named below as nominees to serve
until the next annual meeting of stockholders and until a successor in office
shall be duly elected and qualified. Each of the nominees has consented to be
named as a nominee in this Proxy Statement and to serve as a Director if
elected. Messrs. Dowden, Goldstein, Hammer, Verratti and Yoskin have agreed to
resign upon consummation of the Transactions and Messrs. Buchalter, Crawford
and Salzman have agreed to serve on the Board of Directors following
consummation of the Transactions. Should any nominee become unable or
unwilling to accept his nomination or election, the persons named in the
enclosed proxy will vote for the election of a nominee designated by the Board
of Directors.
VOTE REQUIRED FOR APPROVAL
The nine Directors are required to be elected by a plurality of the votes
cast as to the subject Board of Directors seat. Votes may be cast in favor of
or withheld for any or all of the appropriate nominees. Unless
24
<PAGE>
otherwise instructed by a record holder submitting a proxy, the persons named
in a proxy will vote the shares represented thereby for the election of all
such appropriate nominees. Abstentions and broker non-votes will not be
counted toward a nominee's achievement of a plurality and thus will have no
effect on the outcome of the election of Directors.
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE FOR EACH OF THE
NOMINEES LISTED BELOW.
The following persons have been nominated for election as Directors:
NOMINEES FOR ELECTION TO THE BOARD OF DIRECTORS
NAME DESCRIPTION
Albert R. Dowden(1)(2)(3)...... Albert R. Dowden, age 57, has served as a
Director, President and Chief Executive
Officer of Volvo North America Corporation
and Senior Vice President of AB Volvo since
January 1991. Prior to such time, he served
as Executive Vice President and Deputy to the
President and Chief Executive Officer from
June 1989 to January 1991. Mr. Dowden has
been affiliated with Volvo North America
Corporation since 1974. Mr. Dowden also
serves on the Board of Directors of Annuity
and Life Re(Holdings), Ltd., the National
Association of Manufacturers, the Association
of International Automobile Manufacturers,
the Business Committee for the Arts, the
Center for International Leadership, the
Madison Square Boys & Girls Club, the United
Way of New York City, the Cortland Trust, the
American Scandinavian Foundation, the
American Intercultural Student Exchange, the
American Institute for Public Service and the
Swedish American Chamber of Commerce. Mr.
Dowden has served as a Director of the
Company since August 1995. Mr. Dowden has
agreed to resign as a Director upon
consummation of the Transactions.
William M. Goldstein,
Esq.(1)....................... William M. Goldstein, Esq., age 62, is
Chairman of the Tax Department of the law
firm of Drinker, Biddle & Reath LLP in
Philadelphia, Pennsylvania, where he has
practiced since 1982. Mr. Goldstein
specializes in federal taxation, securities
law and general corporate law. He previously
held the position of Deputy Assistant
Secretary for Tax Policy with the United
States Department of Treasury. Mr. Goldstein
has served as a Director of the Company since
April 1996. Mr. Goldstein has agreed to
resign as a Director upon consummation of the
Transactions.
Frederick S. Hammer(3)......... Frederick S. Hammer, age 62, was appointed
Chairman of the Board of Directors of the
Company in February 1997. He has been a
partner of Inter-Atlantic Securities
Corporation, an investment banking firm
focused primarily on the financial services
industry, since December 1994. From February
1993 to June 1994, Mr. Hammer was Chairman of
Mutual of America Capital Management
Corporation. From 1989 until 1993, Mr. Hammer
was President of the SEI Asset Management
Group in Wayne, Pennsylvania. From 1989 until
1991, Mr. Hammer was Mazur Fellow at the
Wharton School of the University of
25
<PAGE>
Pennsylvania. Mr. Hammer presently serves on
the Board of Directors of IKON Office
Solutions, Tri-Arc Financial Services, Inc.,
Medallion Financial Corporation, Annuity and
Life Re(Holdings), Ltd. and Provident
American Corporation. Mr. Hammer has served
as a Director of the Company since October
1994. Mr. Hammer has agreed to resign as a
Director upon consummation of the
Transactions.
John W. Kirby.................. John W. Kirby, age 38, has served as
President of the Company since March 1998 and
as Chairman, Chief Executive Officer and
President of Quantum Television (formerly
d/b/a DirectAmerica Corporation) since the
Company's acquisition of DirectAmerica in
October 1995. Mr. Kirby also served as
Executive Vice President of the Company from
October 1995 until March 1998. Mr. Kirby
previously served as Chairman of the Board,
Chief Executive Officer and President of
California Production Group, Inc. ("CAPG")
from January 1991 until the Company's
acquisition of CAPG in October 1995. Mr.
Kirby has served as a Director of the Company
since March 1998.
Stephen C. Lehman.............. Stephen C. Lehman, age 44, has served as
Acting Chief Executive Officer of the Company
since August 1998. Prior thereto, from its
formation in January 1987 until August 1998,
Mr. Lehman served as President, Chief
Executive Officer and Chairman of the Board
of Premiere Radio Networks, Inc. From 1984 to
1987, Mr. Lehman was President of Stephen
Lehman Productions, a syndicated radio
program company, while also serving as an on-
air personality at KIIS-AM and FM/Los
Angeles. From 1982 to 1984, he specialized in
building radio networks for independent radio
syndicators. From 1980 to 1981, Mr. Lehman
was National Sales Manager for Innerview
Radio Networks. From 1976 to 1980, Mr. Lehman
was president of a promotion advertising
agency. Mr. Lehman is a Director of Video
City, Inc. Mr. Lehman has served as a
Director of the Company since August 1998.
Mr. Lehman is an ACO designee to the Board of
Directors.
Andrew M. Schuon (2)........... Andrew M. Schuon, age 32, has served as
Executive Vice President of Programming for
MTV Music Television, a unit of Viacom, Inc.
("MTV") since November 1995. In such
capacity, Mr. Schuon oversees MTV's music,
talent and programming departments. From May
1992 until November 1995, Mr. Schuon served
in various capacities at MTV, starting as
Vice President/Music, Programming and
Promotion. From 1989 until 1992, Mr. Schuon
served as the program director of radio
station KROQ-FM in Los Angeles, California.
Mr. Schuon has served as a Director of the
Company since August 1998 and was a Director
of Premiere Radio Networks, Inc. from August
1996 until August 1998. Mr. Schuon is an ACO
designee to the Board of Directors.
Robert N. Verratti (1)......... Robert N. Verratti, age 55, served as Chief
Executive Officer of the Company from March
1998 until August 1998. From May
26
<PAGE>
1997 until March 1998, Mr. Verratti served as
President and Chief Executive Officer of the
Company. Prior to joining the Company, from
January 1997 to May 1997, he served as
Special Adviser for Acquisitions to the
Chairman and Chief Executive Officer of
Safeguard. Prior to joining Safeguard, from
December 1988 to June 1990, Mr. Verratti
served as Chief Executive Officer of Total
Care Systems, a congregate care management
company. Mr. Verratti is also President of
Charlestown Investments, Ltd., an investment
company. Mr. Verratti also serves on the
Boards of Directors of CRW Financial. Mr.
Verratti has served as a Director of the
Company since May 1997. Mr. Verratti has
agreed to resign as a Director upon
consummation of the Transactions.
Eric R. Weiss.................. Eric R. Weiss, age 40, served as a Director
of Premiere Radio Networks, Inc. from January
1997 until August 1998. During 1996, Mr.
Weiss served as Chairman and Chief Executive
Officer of After MidNite Entertainment, Inc.
From 1986 until 1995, Mr. Weiss served as an
executive officer of Westwood One, Inc.,
serving as Executive Vice President and Vice
President/Business and Legal Affairs. Mr.
Weiss has served as a Director of the Company
since August 1998. Mr. Weiss is an ACO
designee to the Board of Directors.
Jon W. Yoskin, II(1)(2)........ Jon W. Yoskin, II, age 57, has served as
Chairman, Chief Executive Officer and a
Director of Tri-Arc Financial Services, Inc.,
a provider of specialized insurance products
to the financial services industry, since
1986. Prior to that time, Mr. Yoskin worked
in the insurance and banking industries with
companies such as Meritor Savings Bank,
TransAtlantic Life Insurance Assurance
Company and Royal Oak Insurance Company. Mr.
Yoskin has served as a Director of the
Company since June 1994. Mr. Yoskin has
agreed to resign as a Director upon
consummation of the Transactions.
- --------
(1) Member of the Audit Committee.
(2) Member of the Compensation Committee.
(3) Member of the Board Affairs Committee.
BIOGRAPHICAL INFORMATION OF ACO BOARD OF DIRECTORS APPOINTEES
Effective upon consummation of the Transactions, the Board of Directors
shall reduce the number of Directors of the Company from nine to seven,
Messrs. Dowden, Goldstein, Hammer, Verratti, and Yoskin will each resign, and
the following persons will be appointed to the Board of Directors.
Stuart D. Buchalter............ Stuart D. Buchalter, age 61, has been Of
Counsel with the California law firm of
Buchalter, Nemer, Fields & Younger, a
Professional Corporation, since August 1980.
From August 1980 to June 1993, he served as
Chairman of the Board of Directors and Chief
Executive Officer of Standard Brands Paint
Company, a paint retailer and manufacturer.
Mr. Buchalter is a director of Authentic
Fitness Corp., an athletic apparel
manufacturer, Earl
27
<PAGE>
Scheib, Inc., an automotive painting company,
Faroudja, Inc., a television image
enhancement company, and City National Corp.,
the holding company for City National Bank.
He is also Vice-Chairman of the Board of
Trustees of Otis College of Art and Design.
David E. Salzman............... [TBP]
Roberto Crawford............... Roberto Crawford, age 57, is currently
engaged as a management consultant. Since
July 1984, Mr. Crawford has been President of
Pro Active Management, Inc. Since January
1987, Mr. Crawford has been a senior
executive of Premiere Radio Networks, Inc.
From March 1983 until July 1997, Mr. Crawford
served as Chairman of Crystal Springs Water
Company.
BIOGRAPHICAL INFORMATION OF NATIONAL MEDIA BOARD OF DIRECTORS APPOINTEES
In the event the Transactions are not consummated, Andrew M. Schuon and Eric
R. Weiss will each resign, and the following persons will be appointed to the
Board of Directors to fill the vacancies created by such resignations.
Constantinos I. Costalas....... Constantinos I. Costalas, age 62, has been
the Chief Operating Officer since early 1997,
was Vice Chairman of the Company from
September 1994 until August 1998, and was the
Senior Financial Officer from April 1995
until May 1996. He served as Chairman of the
Board, President and Chief Executive Officer
of Glendale Bancorporation and as Chairman of
the Board, President and Chief Executive
Officer of Glendale National Bank of New
Jersey until February 1994. Such positions
were held since 1985 and 1976, respectively.
Mr. Costalas served as a Director of the
Company from May 1993 until August 1998.
Robert E. Keith, Jr............ Robert E. Keith, Jr., age 56, serves as Chief
Executive Officer of Technology Leaders I
Management, Technology Leaders II Management
and Radnor Venture Partners, venture capital
funds affiliated with Safeguard. Prior to his
affiliation with Safeguard in 1989, Mr. Keith
held executive positions with Fidelity Bank
for over twenty years, most recently as Vice
Chairman. Mr. Keith is also a Director of
Cambridge Technology Partners, Gandalf
Technologies, Inc. and Wave Technologies
International, Inc. Mr. Keith served as a
Director of the Company from November 1996
until August 1998.
MEETINGS OF THE BOARD OF DIRECTORS AND ITS COMMITTEES
During the fiscal year ended March 31, 1998, there were 18 meetings of the
Board of Directors. All nominees attended at least 75% of the meetings held
during their terms as Directors. The Company's Board of Directors has, among
others, an Audit Committee, a Compensation Committee and a Board Affairs
Committee (which functions as the Company's Nominating Committee). Each of
such committees met at least once during the fiscal year ended March 31, 1998.
All committee members attended at least 75% of all committee meetings held
during their terms as members of such committees.
28
<PAGE>
Audit Committee. The Audit Committee is currently composed of three non-
employee Directors. The current members of the Audit Committee are Messrs.
Dowden (Chairman), Goldstein and Yoskin. This committee meets with the
Company's independent public accountants to review the scope and results of
auditing procedures and the Company's accounting procedures and controls. The
Audit Committee also provides general oversight with respect to the accounting
principles employed in the Company's financial reporting. The Audit Committee
met once during the fiscal year ended March 31, 1998.
Compensation Committee. The Compensation Committee is composed of three non-
employee Directors. The current members of the Compensation Committee are
Messrs. Yoskin (Chairman), Dowden and Schuon. The Compensation Committee is
responsible for determining and reviewing the compensation of the officers of
the Company, including the Company's Chief Executive Officer. The Compensation
Committee determines and reviews executive compensation matters and
administers the terms and provisions of the Company's stock option plans. The
Compensation Committee met three times during the fiscal year ended March 31,
1998.
Board Affairs Committee. The Board Affairs Committee is composed of two
Directors. The current members of the Board Affairs Committee are Messrs.
Hammer (Chairman) and Dowden. The Board Affairs Committee oversees the
structure, composition and committees of the Board of Directors, including
reviewing candidates and recommending to the Board of Directors nominees for
membership on the Board of Directors. The Board Affairs Committee was
constituted in May 1997. The Board Affairs Committee met twice during the
fiscal year ended March 31, 1998.
29
<PAGE>
PROPOSAL III
APPROVAL OF AMENDMENT TO THE COMPANY'S 1991 STOCK OPTION PLAN
At the Stockholders' Meeting, there will be presented to the stockholders a
proposal increasing the number of shares covered by the 1991 Stock Option
Plan, as heretofore amended (the "1991 Option Plan"), by 800,000 shares.
Previously, stockholders have approved a total of 6,565,000 shares of Common
Stock for issuance under the 1991 Option Plan.
In addition to the TMC Warrants (as more fully described under Proposal I),
the Board of Directors has determined that an additional 800,000 shares of
Common Stock are required for the Company to retain and attract highly
qualified personnel to the Company following consummation of the Transactions.
The Company currently has only approximately 280,000 shares of Common Stock
available for awards under the 1991 Option Plan. While it is expected that a
modest number of shares of Common Stock will become available to the Company
due to forfeiture, the Board of Directors believes that the TMC Warrants and
existing shares of Common Stock available for awards under the 1991 Option
Plan are insufficient to meet the corporate goals of the Investor Group
following consummation of the Transactions.
This amendment will not be effective unless and until stockholder approval
is obtained, and will not change the 1991 Option Plan except as stated above.
SUMMARY DESCRIPTION OF THE 1991 OPTION PLAN, AS IT APPLIES TO PROPOSAL III.
In July 1996 the Board adopted and the stockholders of the Company approved
the most recent amendments to the Company's 1991 Option Plan. As in effect,
the 1991 Option Plan provides for the granting of options intended to qualify
as incentive stock options ("ISOs") as defined in Section 422 of the Internal
Revenue Code of 1986, as amended (the "Code"), nonqualified stock options
("NQSOs") (ISOs and NQSOs, collectively, the "Stock Options"), restricted
stock, and stock appreciation rights ("SARs"). Effective August 28, 1998, the
Board of Directors adopted a further amendment and restatement to the 1991
Option Plan, subject to receipt of stockholder approval at the Stockholders'
Meeting. The 1991 Option Plan as adopted by the Board of Directors is set
forth as Annex C to this Proxy Statement. The description of the 1991 Option
Plan contained herein is qualified in its entirety by reference to such Annex
C.
General. Employees eligible for participation in the 1991 Option Plan
include key employees, independent contractors and consultants who perform
services for the Company or a subsidiary company, and non-employee directors
("Eligible Participants"). Only Eligible Participants who are officers or
other employees of the Company or a subsidiary company are eligible to receive
ISOs. All Eligible Participants are eligible to receive NQSOs, restricted
stock and SARs. No Eligible Participant may be granted Stock Options for more
than 1,000,000 shares in any one taxable year of the Company. Under the terms
of the current 1991 Option Plan, options to purchase 6,565,000 shares of
Common Stock are available for issuance. Approval of the proposed amendment to
the 1991 Option Plan would increase the maximum number of shares of Common
Stock that would be issuable under the 1991 Option Plan by an additional
800,000 shares.
Administration. The 1991 Option Plan is administered by a committee (the
"Committee") of the Board of Directors consisting of not less than two persons
who are "disinterested persons" under Rule 16b-3 of the Exchange Act and
"outside directors" under Section 162(m) of the Code. The Committee has full
power to administer and interpret the 1991 Option Plan. The Company's
Compensation Committee serves as the "Committee" for the 1991 Option Plan.
The Shares. Each of the Stock Options will be granted for a term of ten
years from the date of grant, subject to earlier termination on the optionee's
death, disability or termination of employment or other relationship with the
Company. The Stock Options are subject to vesting, which commences on the date
of grant
30
<PAGE>
and ends on the date or dates determined by the Committee. In the event of a
change of control, as defined in the 1991 Option Plan, all options granted
become immediately vested and exercisable. The Stock Options are not
assignable or otherwise transferrable except by will or the laws of descent
and distribution and, if permitted under Rule 16b-3 of the Exchange Act and
the Committee, pursuant to a qualified domestic relations order as defined
under the Code or Title I of ERISA. The exercise price of the Stock Option is
payable in cash, or, with the consent of the Committee, by delivering shares
of Common Stock already owned by the optionee, by a combination of cash and
shares, or by delivering a note approved by the Committee at the time of
grant. Shares subject to Stock Options granted under the 1991 Option Plan
which lapse or terminate may again be granted under the 1991 Option Plan. The
Committee may offer to exchange new options for existing options, with the
shares subject to the existing options being again available for grant under
the 1991 Option Plan.
Amendments. The Committee has the full authority to amend the 1991 Option
Plan, except that stockholder approval is required to (i) increase the number
of shares available for the 1991 Option Plan, (ii) materially increase the
benefits accruing to optionees, (iii) materially modify the eligibility
requirements for options granted under the 1991 Option Plan, (iv) increase the
number of shares for which any optionee may be granted Stock Options, or (v)
modify the provisions for determining fair market value under the 1991 Option
Plan. The 1991 Option Plan shall be effective as of August 28, 1998, subject
to stockholder approval and will terminate on August 28, 2008, the tenth
anniversary of its effective date.
Federal Income Tax Consequences. The federal income tax consequences of an
optionee's participation in the 1991 Option Plan are complex and subject to
change. The following discussion is only a summary of the general rules
applicable to Stock Options.
The tax consequences of a Stock Option depend on whether the Stock Option is
an ISO or a NQSO. An optionee will not recognize income at the time of a grant
or exercise of an ISO and the Company may not deduct the related expense at
those times. However, for purposes of the alternative minimum tax, the
difference between the exercise price and the fair market value of the stock
will be included in alternative minimum tax income. The optionee has a taxable
event only upon a later sale or disposition of the stock acquired pursuant to
the exercise of the ISO. The tax treatment of the disposition of the stock
will depend on when the optionee disposes of the stock. An optionee who
disposes of stock acquired pursuant to the exercise of an ISO within one year
from the date of exercise or within two years of the date of grant will
recognize ordinary income equal to the difference between the ISO's exercise
price and the lesser of the fair market value of the stock on the date of
exercise or the date of disposition and capital gain to the extent that the
amount received on disposition exceeds such fair market value on the date of
exercise. To the extent that an optionee recognizes ordinary income pursuant
to the preceding sentence, the Company is allowed a deduction for federal
income tax purposes in like amount in the year of disposition. An optionee who
disposes of stock after a date that is both two years after the grant and one
year after its exercise will recognize capital gain equal to the difference
between the amount received on disposition and the adjusted basis in the
stock.
A different set of rules govern NQSOs. There are no federal income tax
consequences to the optionee or the Company upon the grant of NQSOs. Upon
exercise of a NQSO, the optionee will recognize ordinary income in the amount
by which the fair market value of the Stock Option exceeds the exercise price
of the Stock Option. The Company is allowed a deduction for federal income tax
purposes equal to the amount of ordinary income recognized by the optionee at
the time of exercise of NQSOs. The optionee's holding period for purposes of
determining whether any subsequently realized gain or loss will be long-term
or short-term will begin at the time the optionee recognizes ordinary income.
If, at the time of issuance of the option shares, the optionee is subject to
the restrictions of Section 16(b) of the Exchange Act, then the optionee
generally will recognize ordinary income as of the later of (i) the date of
exercise, or (ii) the expiration of six months from the date of option grant,
based upon the difference between the fair market value of the option shares
at such time and the exercise price.
Section 162(m). Under Section 162(m) of the Code, the Company may be
precluded from claiming a federal income tax deduction for total remuneration
in excess of $1,000,000 paid to the chief executive officer or
31
<PAGE>
to any of the other four most highly compensated officers in any one year.
Total remuneration would include amounts received upon the exercise of Stock
Options granted after February 17, 1993. An exception does exist, however, for
"performance-based" remuneration, including amounts received upon the exercise
of Stock Options pursuant to a plan approved by stockholders that meets
certain requirements. The Option Plan is intended to make option grants
thereunder meet the requirements of "performance-based" remuneration.
VOTE REQUIRED FOR APPROVAL
The proposal to approve the issuance and grants of up to 800,000 additional
shares of Common Stock under the 1991 Option Plan requires the affirmative
vote of a majority of shares present in person or represented by proxy at the
Stockholders' Meeting for its approval. Abstentions may be specified on the
proxy and will be considered present at the Stockholders' Meeting, but will
not be counted as affirmative votes. Abstentions, therefore, will have the
practical effect of voting against the proposal because the affirmative vote
of a majority of the shares present at the Stockholders' Meeting is required
to approve the proposal. Broker non-votes will not be voted or have any effect
on Proposal III.
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE FOR PROPOSAL III.
32
<PAGE>
PROPOSAL IV
RATIFICATION OF APPOINTMENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS
The Board of Directors has, subject to the ratification by the stockholders,
appointed Ernst & Young LLP, independent certified public accountants, to
audit the financial statements of the Company for the fiscal year ending March
31, 1999. Ernst & Young LLP has audited the financial statements of the
Company for each of the six fiscal years ended March 31, 1998. Representatives
of Ernst & Young LLP are expected to be present at the Stockholders' Meeting,
will have the opportunity to make a statement if they desire to do so and are
expected to be available to respond to appropriate questions from those
attending the Stockholders' Meeting.
VOTE REQUIRED FOR APPROVAL
The proposal to ratify the appointment of Ernst & Young LLP requires the
affirmative vote of the majority of shares present in person or represented by
proxy at the Stockholders' Meeting for its approval. Abstentions may be
specified on the proposal and will be considered present at the Stockholders'
Meeting, but will not be counted as affirmative votes. Abstentions, therefore,
will have the practical effect of voting against the proposal because the
affirmative vote of a majority of the shares present at the Stockholders'
Meeting is required to approve the proposal. Broker non-votes will not be
voted or have any effect on Proposal IV.
THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE FOR PROPOSAL IV.
33
<PAGE>
SECURITY OWNERSHIP OF MANAGEMENT
On September 18, 1998, there were outstanding and entitled to vote
approximately [25,453,752] shares of Common Stock and 81,250 shares of Series
B Preferred Stock (each of which is entitled to ten votes on all non-election
matters expected to be presented to the Company's stockholders at the
Stockholders' Meeting). The following table sets forth certain information at
September 18, 1998 with respect to the beneficial ownership of shares of
Common Stock by (i) each existing Director (including all nominees), (ii) each
executive officer of the Company and (iii) all Directors and executive
officers of the Company as a group. Except for John W. Kirby, Stephen C.
Lehman, Andrew M. Schuon, Robert N. Verratti and Eric R. Weiss, the address
for each such person is Eleven Penn Center, Suite 1100, 1835 Market Street,
Philadelphia, Pennsylvania. The address for Messrs. Kirby, Lehman, Schuon,
Verratti and Weiss is 15821 Ventura Boulevard, Suite 570, Los Angeles,
California.
NUMBER OF ISSUED AND OUTSTANDING SHARES OF STOCK OWNED
<TABLE>
<CAPTION>
TOTAL NUMBER OF SHARES PERCENT OF COMMON PERCENT OF
OF COMMON STOCK STOCK BENEFICIALLY TOTAL VOTING
NAME(1) BENEFICIALLY OWNED(2)(3) OWNED(4)(5) POWER(4)(6)
------- ------------------------ ------------------ ------------
<S> <C> <C> <C>
Constantinos I. Costalas
(7).................... 222,349 * *
Albert R. Dowden........ 11,000 * *
William M. Goldstein.... 20,000 * *
Frederick S. Hammer..... 202,500 * *
John W. Kirby........... 639,784 2.5% 2.4%
Stephen C. Lehman (8)... 10,382,354 29.0% 28.3%
Andrew M. Schuon........ 0 -- --
Brian J. Sisko (9)...... 63,384 * *
John J. Sullivan........ 153,605 * *
Robert N. Verratti...... 700,000 2.7% 2.6%
Jon W. Yoskin, II....... 117,952 * *
Eric R. Weiss (8)....... 10,382,354 29.0% 28.3%
All executive officers
and Directors
as a group
(12 persons)........... 12,513,110 33.4% 32.7%
</TABLE>
- --------
* Less than 1%.
(1) To the Company's knowledge, except as noted below each Director and
executive officer listed above has sole voting and investment power (with
his spouse, in certain circumstances) with respect to all shares indicated
as beneficially owned by such Director or executive officer.
(2) Includes shares which may be acquired upon the exercise of immediately
exercisable outstanding employee stock options in accordance with Rule
13d-3 under the Exchange Act as follows: Mr. Costalas: 220,000; Mr.
Hammer: 162,500; Mr. Kirby: 300,000; Mr. Sisko: 57,500; Mr. Sullivan:
80,000; Mr. Verratti: 700,000; and Mr. Yoskin: 25,000.
(3) Includes shares which may be acquired upon the exercise of immediately
exercisable warrants in accordance with Rule 13d-3 under the Exchange Act
as follows: Mr. Hammer: 30,000; Mr. Keith: 30,000; and Mr. Sullivan:
22,500.
(4) All percentages are rounded to the nearest tenth of a percent.
(5) Based on [25,453,752] shares issued and outstanding as of September 18,
1998, as determined in accordance with Rule 13d-3.
(6) Based on [26,266,252] shares issued and outstanding as of September 18,
1998, including all shares of Common Stock owned and all shares of Common
Stock issuable upon exercise of Series B Preferred Stock owned, but not
including options to purchase Common Stock or warrants exercisable into
Common Stock.
(7) Includes 300 shares of Common Stock beneficially owned by Mr. Costalas'
son. Mr. Costalas disclaims any beneficial ownership of such shares of
Common Stock.
(8) Consists of shares of Common Stock underlying the TMC Options exercisable
within sixty days of the date hereof and shares of Common Stock underlying
the Series D Preferred Stock held by ACO. TMC is the manager of ACO and
has voting and dispositive power of the securities held by ACO. Messrs.
Lehman, Weiss (through an entity controlled by Mr. Weiss) and Yukelson own
all of the equity interests in TMC and thus are deemed to share voting and
dispositive power with TMC. See "Security Ownership of Certain Beneficial
Owners."
(9) Includes 2,000 shares of Common Stock beneficially owned by Mr. Sisko's
wife.
34
<PAGE>
BIOGRAPHICAL INFORMATION OF CERTAIN EXECUTIVE OFFICERS
Constantinos I. Costalas, age 62, presently serves as Chief Operating
Officer of the Company. From September 1994 until August 1998, he was Vice
Chairman of the Company, and from April 1995 until May 1996 he was Senior
Financial Officer of the Company. He served as Chairman of the Board,
President and Chief Executive Officer of Glendale Bancorporation and as
Chairman of the Board, President and Chief Executive Officer of Glendale
National Bank of New Jersey until February 1994. Such positions were held
since 1985 and 1976, respectively. Mr. Costalas served as a Director of the
Company from May 1993 until August 1998.
Brian J. Sisko, age 37, presently serves as Senior Vice President, Chief
Administrative Officer, Secretary and General Counsel. From January 1996 to
January 1997, Mr. Sisko was Vice President/Global Corporate Development of the
Company. Prior to joining the Company, Mr. Sisko was a partner with Klehr,
Harrison, Harvey, Branzburg & Ellers, LLP, Philadelphia, Pennsylvania, outside
legal counsel to the Company.
John J. Sullivan, age 51, has served as Senior Vice President and Chief
Financial Officer of the Company since January 1998. From April 1995 until
January 1998, Mr. Sullivan served as Senior Vice President-Administration.
From September 1991 until April 1995, Mr. Sullivan served as Chief Financial
Officer of the Company. Mr. Sullivan serves as a Director of the Franklin Mint
Credit Union.
35
<PAGE>
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
The following table sets forth certain information at September 18, 1998
with respect to each person, known by the Company to beneficially own more
than 5% of the Common Stock as determined in accordance with Rule 13d-3. The
information set forth below is derived, without independent investigation on
the part of the Company, from the most recent filings made by such persons on
Schedule 13D and Schedule 13G pursuant to Rule 13d-3. RGC Capital Investors
LDC and Capital Ventures International each own shares of Series D Securities
which may, in certain circumstances, be converted into or exercised for a
number of shares of Common Stock in excess of 4.9% of the number of
outstanding shares of Common Stock.
NUMBER OF ISSUED AND OUTSTANDING SHARES OF STOCK OWNED
<TABLE>
<CAPTION>
TOTAL NUMBER
OF SHARES OF PERCENT OF
SERIES B COMMON STOCK COMMON STOCK PERCENT OF
COMMON PREFERRED BENEFICIALLY BENEFICIALLY TOTAL VOTING
NAME(1) STOCK(2) STOCK OWNED(3) OWNED(4)(5) POWER(4)(6)
------- ---------- --------- ------------ ------------ ------------
<S> <C> <C> <C> <C> <C>
McCullough, Andrews & 1,861,632 0 1,861,632 7.3% 7.1%
Cappiello, Inc.(7).....
101 California Street
Suite 4250
San Francisco, CA 94111
NM Acquisition Co., 10,382,354 0 10,382,354 29.0% 28.3%
LLC(8).................
15821 Ventura Boulevard
Suite 570
Encino, CA 91436
Safeguard Group(9)(10).. 2,902,500 55,000 3,452,500 12.2% 11.9%
800 The Safeguard
Building
435 Devon Park Drive
Wayne, PA 19087
(a) Safeguard
Scientifics,
Inc.(10)(11)........ 1,950,000 50,000 2,450,000 8.9% 8.7%
(b) Technology Leaders
II Management
L.P.(10)(12)........ 750,000 0 750,000 2.9% 2.8%
(c) Robert E. Keith,
Jr.................. 55,000 0 55,000 * *
</TABLE>
- --------
* Less than 1%
(1) To the Company's knowledge, except as otherwise indicated in the
footnotes to this table, each of the persons named in this table has sole
voting and investment power with respect to all shares of Common Stock
reported as beneficially owned by such person.
(2) In accordance with Rule 13d-3, includes shares which may be acquired upon
the exercise of immediately exercisable outstanding stock options and
warrants.
(3) In accordance with Rule 13d-3, includes shares of Common Stock issuable
upon the conversion of Series B Preferred Stock.
(4) All percentages are rounded to the nearest tenth of a percent.
(5) Based on 25,453,752 shares issued and outstanding as of September 18,
1998, as determined in accordance with Rule 13d-3.
(6) Based on 26,266,252 shares issued and outstanding as of September 18,
1998, including all shares of Common Stock owned and all shares of Common
Stock issuable upon exercise of Series B Preferred Stock owned, but not
including options to purchase Common Stock and warrants exercisable into
Common Stock.
(7) Based on information contained in a Schedule 13G dated February 17, 1998.
McCullough, Andrews & Cappiello, Inc. have sole voting and dispositive
power with respect to 17,232 shares of Common Stock and shared voting and
dispositive power with respect to 1,844,400 shares of Common Stock.
36
<PAGE>
(8) The shares included represent: (a) the exercise of the vested TMC Options
into 70,833 shares of Common Stock; (b) the conversion of 10,000 shares
of Series D Preferred Stock held by ACO into 9,318,579 shares of Common
Stock within sixty days of the date hereof; (c) the exercise of the
992,942 warrants acquired by ACO pursuant to the Series D Agreement. For
the purposes of the definition of "beneficial ownership" pursuant to Rule
13d-3 under the Exchange Act, Messrs. Lehman, Weiss, Yukelson and Schuon
are deemed to be the beneficial owner of all shares held by ACO and TMC.
(9) Based on information provided by the Safeguard Group.
(10) Includes shares which may be acquired upon the exercise of immediately
exercisable warrants in accordance with Rule 13d-3 under the Exchange
Act.
(11) All shares listed as beneficially owned by Safeguard are held in the name
of Safeguard Scientifics (Delaware), Inc. ("SSD"). SSD is a wholly owned
subsidiary of Safeguard. Safeguard and SSD each have shared voting and
investment power with respect to such shares.
(12) All shares listed as beneficially owned by TLM are held in the name of
Technology Leaders II L.P. and Technology Leaders II Offshore C.V. TLM is
the general partner of each of such entities has sole voting and
investment power with respect to such shares.
37
<PAGE>
EXECUTIVE COMPENSATION
The following Summary Compensation Table sets forth the cash compensation
and certain other components of the compensation received by (i) Robert N.
Verratti, former Chief Executive Officer of the Company, (ii) Mark P.
Hershhorn, former President and Chief Executive Officer of the Company, and
(iii) the other four most highly compensated executive officers of the Company
during the fiscal year ended March 31, 1998 for each of the fiscal years ended
March 31, 1998, 1997 and 1996.
SUMMARY COMPENSATION TABLE
<TABLE>
<CAPTION>
LONG-TERM
ANNUAL COMPENSATION COMPENSATION
---------------------------------------- ----------------------------------------
OTHER RESTRICTED SECURITIES ALL
NAME AND FISCAL ANNUAL STOCK UNDERLYING OTHER
PRINCIPAL POSITION YEAR SALARY BONUS(1) COMPENSATION(2) AWARDS(3) OPTIONS COMPENSATION(4)
------------------ ------ -------- -------- --------------- ---------- ---------- ---------------
<S> <C> <C> <C> <C> <C> <C> <C>
Robert N. Verratti(5)... 1998 $247,860 0 $9,000 0 700,000 $ 0
Former Chief Executive
Officer
Mark P. Hershhorn(6).... 1998 $550,000 0 $2,400 0 0 $ 475
Former President and 1997 $542,022 0 $9,600 0 250,000(7) $1,224,453
Chief
Executive Officer 1996 $439,964 $195,464 $9,600 $195,476 0 $ 11,642
Constantinos I. 1998 $325,000 0 $7,200 0 195,000 $ 39,988
Costalas...............
Vice Chairman of the 1997 $318,078 0 $7,200 0 250,000(8) $ 8,730
Board
and Chief Operating 1996 $212,500 $159,198 $7,200 $159,209 140,000(8) $ 8,730
Officer
John W. Kirby(9)........ 1998 $312,500 $ 37,500 $9,600 0 300,000 $ 7,840
President of the 1997 $300,000 0 $7,200 0 30,000(10) $ 32,255
Company
and Chairman and Chief 1996 $133,957 $ 42,972 $4,288 $ 42,966 0 $ 996
Executive Officer of
Quantum Television
John J. Sullivan........ 1998 $210,000 0 $8,400 0 40,000 $ 2,415
Senior Vice President 1997 $200,348 0 $8,400 0 25,000(10) $ 2,330
and
Chief Financial Officer 1996 $190,017 $119,489 $8,400 $ 13,283 0 $ 8,184
Frederick S. 1998 $198,800 0 $9,000 0 200,000(12) $ 5,190
Hammer(11).............
Chairman of the Board 1997 $ 18,205 0 0 0 100,000 $ 0
of Directors
</TABLE>
- -------
(1) Bonuses (which include cash payments and awards of Common Stock as set
forth under Restricted Stock Awards) have been included in the year
earned, portions of which were actually paid in the following fiscal
year.
(2) Automobile allowance.
(3) Consists of awards made pursuant to the Company's Management Incentive
Plan for the 1996 fiscal year. Such officers received the following
number of shares of Common Stock which have been valued based upon a
closing price of $16.50 per share on March 29, 1996, the date of grant:
Mr. Hershhorn, 11,846 shares; Mr. Costalas, 9,649 shares, Mr. Kirby,
2,604 shares; and Mr. Sullivan, 805 shares.
(4) Amounts for fiscal 1998 consist of: (i) payment to Mr. Costalas for
unused vacation, $31,258; (ii) the Company's contributions under a 401(k)
plan for Mr. Hershhorn, $475; and Mr. Sullivan, $475; and (iii) the
Company's payment of supplemental life insurance premiums on behalf of
each of Mr. Costalas, $8,730; Mr. Kirby, $7,840; Mr. Sullivan, $1,940;
and Mr. Hammer, $5,190. Amounts for fiscal 1997 consist of: (i) severance
payments made or accrued for Mr. Hershhorn, $1,219,453: (ii) the
Company's contributions under a 401(k) plan for Mr. Hershhorn, $502; and
Mr. Sullivan, $500; and (iii) the Company's payment of supplemental life
insurance premiums on behalf of Mr. Hershhorn, $4,884; Mr. Costalas,
$8,730; Mr. Kirby, $5,530; and Mr. Sullivan $1,830; (iv) the Company's
payment of moving expenses on behalf of Mr. Kirby: $25,000; and (v) the
Company's payment to Mr. Kirby for use of Mr. Kirby's
38
<PAGE>
automobile: $1,725. Amounts for fiscal 1996 consist of: (i) the Company's
contributions under a 401(k) plan for Mr. Hershhorn, $6,672; and Mr.
Sullivan, $6,454; and (ii) the Company's payment of supplemental life
insurance premiums on behalf of each of Mr. Hershhorn, $4,970; Mr.
Costalas, $8,730; and Mr. Sullivan, $1,730 and (iii) the Company's payment
to Mr. Kirby for use of Mr. Kirby's automobile: $996.
(5) Mr. Verratti joined the Company in May 1997 and served as the Company's
Chief Executive Officer until August 1998, at which time Stephen C.
Lehman was named acting Chief Executive Officer of the Company.
(6) Mr. Hershhorn resigned from the Company in April 1997. Payments made to
Mr. Hershhorn in fiscal 1998 reflect amounts accrued in fiscal 1997.
(7) Such options lapsed in connection with Mr. Hershhorn's resignation from
the Company.
(8) In connection with the execution of an amendment to Mr. Costalas'
employment agreement in April 1997, such options were subsequently
cancelled and replaced by options to purchase 195,000 shares of Common
Stock.
(9) Mr. Kirby joined the Company in October 1995.
(10) During fiscal 1997, Messrs. Kirby and Sullivan were granted options to
purchase 60,000 and 50,000 shares of Common Stock, respectively. In
fiscal 1997, such options were cancelled and the Company granted
replacement options to purchase 30,000 and 25,000 shares of Common Stock,
respectively, to such officers.
(11) Mr. Hammer was appointed Chairman of the Board of Directors of the
Company in February 1997.
(12) During fiscal 1997, Mr. Hammer was granted options to purchase 50,000
shares of Common Stock. In fiscal 1998, such options were cancelled and
the Company granted Mr. Hammer replacement options to purchase 25,000
shares of Common Stock. See "10-Year Option Repricings."
39
<PAGE>
EMPLOYMENT CONTRACTS, TERMINATION OF EMPLOYMENT AND CHANGE-IN-CONTROL
ARRANGEMENTS
ROBERT N. VERRATTI, Chief Executive Officer.
In January 1998, the Company entered into an amended and restated employment
agreement with Mr. Verratti pursuant to which Mr. Verratti was employed as
Chief Executive Officer of the Company, at an annual minimum salary of
$200,000. Mr. Verratti is entitled to participate in the Company's Management
Incentive Plan and its other executive compensation programs. The Company also
maintains $1,000,000 of insurance on the life of Mr. Verratti, which is
payable to the beneficiaries designated by Mr. Verratti, and pays Mr. Verratti
an automobile allowance. Pursuant to Mr. Verratti's original employment
agreement with the Company, he holds options to purchase 700,000 shares of
Common Stock. The options are exercisable at a price of $4.75 per share. The
options are for a term of ten years from the date of grant.
The agreement provides that either party may terminate the agreement upon 60
days' prior written notice. If the Company terminates the agreement without
Cause (as defined in the agreement) or if Mr. Verratti terminates the
agreement for Good Reason (as defined in the agreement), the Company will be
required to (i) pay Mr. Verratti, in installments, an amount equal to the base
salary and bonus payable during the balance of the term of the agreement or
the base salary and bonus payable for one year, whichever is longer, and (ii)
maintain his employee benefits for one year after termination or for the
balance of the term of the agreement, whichever is longer.
If Mr. Verratti's employment with the Company is terminated within 30 days
of a Change in Control (as defined in the agreement), Mr. Verratti will be
entitled to receive, within 30 days of such termination of employment, a lump-
sum payment in an amount equal to $600,000. Pursuant to the agreement, the
Company has also agreed to indemnify Mr. Verratti in his capacity as an
officer and Director of the Company to the maximum extent permitted by law and
to make advances to Mr. Verratti for his expenses (including attorneys' fees)
incurred in defending any civil, criminal, administrative or investigative
action, suit or proceeding upon receipt by the Company of an undertaking by or
on behalf of Mr. Verratti to repay such amounts if it is ultimately determined
that Mr. Verratti is not entitled to such indemnification.
The foregoing description is qualified in its entirety by the discussion set
forth above under "Proposal I, Description of Related Agreements and
Transactions--Certain Waivers." Upon consummation of the Transactions
described in Proposal I, Mr. Verratti's employment will terminate without any
effect other than as discussed in such section above.
MARK P. HERSHHORN, Former President and Chief Executive Officer.
On April 24, 1997, the Company entered into a separation agreement with Mark
P. Hershhorn, the Company's former President and Chief Executive Officer, and
a former Director of the Company. Pursuant to the separation agreement, Mr.
Hershhorn was provided 60 days' prior written notice of termination pursuant
to the terms of his employment agreement with the Company. The separation
agreement served as formal notice of Mr. Hershhorn's resignation as an officer
or Director of the Company and of each subsidiary and affiliate of the
Company. The separation agreement provides, in accordance with the termination
provisions of his prior employment agreement, that Mr. Hershhorn will be paid
$550,000 per annum until June 22, 1999. Additionally, the separation agreement
requires the Company to maintain through August 30, 1998 all employee benefit
plans and programs provided to Mr. Hershhorn during his employment with the
Company, with the exception of the Company's stock option plans and bonus
plans, including the Company's Management Incentive Plan. Mr. Hershhorn also
agreed to consult and cooperate with the Company in connection with any
litigation or business which arose during Mr. Hershhorn's tenure with the
Company.
CONSTANTINOS I. COSTALAS, Vice Chairman of the Board of Directors and Chief
Operating Officer.
On April 28, 1997, the Company entered into an amended and restated
employment agreement with Mr. Costalas. Pursuant to the agreement, as
subsequently amended, Mr. Costalas is employed as Vice Chairman of
40
<PAGE>
the Company for a term ending on September 27, 1999, at an annual minimum base
salary of $325,000. Mr. Costalas is entitled to participate in the Company's
Management Incentive Plan and its other executive compensation programs. The
Company maintains $1,000,000 of insurance on the life of Mr. Costalas, which
is payable to beneficiaries designated by Mr. Costalas, pays certain of Mr.
Costalas's club dues and pays Mr. Costalas an automobile allowance. Pursuant
to this employment agreement, Mr. Costalas was granted options to purchase up
to 195,000 shares of Common Stock in replacement of options to purchase
390,000 shares of Common Stock held by Mr. Costalas at the time the employment
agreement was executed. The replacement options are exercisable at a price of
$7.00 per share and vest in one-third increments, on April 28, 1997, March 27,
1998 and September 27, 1998. All of such options expire on April 28, 2007.
The agreement provides that either party may terminate the agreement upon 60
days' prior written notice. If the Company terminates the agreement without
Cause (as defined in the agreement) or if Mr. Costalas terminates the
agreement for Good Reason (as defined in the agreement), the Company will be
required to (i) pay Mr. Costalas, in installments, an amount equal to the base
salary payable during the remainder of the term plus six months after the end
of such term, and (ii) maintain his employee benefits for the remainder of the
term plus a period of six months. The agreement also provides that, in the
event of the termination of Mr. Costalas' employment upon the occurrence of a
Change of Control (as defined in the agreement), Mr. Costalas will be entitled
to receive, within 30 days of the Change of Control, a lump-sum payment in an
amount equal to three years' base salary at the then current amount and a
lump-sum payment representing the annual bonuses to which Mr. Costalas would
otherwise have been entitled through the remainder of the term based on the
last annual bonus received by Mr. Costalas in the prior fiscal year. In
addition, Mr. Costalas will be entitled to the continuation of certain
allowances and benefits for the remainder of the term and the immediate
vesting of all unvested stock options. If Mr. Costalas' employment is not
terminated within 30 days after a Change of Control, his employment agreement
shall automatically be extended for an additional three years from the date of
the Change of Control. Pursuant to the agreement, the Company has also agreed
to indemnify Mr. Costalas in his capacity as an officer and Director of the
Company to the maximum extent permitted by law and to make advances to Mr.
Costalas for his expenses (including attorneys' fees) incurred in defending
any civil, criminal, administrative or investigative action, suit or
proceeding upon receipt by the Company of an undertaking by or on behalf of
Mr. Costalas to repay such amounts if it is ultimately determined that Mr.
Costalas is not entitled to such indemnification.
The foregoing description is qualified in its entirety by the discussion set
forth above under "Proposal I, Description of Related Agreements and
Transactions--Certain Waivers." Upon consummation of the Transactions
described in Proposal I, Mr. Costalas' employment agreement will be amended as
described above under "Proposal I, Description of Related Agreements and
Transactions--Certain Waivers."
JOHN W. KIRBY, President.
On March 20, 1998 the Company entered into an employment agreement with Mr.
Kirby pursuant to which Mr. Kirby serves as President of the Company and as
Chairman, President and Chief Executive Officer of Quantum Television until
September 30, 1998 at an annual minimum base salary of $325,000. In addition
to the base salary payable pursuant to the agreement, Mr. Kirby is entitled to
receive a minimum of $75,000 per annum in bonuses, which $75,000 is advanced
pro rata during the year. Under the terms of the agreement, the increased base
salary and bonus were deemed to have commenced as of October 1997. Mr. Kirby
is not entitled to participate in the Company's Management Incentive Plan, the
DirectAmerica Bonus Plan and the Company's other executive compensation plans;
in lieu thereof, he is eligible to participate in the Company's Production
Bonus Program. The Company reimburses Mr. Kirby for premiums associated with
up to $1,000,000 of insurance on the life of Mr. Kirby, which is payable to
beneficiaries designated by Mr. Kirby; pays certain of Mr. Kirby's club dues;
and, pays Mr. Kirby an automobile allowance. Pursuant to this employment
agreement, Mr. Kirby was granted options to purchase up to 300,000 shares of
Common Stock. The options were immediately exercisable at a price of $2.69 per
share. Such options expire on January 28, 2008.
In the event Mr. Kirby terminates this agreement on account of a material
breach of the Agreement by the Company, or if Mr. Kirby is terminated by the
Company without Cause (as defined in the agreement), the
41
<PAGE>
Company will be required to pay Mr. Kirby, in installments, an amount equal
his full base salary payable during the remainder of the term, and to maintain
his employee benefits for the remainder of the term. The agreement also
provides that in the event of a Change of Control (as defined in the
agreement) of the Company, Mr. Kirby may terminate this Agreement by giving
the Company 30 days' written notice. Pursuant to the agreement, the Company
has agreed to indemnify Mr. Kirby in his capacity as an officer of the Company
to the maximum extent permitted by law and to pay Mr. Kirby's expenses
(including attorneys' fees) incurred in defending any civil, criminal,
administrative or investigative action, suit or proceeding upon receipt by the
Company of an undertaking by or on behalf of Mr. Kirby to repay such amounts
if it is ultimately determined that Mr. Kirby is not entitled to such
indemnification.
JOHN J. SULLIVAN, Senior Vice President.
On June 2, 1998, the Company entered into an employment agreement with Mr.
Sullivan, pursuant to which he is employed as a Senior Vice President of the
Company at an annual minimum base salary of $210,000. The agreement provides
for an eight month notice period prior to termination. Mr. Sullivan is
entitled to participate in the Management Incentive Program and the Company
reimburses Mr. Sullivan for premiums associated with up to $1,000,000 of
insurance on the life of Mr. Sullivan, which is payable to beneficiaries
designated by Mr. Sullivan. The Company also pays Mr. Sullivan an automobile
allowance.
If the Company terminates the agreement without Cause (as defined in the
agreement) or if Mr. Sullivan terminates the agreement for Good Reason (as
defined in the agreement), the Company will be required to (i) pay Mr.
Sullivan, in installments, an amount equal to the base salary due under the
agreement for the remainder of the term, and (ii) maintain his employee
benefits for the remainder of the term. Pursuant to the agreement, the Company
has also agreed to indemnify Mr. Sullivan in his capacity as an officer of the
Company to the maximum extent permitted by law and to make advances to Mr.
Sullivan for his expenses (including attorneys' fees) incurred in defending
any civil, criminal, administrative or investigative action, suit or
proceeding upon receipt by the Company of an undertaking by or on behalf of
Mr. Sullivan to repay such amounts if it is ultimately determined that Mr.
Sullivan is not entitled to such indemnification.
FREDERICK S. HAMMER, Chairman of the Board of Directors.
On February 27, 1997, the Company entered into an employment agreement with
Mr. Hammer. Pursuant to the agreement, Mr. Hammer is employed as Chairman of
the Board of Directors of the Company at an annual minimum base salary of
$200,000. The Company maintains $1,000,000 of insurance on the life of Mr.
Hammer, which is payable to beneficiaries designated by Mr. Hammer. The
Company also pays Mr. Hammer an automobile allowance. Pursuant to his
employment agreement, Mr. Hammer was granted options to purchase up to 100,000
shares of Common Stock at a price of $6.625 per share which vest in annual
one-quarter increments, beginning on February 27, 1997. All of such options
expire on February 27, 2007.
The agreement provides that either party may terminate the agreement upon
ten days' prior written notice. If the Company terminates the agreement
without Cause (as defined in the agreement) or if Mr. Hammer terminates the
agreement for Good Reason (as defined in the agreement), the Company will be
required to (i) pay Mr. Hammer, in installments, an amount equal to one year's
base salary under the agreement, and (ii) maintain his employee benefits for a
period of six months. The agreement also provides that, in the event of the
termination of Mr. Hammer's employment within one year of the occurrence of a
Change of Control (as defined in the agreement), Mr. Hammer will be entitled
to receive, within 30 days of such termination, a lump-sum payment in an
amount equal to one year's base salary at the then current amount. In
addition, Mr. Hammer will be entitled to the continuation of certain
allowances and benefits for one year from the date of termination and the
immediate vesting of all unvested stock options. Pursuant to the agreement,
the Company has also agreed to indemnify Mr. Hammer in his capacity as an
officer and Director of the Company to the maximum extent permitted by law and
to make advances to Mr. Hammer for his expenses (including attorneys' fees)
incurred in defending any civil, criminal, administrative or investigative
action, suit or proceeding upon receipt by the Company of an undertaking by or
on behalf of Mr. Hammer to repay such amounts if it is ultimately determined
that Mr. Hammer is not entitled to such indemnification.
42
<PAGE>
The foregoing description is qualified in its entirety by the discussion set
forth above under "Proposal I, Description of Related Agreements and
Transactions--Certain Waivers." Upon consummation of the Transactions
described in Proposal I, Mr. Hammer's employment will terminate without any
effect other than as discussed in such section above.
STOCK OPTIONS GRANTED DURING FISCAL 1998
The following table sets forth certain information concerning options to
purchase Common Stock of the Company granted to the executive officers named
in the Summary Compensation Table in the fiscal year ended March 31, 1998.
OPTION GRANTS IN LAST FISCAL YEAR
<TABLE>
<CAPTION>
POTENTIAL REALIZABLE VALUE AT
ASSUMED ANNUAL RATES OF
STOCK PRICE APPRECIATION
INDIVIDUAL GRANTS FOR OPTION TERM(1)
----------------------------------------- ------------------------------
% OF TOTAL
NUMBER OF OPTIONS
SECURITIES GRANTED TO
UNDERLYING EMPLOYEES
OPTIONS IN FISCAL EXERCISE EXPIRATION
NAME GRANTED YEAR PRICE DATE 5% 10%
---- ---------- ---------- -------- ---------- -------------- ---------------
<S> <C> <C> <C> <C> <C> <C>
Robert N. Verratti...... 700,000 26.1% $4.75/sh 1/28/08 $ 2,091,075 $ 5,299,194
Mark P. Hershhorn....... 0 -- -- -- -- --
Constantinos I.
Costalas(2)............ 195,000 7.3% $7.00/sh 7/23/07 $ 858,441 $ 2,175,458
John W. Kirby........... 300,000 11.2% $2.69/sh 1/28/08 $ 507,518 $ 1,286,150
John J. Sullivan........ 25,000 0.9% $4.75/sh 12/8/07 $ 74,681 $ 189,257
John J. Sullivan........ 15,000 0.6% $3.94/sh 12/8/07 $ 37,168 $ 94,190
Frederick S. Hammer..... 25,000 0.9% $7.25/sh 6/18/07 $ 113,987 $ 288,866
Frederick S. Hammer..... 175,000 6.5% $5.63/sh 7/10/07 $ 619,618 $ 1,570,235
</TABLE>
- --------
(1) The exercise price of each stock option was equal to the market price of
the Common Stock on the date of grant. The actual value, if any, an option
holder may realize will be a function of the extent to which the stock
price exceeds the exercise price on the date the option is exercised and
also will depend on the option holder's continued employment through the
vesting period. The actual value to be reached by the option holder may be
greater or less than the values estimated in this table.
(2) In connection with the execution of an amendment to Mr. Costalas'
employment agreement with the Company in April 1997, 390,000 options were
subsequently cancelled and replaced by options to purchase 195,000 shares
of Common Stock at an exercise price of $7.00 per share.
43
<PAGE>
The following table sets forth certain information concerning the exercise
in the fiscal year ended March 31, 1998 of options to purchase Common Stock of
the Company by the executive officers named in the Summary Compensation Table
and the unexercised options to purchase Common Stock of the Company held by
such individuals at March 31, 1998. Year-end values are based upon the closing
market price per share of the Company's Common Stock on March 31, 1998 of
$2.50.
AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR AND FISCAL YEAR END OPTION
VALUES
<TABLE>
<CAPTION>
NUMBER OF SECURITIES
UNDERLYING UNEXERCISED VALUE OF UNEXERCISED
OPTIONS AT IN-THE-MONEY OPTIONS
FY-END (#) AT FY-END ($)(1)
------------------------- -------------------------
SHARES
ACQUIRED ON VALUE
NAME EXERCISE REALIZED(1) EXERCISABLE UNEXERCISABLE EXERCISABLE UNEXERCISABLE
---- ------------ ----------- ----------- ------------- ----------- -------------
<S> <C> <C> <C> <C> <C> <C>
Robert N. Verratti...... 0 0 700,000 0 -- --
Mark P. Hershhorn....... 0 0 -- -- -- --
Constantinos I.
Costalas............... 0 0 155,000 65,000 -- --
John W. Kirby........... 0 0 300,000 30,000 -- --
John J. Sullivan........ 0 0 80,000 35,000 -- --
Frederick S. Hammer..... 0 0 118,750 206,250 -- --
</TABLE>
- --------
(1) Values are calculated by subtracting the exercise price from the fair
market value as of the exercise date or fiscal year end, as appropriate.
Values are reported before any taxes associated with exercise or
subsequent sale of the underlying stock.
The following table sets forth certain information concerning the repricing
of options for the ten-year period ending on March 31, 1998.
10-YEAR OPTION REPRICINGS
<TABLE>
<CAPTION>
LENGTH OF ORIGINAL
NUMBER OF MARKET PRICE OF EXERCISE PRICE OPTION TERM
SECURITIES STOCK AT TIME AT TIME OF NEW REMAINING AT DATE
UNDERLYING OF REPRICING OR REPRICING OR EXERCISE OF REPRICING
NAME DATE OPTIONS REPRICED AMENDMENT AMENDMENT PRICE OR AMENDMENT
---- ------- ---------------- --------------- -------------- -------- -------------------
<S> <C> <C> <C> <C> <C> <C>
Constantinos I.
Costalas, Vice
Chairman............... 4/24/97 125,000 $8.125/sh $16.375/sh $7.00/sh 9 years, 90 days
4/24/97 70,000 $8.125/sh $ 12.99/sh $7.00/sh 8 years, 153 days
Frederick S. Hammer..... 6/18/97 25,000 $ 7.25/sh $16.375/sh $7.25/sh 9 years, 37 days
</TABLE>
COMPENSATION COMMITTEE REPORT ON OPTION REPRICING FOR THE FISCAL YEAR ENDED
MARCH 31, 1998
At a meeting of the Board of Directors held on April 24, 1997, based upon
the recommendation of the Compensation Committee, the Board of Directors
approved an offer to be made to Mr. Costalas concerning the repricing of
certain of his stock options. Such offer was recommended and approved based on
the service which Mr. Costalas had provided to the Company since the outset of
his employment with the Company and the then recent departures of Messrs.
McAdams and Hershhorn from the Company, leaving Mr. Costalas as the senior
ranking executive at the Company. At the time of the offer, Mr. Costalas held
options to purchase 250,000 shares of Common Stock at an exercise price of
$16.375 per share; options to purchase 140,000 shares of Common Stock at an
exercise price of $12.99 per share; and options to purchase 25,000 shares of
Common Stock at an exercise price of $10.75 per share. The offer which Mr.
Costalas accepted was to exchange a total of 390,000 options, the 250,000
options with an exercise price of $16.75 per share and 140,000 options with an
exercise price of $12.99 per share, for options to purchase an aggregate of
195,000 shares of Common Stock at an exercise price of $7.00 per share. On the
date such offer was made and accepted, the closing price of the Common Stock
on the NYSE was $8.125 per share.
44
<PAGE>
On June 18, 1997, the Board of Directors, with the concurrence of the
Compensation Committee, approved an offer to members of the Board of Directors
who held options, issued in July 1996 following the Company's 1996 Annual
Meeting of Stockholders (the "1996 Options"). The 1996 Options consisted of
options to purchase 50,000 shares at a per share exercise price of $16.375
issued to each non-employee Director. The offer, which was approved and made
to Messrs. Hammer, Dowden, Yoskin and Goldstein, Ira M. Lubert and Michael
Emmi, was to exchange the 1996 Options for options to purchase 25,000 shares
at an exercise price of $7.25 per share. Each of such persons accepted such
offer. The closing price of the Common Stock on the date of the offer was
$7.25 per share.
The Compensation Committee believes that Mr. Costalas' stock options and the
stock options granted to the non-employee Directors listed above, at the
original exercise prices, did not provide appropriate reward or incentive to
Mr. Costalas. The Compensation Committee also is of the view that such
repricing benefitted the Company's stockholders by encouraging Mr. Costalas
and the non-employee Directors to remain with the Company.
THE COMPENSATION COMMITTEE OF NATIONAL MEDIA CORPORATION
Jon W. Yoskin, II (Chairman)
Albert R. Dowden
Andrew M. Schuon
COMPENSATION OF DIRECTORS
Each Director who is not an employee of the Company is paid an annual cash
fee of $25,000 a year for his service as a Director, and an additional $1,000
in cash per calendar quarter for each committee on which he serves, subject to
an adjustment based on attendance at committee meetings during each quarter. A
Director may also receive an additional $2,000 in cash per year for service as
a committee chairman, over and above the payment for committee service.
Directors who are employees of the Company do not receive additional
compensation for their service on the Board of Directors or on any committee
thereof. During the fiscal year ended March 31, 1998, the Company incurred
expenses of approximately $240,000 for Directors' fees.
OPTIONS
The Company also granted an aggregate of 300,000 options to purchase Common
Stock to six non-employee Directors following the election of such Directors
to the Company's Board of Directors in July 1996. Each non-employee Director
received 50,000 options at an exercise price of $16.375 per share. Subject to
such Director's continued membership on the Company's Board of Directors, such
options vest on April 25, 2001, subject to certain provisions for accelerated
vesting, including a change of control of the Company, attainment of certain
trading prices for the Company's Common Stock or achievement of certain
earnings per share ratios. In June 1997, each non-employee Director exchanged
such options for 25,000 options, exercisable at a price of $7.25 per share,
with the same vesting schedule. In August 1998, the Board of Directors
approved a resolution amending the Company's 1991 Stock Option Plan to
eliminate the automatic grant of stock options to non-employee Directors.
45
<PAGE>
COMPENSATION COMMITTEE REPORT
The following report shall not be deemed incorporated by reference by any
general statement incorporating by reference this Proxy Statement into any
filing under the Securities Act of 1933 or under the Securities Exchange Act
of 1934, except in the event that the Company specifically incorporates this
information by reference, and shall not otherwise be deemed filed under such
statutes.
The executive compensation program of the Company is administered by the
Compensation Committee, which is composed of two independent, non-employee
Directors. The function of the Compensation Committee is to review general
compensation policies and to review recommendations made regarding the
compensation of executive officers. The Company seeks to provide executive
compensation that will support the achievement of the Company's financial
goals while attracting and retaining talented executives and rewarding
superior performance.
This report covers the compensation of the Chief Executive Officer and the
Company's other executive officers for the year ended March 31, 1998, the
Company's most recently completed fiscal year, as required under applicable
rules of the Securities and Exchange Commission.
COMPENSATION PHILOSOPHY
Beginning in 1995, the Compensation Committee adopted the philosophy that
compensation should reflect individual performance and the value created for
stockholders while supporting the Company's strategic goals. During the past
eighteen months, the Company's precarious financial condition has made it
necessary for the Compensation Committee to deviate from its core philosophy
in order to retain and/or attract competent personnel. It is the intention of
the Compensation Committee to return to its core philosophy as the Company
returns to profitability.
PAYMENTS AND MEASUREMENT
The Compensation Committee will generally attempt to structure executive
compensation packages based on the following components, both of which are
intended to serve the long term compensation philosophy.
Base Salary. Base salaries for executive officers to be initially determined
based upon a subjective evaluation by the Compensation Committee of the
responsibilities of the position held and the experience of the individual,
with reference to the officer's prior salary history and the competitive
marketplace for executive talent generally. The Company will compare itself to
a peer group of companies in related businesses, as well as competition within
the relevant geographic area. Salaries for executives are reviewed by the
Committee on an annual basis, and may be increased or decreased based on the
Committee's determination of the individual's contribution to the Company.
Long-term Incentives. Prior to 1995, long-term incentives were provided
principally through grants of stock options. Stock options were granted with
exercise prices set at the prevailing market value as of the date of grants.
Therefore such options had no realizable value to the executive unless the
Company's stock price increased. In 1995, the Company's Board of Directors
proposed and the Company's stockholders approved the Management Incentive
Plan, as described below.
In early 1996, after consultation with Ernst & Young LLP as to compensation
matters, the Committee concluded that grants of options to purchase Common
Stock pursuant to the 1991 Stock Option Plan, in conjunction with the
Company's Management Incentive Plan, would be the most effective method for
aligning compensation of executives with the goals of the Company's
stockholders. Due to the financial constraints referred to above, the
Company's ability to utilize the Management Incentive Plan as a compensation
tool has been completely negated. Likewise, the Company has not utilized
broad-based stock option grants since July
46
<PAGE>
1996. As the Company returns to a more secure financial footing, the
Management Incentive Plan, or a replacement plan, as well as stock options,
will likely play a larger role in compensation packages.
1995 MANAGEMENT INCENTIVE PLAN
Effective April 1, 1995, the Management Incentive Plan replaced the
Company's annual bonus program. Under the Management Incentive Plan, eligible
management personnel may receive corporate and individual performance units at
the beginning of the Company's fiscal years which provide incentive
compensation based upon predetermined corporate and individual goals.
The corporate goals may be fixed annually by the Board of Directors based on
the recommendations of the Compensation Committee. These goals include things
such as (i) attainment of a specified share price, (ii) attainment of a
specified earnings-per-share of Common Stock outstanding, and (iii)
achievement of specified strategic objectives. The value of corporate units
depend upon the extent to which the corporate goals for the fiscal year are
achieved, and the maximum award cannot be received unless each of the
corporate goals have been met. The value of individual units depend upon both
corporate success and individual performance. Units assigned vary from
individual to individual, and the targeted, maximum awards range from 11% to
150% of base salary.
Payment of awards to the Chairman, Vice Chairman, President and Executive
Vice Presidents of the Company are made 50% in cash and 50% in Common Stock of
the Company, and payment to other participants will be 90% in cash and 10% in
Common Stock, although such participants may elect to receive higher
percentages of the incentive payment in Common Stock.
At the Company's Annual Meeting of Stockholders held in July 1996, the
stockholders approved a proposal to extend the Management Incentive Plan so
that awards may be made under the Management Incentive Plan indefinitely.
For the fiscal year ended March 31, 1998, due to the financial performance
of the Company, no bonuses were paid to any employee of the Company under the
Management Incentive Plan.
COMPENSATION OF THE CHIEF EXECUTIVE OFFICER
Mr. Hershhorn served as the Company's Chief Executive Officer from April
1995 until April 1997. The Company and Mr. Hershhorn entered into an
employment agreement in August 1994 pursuant to which Mr. Hershhorn was to be
employed as the Company's President and would receive a minimum annual base
salary of $425,000 and the grant of options, among other things. Mr.
Hershhorn's compensation was based on an analysis of the compensation paid to
Mr. Hershhorn's predecessors and other executives of similar companies, Mr.
Hershhorn's expected contribution to the Company's business, and Mr.
Hershhorn's position and compensation at his former employer. As Chief
Executive Officer, Mr. Hershhorn continued to be compensated under his
employment agreement. His annual salary was raised in July 1996 to $550,000.
Mr. Hershhorn resigned as President and Chief Executive Officer, and as a
Director, of the Company in April 1997.
The Compensation Committee believes that, at the time of Mr. Hershhorn's
hiring, based upon the then current situation of the Company and Mr.
Hershhorn's level of experience in the direct marketing industry, the
compensation agreed to be paid to Mr. Hershhorn was appropriate.
Following Mr. Hershhorn's resignation, the Company retained Robert Verratti
as the Company's chief executive officer. Mr. Verratti's compensation package
and employment agreement are described above under "Employment Contracts,
Termination of Employment and Change-in-Control Arrangements." The agreement
reflects the Compensation Committee's and the Board of Director's view of Mr.
Verratti's experience and past
47
<PAGE>
performance in previous positions. Mr. Verratti's compensation package was
highly incentive-based, reflecting the desire to improve the Company's
performance and, thereby, the market value of the Common Stock.
Effective upon execution of the Stock Purchase Agreement and the related
Consulting Agreement, Mr. Lehman became Acting Chief Executive Officer of the
Company. He is compensated through the Consulting Agreement as described under
"Proposal I, Description of the Consulting Agreement."
THE COMPENSATION COMMITTEE OF NATIONAL MEDIA CORPORATION
Jon W. Yoskin II (Chairman)
Albert R. Dowden
Andrew M. Schuon
48
<PAGE>
COMPARATIVE STOCK PERFORMANCE GRAPH
The graph below compares the cumulative total stockholder return on the
Common Stock with the cumulative total stockholder return of (i) the S&P
SmallCap 600 Index, and (ii) an index of four companies in the Company's peer
group (the "Peer Group Index"), assuming an investment of $100 on March 31,
1993 in each of the Common Stock of the Company, the companies comprising the
S&P SmallCap 600 Index and the companies comprising the Peer Group Index. The
companies in the Peer Group Index are Fingerhut Companies, Inc., Home Shopping
Network, Inc., Hanover Direct, Inc. (formed September 1993 and formerly known
as Horn & Hardart Company) and Lillian Vernon Corporation.
[MAC CHART]
<TABLE>
<CAPTION>
CUMULATIVE TOTAL RETURN
---------------------------------------
3/93 3/94 3/95 3/96 3/97 3/98
---- ------ ------ ------ ------ ------
<S> <C> <C> <C> <C> <C> <C>
National Media Corporation.............. 100 85.71 80.52 171.43 88.31 25.97
Peer Group.............................. 100 156.47 82.18 84.36 89.02 189.62
S&P SmallCap 600........................ 100 108.65 114.38 150.05 162.64 240.19
</TABLE>
49
<PAGE>
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
Set forth below is a description concerning transactions which may not
otherwise be described herein by and between the Company and/or its affiliates
and other persons or entities affiliated with the Company or its affiliates.
The Company is of the view that each of such transactions was on terms no less
favorable to the Company than would otherwise have been available to the
Company in transactions with unaffiliated third parties, if available at all.
CONSULTING AGREEMENT
In connection with the execution of the Stock Purchase Agreement, the
Company entered into the Consulting Agreement with TMC pursuant to which TMC
is providing executive management services to the Company. Pursuant to the
terms of the Consulting Agreement, Messrs. Lehman, Weiss and Yukelson are
providing at least an aggregate of 100 hours per week of such services to the
Company. Mr. Lehman is Acting Chief Executive Officer of the Company and Mr.
Lehman, Mr. Weiss (through an entity controlled by Mr. Weiss and Mr. Yukelson
are members of TMC. See "Proposal I, Approval of the Transactions--Description
of the Consulting Agreement."
BROADCAST.COM AGREEMENT
On August 23, 1998, the Company entered into an exclusive services agreement
with Broadcast.com pursuant to which Broadcast.com has agreed to provide
complete Internet broadcasting services for the Company's direct response
programming. Pursuant to the terms of the agreement, the Company is required
to pay Broadcast.com (i) an advance fee of $250,000, (ii) a monthly fee of
$41,666 for three months; (iii) a monthly fee of $83,333 for the remaining
eighteen months of the Agreement, and (iv) certain programming and encoding
fees. Mark Cuban and Todd Wagner are Chief Executive Officer and President,
respectively, of Broadcast.com and are also members of the Investor Group. The
agreement was ratified by the unanimous vote of the disinterested members of
the Board of Directors.
LEASE OF OFFICE SPACE
Paul Meier, an officer of the Company, is the owner of the facilities leased
by the Company's Prestige subsidiary for its operations in Auckland, New
Zealand. Such facilities consist of approximately 1,245 square meters of
office space and 2,447 square meters of warehouse space which Prestige
presently leases at the annual rate of NZ$376,000 (approximately US$207,500 as
of March 31, 1998) plus New Zealand Goods and Services Tax. Such payments are
guaranteed by the Company. The lease expires on March 31, 2006. An independent
firm engaged by the Company determined that such lease is fair, based on
market conditions.
MANAGEMENT INDEBTEDNESS
In November 1996, the Company loaned an aggregate of $155,000 to
Constantinos I. Costalas, the Company's Chief Operating Officer. The
promissory note evidencing such indebtedness bears interest at 8% per annum
and is due December 31, 1998. Such funds were used by Mr. Costalas for
personal purposes. As of August 31, 1998, aggregate principal and accrued
interest of approximately $177,400 was outstanding under such note. Such
amount represents the largest aggregate amount of indebtedness outstanding
since the beginning of the Company's last fiscal year. Mr. Costalas has agreed
to satisfy this loan with certain of the proceeds he will receive upon
consummation of the Transactions pursuant to his waiver agreement. See
"Proposal I, Description of Related Agreements and Transactions--Certain
Waivers."
During the fiscal year ended March 31, 1998, the Company advanced to Mr.
Costalas certain funds for his personal use. During fiscal 1998, the largest
amount outstanding under such advances was $111,500, all of which was repaid
as of March 31, 1998.
50
<PAGE>
In March 1998, the Company entered into an employment agreement with John W.
Kirby, pursuant to which Mr. Kirby serves as the President of the Company. The
terms of the agreement included the forgiveness of a loan, including accrued
interest, in the amount of $190,000 and the issuance of a new $545,000 loan to
Mr. Kirby. The new loan bears interest at a rate equal to prime plus 1 1/2%
per annum and is due May 30, 2000. Such funds were used by Mr. Kirby for
personal purposes. As collateral for the indebtedness, Mr. Kirby pledged
339,784 shares of Common Stock. As of August 31, 1998, principal and accrued
interest thereon of approximately $567,860 was outstanding under such note.
Such amount represents the largest aggregate amount of indebtedness
outstanding since the issuance of the promissory note. Mr. Kirby also held an
allowance from the Company in the amount of $18,000, bearing no interest,
which was advanced to him for personal reasons in November 1995. Mr. Kirby
also acts as surety for debt owing to the Company in the principal amount of
approximately $32,000, plus accrued interest, which was outstanding as of
August 31, 1998.
At the time of the Company's acquisition PRTV in May 1996, Michael Levey, an
officer of the Company, had a note outstanding to PRTV in the principal amount
of approximately $72,771. Such amount, together with additional accrued
interest, was due to be repaid December 31, 1996, but as of the date hereof,
the total amount due under such note was $50,315, which represents the largest
aggregate amount of indebtedness outstanding since the beginning of the
Company's last fiscal year.
OTHER MATTERS
Align, Inc., an information systems consulting firm which is affiliated with
Safeguard, has provided consulting services to the Company during the 1998
fiscal year and continues to provide such services as of the date hereof. The
Company paid an aggregate of $316,843 in fiscal 1998 and currently pays Align
$25,000 per month for ongoing services.
William M. Goldstein, a Director of the Company, is a partner at Drinker,
Biddle & Reath LLP, a law firm that has provided legal services to the
Company. In fiscal 1998, the Company paid $161,705 in legal fees to Drinker,
Biddle & Reath LLP.
INDEMNIFICATION PAYMENTS
During the period April 1, 1997 to the present, the Company has assumed and
paid defense costs and/or made required indemnification payments on behalf of
present and former officers and Directors in connection with securities class
and derivative actions against the Company and such individuals which were
pending during the period between April 1, 1997 and the present. The Company
may be required to pay additional amounts in connection with these actions.
OTHER STOCKHOLDER MATTERS
STOCKHOLDER PROPOSALS AND NOMINATIONS OF DIRECTORS FOR THE COMPANY'S NEXT
ANNUAL MEETING OF STOCKHOLDERS
Any stockholder who intends to present a proposal for consideration at the
Company's next annual meeting of stockholders intended to occur on or about
August 31, 1999, must submit his proposal to the Company on or before May 2,
1999 in order to have the Company consider the inclusion of such proposal in
the Company's Proxy Statement and form of proxy relating to such annual
meeting. Reference is made to Rule 14a-8 under the Exchange Act for
information concerning the content and form of such proposal and the manner in
which such proposal must be made.
Nominations for election to the Board of Directors at the Company's next
annual meeting may be made only in writing by a stockholder entitled to vote
at such annual meeting and must be addressed to the Secretary,
51
<PAGE>
National Media Corporation, Eleven Penn Center, Suite 1100, 1835 Market
Street, Philadelphia, PA 19103, who will forward such information to the Board
Affairs Committee. Nominations must be received by the Secretary on or before
May 2, 1999, and must be accompanied by the written consent of the nominee.
Nominations should also be accompanied by a description of the nominee's
business or professional background and otherwise contain the information
required by Schedule 14A of the Exchange Act.
OTHER BUSINESS
The Board of Directors is not aware of any other matters that may be brought
before the Stockholders' Meeting. If other matters not now known come before
the Stockholders' Meeting, the persons named in the accompanying form of proxy
or their substitutes will vote such proxy in accordance with their judgment.
SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Section 16(a) of the Securities Exchange Act of 1934 requires the Company's
officers and Directors and persons who own more than 10% of the Company's
Common Stock to file reports of ownership and changes in ownership with the
Securities and Exchange Commission and the New York and Philadelphia Stock
Exchanges. Officers, Directors and greater than 10% owners are required by the
Securities and Exchange Commission regulations to furnish the Company with
copies of all Section 16(a) forms they file.
Based solely on the Company's review of the copies of such forms received by
it, the Company believes that, during the fiscal year ended March 31, 1998,
all filing requirements applicable to its officers, Directors and greater than
10% owners were complied with.
INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS
Representatives of Ernst & Young LLP are expected to be present at the
Stockholders' Meeting, will have the opportunity to make a statement if they
desire to do so, and are expected to be available to respond to appropriate
questions.
ANNUAL REPORT TO STOCKHOLDERS
A copy of the Company's Annual Report to Stockholders on Form 10-K for the
fiscal year ended March 31, 1998 (the "Annual Report") which contains copies
of the Company's audited financial statements is being sent to stockholders
with this Proxy Statement. The Annual Report shall not be deemed proxy
solicitation material.
THE COMPANY'S ANNUAL REPORT, THE COMPANY'S JUNE 30, 1998 10-Q AND THE
COMPANY'S TRANSACTIONS FORM 8-K ARE HEREBY INCORPORATED BY REFERENCE INTO THIS
PROXY STATEMENT. THE COMPANY WILL FURNISH WITHOUT CHARGE TO ANY STOCKHOLDER,
UPON THE WRITTEN OR ORAL REQUEST OF SUCH PERSON, COPIES OF THE COMPANY'S
ANNUAL REPORT, THE JUNE 30, 1998 10-Q AND THE TRANSACTIONS FORM 8-K. WRITTEN
REQUESTS SHOULD BE ADDRESSED TO JOHN J. SULLIVAN, CHIEF FINANCIAL OFFICER OF
NATIONAL MEDIA CORPORATION, ELEVEN PENN CENTER, SUITE 1100, 1835 MARKET
STREET, PHILADELPHIA, PENNSYLVANIA 19103. TELEPHONIC REQUESTS SHOULD BE
DIRECTED TO INVESTOR RELATIONS AT (215) 988-4600.
52
<PAGE>
ANNEX A
NATIONAL MEDIA CORPORATION
SERIES E PREFERRED STOCK
STOCK PURCHASE AGREEMENT
DATED AS OF
AUGUST 11, 1998
<PAGE>
TABLE OF CONTENTS
<TABLE>
<CAPTION>
PAGE
----
<C> <S> <C>
ARTICLE I
DEFINITIONS.............................................................. 1
Section 1.1 Definitions................................................ 1
Section 1.2 Accounting Terms and Determinations........................ 7
Section 1.3 Computation of Time Periods................................ 7
Section 1.4 Construction............................................... 7
Section 1.5 Exhibits and Schedules..................................... 7
Section 1.6 No Presumption Against Any Party........................... 7
ARTICLE II
THE PURCHASES............................................................ 7
Section 2.1 Initial Purchase........................................... 7
Section 2.2 Further Purchase........................................... 8
Section 2.3 Transaction Initiation Fee................................. 8
Section 2.4 Register of Securities..................................... 8
Section 2.5 Restrictions on Transfer................................... 8
Section 2.6 Removal of Transfer Restrictions........................... 9
Section 2.7 Additional Representations and Warranties by ACO........... 9
Section 2.8 No Brokers or Finders...................................... 10
Section 2.9 Information in Proxy Statement............................. 10
ARTICLE III
CONDITIONS............................................................... 10
Section 3.1 Conditions to Each Party's Obligation to Effect the
Purchase.................................................. 10
Section 3.2 Further Conditions to ACO's Obligation to Purchase......... 11
Section 3.3 Conditions to the Company's Obligations to Effect the
Purchase.................................................. 12
ARTICLE IV
REPRESENTATIONS AND WARRANTIES BY THE COMPANY............................ 13
Section 4.1 Organization of the Company................................ 13
Section 4.2 The Company Capital Structure.............................. 13
Section 4.3 Authority; No Conflict; Required Filings and Consents...... 14
Section 4.4 SEC Filings; Financial Statements.......................... 15
Section 4.5 No Undisclosed Liabilities................................. 16
Section 4.6 Absence of Certain Changes or Events....................... 16
Section 4.7 Taxes...................................................... 16
Section 4.8 Properties................................................. 17
Section 4.9 Intellectual Property...................................... 17
Section 4.10 Agreements, Contracts and Commitments...................... 17
Section 4.11 Litigation and Regulatory Matters.......................... 17
Section 4.12 Environmental Matters...................................... 17
Section 4.13 Employee Benefit Plans..................................... 18
Section 4.14 Compliance With Laws....................................... 20
Section 4.15 Registration Statement; Proxy Statement.................... 20
Section 4.16 Labor Matters.............................................. 20
Section 4.17 Insurance.................................................. 21
Section 4.18 Broker Fees, etc........................................... 21
Section 4.19 No Existing Discussions.................................... 21
Section 4.20 Section 203 of the DGCL and Sections 2538, 2555 and 2564 of
the Pennsylvania Business Corporation Law Not Applicable.. 21
Section 4.21 The Company Rights Plan.................................... 21
</TABLE>
i
<PAGE>
<TABLE>
<CAPTION>
PAGE
----
<C> <S> <C>
Section 4.22 Board Recommendation..................................... 21
Section 4.23 Required Company Vote.................................... 21
Section 4.24 Full Disclosure.......................................... 22
ARTICLE V
COVENANTS.............................................................. 22
Section 5.1 Information.............................................. 22
Section 5.2 Fiscal Plans............................................. 23
Section 5.3 Payment of Obligations................................... 23
Section 5.4 Maintenance of Property; Insurance....................... 23
Section 5.5 Books and Records; Inspection............................ 24
Section 5.6 Conduct of Business; Maintenance of Subsidiaries;
Compliance with Law..................................... 24
Section 5.7 Debt..................................................... 24
Section 5.8 Consolidations, Mergers and Sales of Assets.............. 25
Section 5.9 Restricted Payments...................................... 25
Section 5.10 Limitations on Investments............................... 25
Section 5.11 Transactions with Affiliates............................. 25
Section 5.12 Replacement of Certificates.............................. 25
Section 5.13 Compensation of Board.................................... 25
Section 5.14 Organizational Documents................................. 25
Section 5.15 Securities Law Filings................................... 25
Section 5.16 Compliance With Certificate and Bylaws................... 26
Section 5.17 Use of Proceeds.......................................... 26
Section 5.18 Employees................................................ 26
Section 5.19 Transition............................................... 26
Section 5.20 Exclusivity.............................................. 26
Section 5.21 Registration............................................. 27
Section 5.22 Reasonable Best Efforts.................................. 27
Section 5.23 Public Announcements..................................... 27
ARTICLE VI
DEFAULTS............................................................... 27
Section 6.1 Defaults................................................. 27
ARTICLE VII
TERMINATION............................................................ 28
Section 7.1 Termination ............................................. 28
Section 7.2 Effect of Termination.................................... 29
ARTICLE VIII
MISCELLANEOUS.......................................................... 29
Section 8.1 Notices.................................................. 29
Section 8.2 No Waivers............................................... 29
Section 8.3 Cumulative Remedies...................................... 29
Section 8.4 Expenses; Documentary Taxes; Indemnification............. 29
Section 8.5 Amendments and Waivers................................... 30
Section 8.6 Successors and Assigns................................... 30
Section 8.7 Survival of Representations and Warranties............... 30
Section 8.8 Governing Law; Submission to Jurisdiction; Waiver of Jury
Trial................................................... 30
Section 8.9 Counterparts; Facsimile Signatures....................... 31
Section 8.10 Entire Agreement......................................... 31
Section 8.11 Confidentiality.......................................... 31
</TABLE>
ii
<PAGE>
STOCK PURCHASE AGREEMENT
This STOCK PURCHASE AGREEMENT, dated as of August 11, 1998 is between
NATIONAL MEDIA CORPORATION, a Delaware corporation (the "Company") and NM
ACQUISITION CO., LLC, a Delaware limited liability company ("ACO").
In consideration of the covenants contained herein, the parties hereto
hereby agree as follows:
ARTICLE I
Definitions
Section 1.1 Definitions. As used herein, the following capitalized terms
have the following meanings (the following definitions being applicable in
both singular and plural forms):
"Accredited Investor" has the meaning set forth in Rule 501 of Regulation D
promulgated under the Securities Act.
"ACO Board Nominees" means Stephen Lehman, Eric Weiss, Andrew Schuon, and
any other person ACO nominates from time to time as a director by written
notice to the Company who is reasonably acceptable to the Company's outside
directors.
"Acquisition Proposal" means any offer or proposal for, or indication of
interest in, any acquisition of, any interest in the Company, whether by way
of a merger, consolidation or other transaction involving any equity interest
in, or substantial portion of the assets of, the Company or the acquisition of
any capital stock of the Company other than (a) pursuant to any Investment
Document; or (b) through the exercise or conversion of any shares of preferred
stock, options, warrants or other equity or debt securities of the Company
which are outstanding at the date of this Agreement or pursuant to any
existing option plan.
"Affiliate" means as to any Person (i) any other Person directly or
indirectly controlling or controlled by or under direct or indirect common
control with such Person, (ii) any spouse, immediate family member or other
relative who has the same principal residence of any Person described in (i)
above, (iii) any trust in which any such Persons described in clauses (i) or
(ii) above has a beneficial interest in excess of 10% of the total beneficial
interests in either the principal or income or both of such trust, and (iv)
any corporation or other organization of which any such Persons described in
clause (i), (ii) or (iii) above collectively own more than 50% of the equity
of such entity. For purposes of this definition, (x) the term "control" means
the possession, directly or indirectly, of the power to direct or cause the
direction of the management and policies of a Person, whether through
ownership of voting securities, by contract or otherwise and (y) beneficial
ownership of 10% or more of the voting common equity (on a fully diluted
basis) or warrants or other rights to purchase such equity (whether or not
currently exercisable) of a Person shall be deemed to be control of such
Person.
"Agreement" means this Stock Purchase Agreement.
"Amendment No. 7 to Rights Agreement" means an agreement between the Company
and Chase Mellon Shareholder Services, Inc. in the form of Exhibit A.
"Bankruptcy and Equity Exception" means (a) bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium and similar laws of general
applicability relating to or affecting creditors rights and (b) general
equitable principles.
"Base Financials" means the consolidated balance sheet of the Company and
its Subsidiaries as of March 31, 1998, and the related consolidated statements
of income, shareholders' equity and cash flows for the fiscal year then ended,
reported on by Ernst & Young LLP on June 29, 1998.
A-1
<PAGE>
"Business Day" means any day except a Saturday, Sunday, or other day on
which commercial banks in New York City are authorized by law to close.
"Certificate of Designations for Series E Stock" means the Company's
Certificate of Designation in the form of Exhibit B.
"Closing Date" has the meaning set forth in Section 2.1.
"Commission" means the Securities and Exchange Commission or any other
Federal agency administering the Securities Act at the time.
"Common Stock" means the Company's currently authorized class of common
stock, $.01 par value, and stock of any other class or other consideration
into which such currently authorized common stock may hereafter have been
changed.
"Company" has the meaning set forth in the introduction to this Agreement.
"Company Rights Plan" means the Rights Agreement dated January 3, 1994 (as
amended by Amendments Nos. 1 through 6 to Rights Agreement and Amendment No. 7
to Rights Agreement) between the Company and ChaseMellon Shareholder Services,
Inc.
"Company Disclosure Schedule" means Schedule 1.
"Compliance Certificate" means a certificate in the form of Exhibit C.
"Consolidated Capital Expenditures" means, for any period, the capital
expenditures of the Company and its Subsidiaries for such period, as the same
are (or would in accordance with GAAP applied on a basis consistent with the
Company's historical financial statements be) set forth in a consolidated
statement of cash flows of the Company and its Subsidiaries for such period.
"Consulting Agreement" means an agreement between the Company and TMC, in
the form of Exhibit E.
"Conversion Stock" means the unissued Common Stock: (a) into which the
Series E Stock may be converted; (b) into which the Company's Series D
Preferred Stock held by ACO may be converted; (c) which is subject to the TMC
Option; or (d) which is subject to the TMC Warrant.
"Costalas Waiver Agreement" means an agreement between the Company and
Constantinos Costalas, substantially in the form of Exhibit F.
"CVI" means Capital Ventures International, a Cayman Islands partnership.
"Debt" of any Person means at any date, without duplication and without
regard to whether matured or unmatured, absolute or contingent: (i) all
obligations of such Person for borrowed money, including unpaid, accrued
interest thereon; (ii) all obligations of such Person evidenced by bonds,
debentures, notes, or other similar instruments; (iii) all obligations of such
Person to pay the deferred purchase price of property or services, except
trade accounts payable arising in the ordinary course of business; (iv) all
obligations of such Person as lessee under capital leases; (v) all obligations
of such Person to reimburse or prepay any bank or other Person in respect of
amounts paid under a letter of credit, banker's acceptance, or similar
instrument, whether drawn or undrawn; (vi) all obligations of such Person to
purchase securities other than shares of the Company's Series D Preferred
Stock which arise out of or in connection with the sale of the same or
substantially similar securities; (vii) all obligations of such Person in
connection with any agreement to purchase, redeem (other than shares of the
Company's Series D Preferred Stock), exchange, convert or otherwise acquire
for value any capital stock of such Person or any warrants, rights or options
to acquire such capital stock, now or hereafter outstanding, except to the
extent that such obligations remain performable solely at the option of such
Person; (viii) all obligations
A-2
<PAGE>
to repurchase assets previously sold (including any obligation to repurchase
any accounts or chattel paper under any factoring, receivables purchase, or
similar arrangement); (ix) obligations of such Person under hedging facilities
and foreign exchange or forward sale contracts or similar arrangements; and
(x) all Debt of others Guaranteed by such Person.
"Default" means any condition or event which constitutes an Event of Default
or which with the giving of notice or lapse of time or both would, unless
cured or waived, become an Event of Default.
"DGCL" means the Delaware General Corporation Law.
"Environmental Laws" means any and all federal, state, local and foreign
statutes, laws, regulations, ordinances, rules, judgments, orders, decrees,
permits, concessions, grants, franchises, licenses, agreements or other
governmental restrictions relating to the environment or to emissions,
discharges or releases of pollutants, contaminants, petroleum or petroleum
products, chemicals or industrial, toxic or hazardous substances or wastes
into the environment including, without limitation, ambient air, surface
water, ground water, or land, or otherwise relating to the manufacture,
processing, distribution, use, treatment, storage, disposal, transport or
handling of pollutants, contaminants, petroleum or petroleum products,
chemicals or industrial, toxic or hazardous substances or wastes or the clean-
up or other remediation thereof.
"Equity Security" means any stock or similar security of the Company or any
security (whether stock or Debt) convertible or exchangeable, with or without
consideration, into any stock or similar security, or any security (whether
stock or Debt) with an attached warrant, stock appreciation right or right to
subscribe to or purchase any stock or similar security, or any such warrant or
right.
"ERISA" means the Employee Retirement Income Security Act of 1974, as
amended from time to time, and any successor statute.
"ERISA Group" means all members of a controlled group of corporations and
all trades or businesses (whether incorporated) under common control which,
together with the Company, are treated as a single employer under Section 414
of the IRC.
"ERISA Material Plan" means any ERISA Plan or ERISA Plans having aggregate
ERISA Unfunded Liabilities in excess of $100,000.
"ERISA Plan" means, at any time, an employee pension benefit plan of the
Company or any member of the ERISA Group which is covered by Title IV of ERISA
or subject to the minimum funding standards under Section 412 of the IRC.
"ERISA Unfunded Liabilities" means, with respect to any ERISA Plan at any
time, the amount (if any) by which: (i) the present value of all vested
nonforfeitable benefits under such ERISA Plan exceeds, (ii) the fair market
value of all ERISA Plan assets allocable to such benefits (exclusive of
accrued but unpaid contributions), all determined as of the then most recent
valuation date for such ERISA Plan, but only to the extent that such excess
represents a potential liability of a member of the ERISA Group to the PBGC or
the ERISA Plan under Title IV of ERISA.
"Event of Default" has the meaning set forth in Section 6.1.
"Exchange Act" means the Securities Exchange Act of 1934, or any successor
Federal statute, and the rules and regulations of the Commission thereunder,
all as the same shall be in effect at the time. Reference to a particular
section of the Exchange Act shall include a reference to the comparable
section, if any, of any such successor Federal statute.
"First Union National Bank Consent Agreement" means the Letter Agreement,
dated July 15, 1995 by and between ACO and First Union National Bank, attached
as Exhibit N (as such may be amended from time to time).
A-3
<PAGE>
"GAAP" means generally accepted accounting principles in the United States
consistently applied.
"Guarantee" by any Person means any obligation, contingent or otherwise, of
such Person directly or indirectly guaranteeing, securing, or otherwise
providing assurances of the payment of any Debt of any other Person and
includes: (a) any Lien or any asset of such Person securing any such Debt (and
without regard to whether such Person has assumed personal liability with
respect thereto), and (b) any obligation, direct or indirect, contingent or
otherwise, of such Person: (i) to purchase or pay (or advance or supply funds
for the purchase or payment of) such Debt (whether arising by virtue of
partnership arrangements, by agreements to keep-well, to purchase assets,
goods, securities or services, to take-or-pay, or to maintain financial
condition, or otherwise); or (ii) entered into for the purpose of assuring in
any other manner the holder of such Debt of the payment thereof or to protect
such holder against loss in respect thereof (in whole or in part); provided
that the term Guarantee shall not include endorsements for collection or
deposit in the ordinary course of business. The term "Guarantee" used as a
verb has a corresponding meaning.
"Hammer Waiver Agreement" means an agreement between the Company and
Frederick Hammer substantially in the form of Exhibit G.
"Investment" means any investment by any Person in any other Person, whether
by means of share purchase, capital contribution, loan, time deposit, or
otherwise.
"Investment Documents" means this Agreement, the Consulting Agreement, the
Amendment No. 7 to Rights Agreement, the Costalas Waiver Agreement, the Hammer
Waiver Agreement, the Verratti Waiver Agreement, the Series B Consent
Agreement, the First Union National Bank Consent Agreement, the Registration
Rights Agreement, the Series D Stock Purchase Agreement, the Certificate of
Designation of Series E Stock and the ValueVision Agreement.
"IRC" means the Internal Revenue Code of 1986, as amended from time to time,
and any successor statute.
"Lien" means, with respect to any asset, any mortgage, lien, pledge, charge,
security interest, or encumbrance of any kind in respect of such asset (or any
agreement to give any of the foregoing, whether or not contingent on the
occurrence of any future event). For the purposes of this Agreement, the
Company or any Subsidiary of the Company shall be deemed to own an asset
subject to a Lien when it has acquired or holds such asset subject to the
interest of a vendor or lessor under any conditional sale agreement, capital
lease, or other title retention agreement relating to such asset.
"Material Adverse Change" means a material adverse change in the financial
condition, business or properties of the Company and its Subsidiaries, taken
as a whole, not including any such change which is the result of any action
taken by or at the instruction of Steve Lehman, as acting CEO of the Company,
or TMC.
"Notice of Assignment" has the meaning set forth in Section 7.5.
"Permitted Liens" shall mean (a) Liens for taxes and assessments or
governmental charge or levies not at the time due or in respect of which the
validity thereof shall currently be contested in good faith by appropriate
proceedings; (b) Liens in respect of pledges or deposits under workmen's
compensation laws or similar legislation, carriers', warehousemen's,
mechanics', laborers' and materialmen's and similar Liens, if the obligations
secured by such Liens are not then delinquent or are being contested in good
faith by appropriate proceedings; (c) Liens incidental to the conduct of the
business of the Company or any Subsidiary (including leases of property, real
and personal) which were not incurred in connection with the borrowing of
money or the obtaining of advance or credits and which do not in the aggregate
materially detract from the value of its property or materially impair the use
thereof in the operation of its business; and (b) any Liens related to any
Debt owed by the Company (or any of its Subsidiaries) to First Union National
Bank or Barclays Bank.
A-4
<PAGE>
"Person" means an individual, a limited liability company, a corporation, a
partnership, an unincorporated association, a trust, or any other entity or
organization, including a government or political subdivision or an agency or
instrumentality thereof.
"Proxy Statement" means the information furnished by the Company to its
stock holders, pursuant to Rules 14a-3 and 4 under the Exchange Act, which
pertains to the transactions contemplated by the Investment Documents.
"Qualification" means, with respect to any report made by the Company's
independent auditors covering financial statements, a qualification to such
report (such as an explanatory paragraph or emphasis paragraph therein setting
forth adverse or qualifying language): (i) resulting from a limitation on the
scope of examination of such financial statements or the underlying data, or
(ii) which could be eliminated by changes in financial statements or notes
thereto covered by such report (such as by the creation of or increase in a
reserve or a decrease in the carrying value of assets) and which if so
eliminated by the making of any such change and after giving effect thereto
would occasion a Default; provided that neither of the following shall
constitute a Qualification: (a) a consistency exception relating to a change
in accounting principles with which the independent public accountants for the
Person whose financial statements are being certified have concurred, or (b) a
qualification relating to the outcome or disposition of threatened litigation,
pending litigation being contested in good faith, pending or threatened claims
or other contingencies, the impact of which litigation, claims or
contingencies cannot be determined with sufficient certainty to permit
quantification in such financial statements.
"Registration Rights Agreement" means an agreement between the Company and
ACO in the form of Exhibit H.
"Restricted Payment" means: (a) any dividend or other distribution on or
payment in respect of any shares of the Company's capital stock (except
dividends payable in respect of capital stock solely in shares of its capital
stock and payment of any premium in respect of the Company's Series D
Preferred Stock), or (b) any payment or other distribution on account of the
purchase, redemption (other than with respect to the Company's Series D
Preferred Stock), retirement, acquisition, or obligations in respect of: (i)
any shares of the Company's capital stock or (ii) any option, warrant, or
other right to acquire shares of the Company's capital stock. Notwithstanding
the foregoing, any distribution or payment pursuant to the Company's 401(k)
Plan or any issuance or exercise of options pursuant to an existing option
plan shall not be deemed to be a Restricted Payment.
"Restricted Stock" means (a) Conversion Stock and (b) any securities issued
or issuable with respect to such Conversion Stock by way of a stock dividend
or stock split or in connection with a combination of shares,
recapitalization, merger or consolidation or reorganization; provided that
shares of Common Stock shall only be treated as Restricted Stock if and so
long as they have not been (i) sold to or through a broker or dealer or
underwriter in a public distribution or a public securities transaction, or
(ii) sold in a transaction exempt from the registration and prospectus
delivery requirements of the Securities Act under Section 4(1) thereof so that
all transfer restrictions and restrictive legends with respect to such Common
Stock are removed upon the consummation of such sale and the seller and
purchaser of such Common Stock receive an opinion of counsel for the Company,
which shall be in form and content reasonably satisfactory to the seller and
buyer and their respective counsel, to the effect that such Common Stock in
the hands of the purchaser is freely transferable without restriction or
registration under the Securities Act in any public or private transaction.
"RGC" means RGC International Investors LDC, a Cayman Islands limited
duration company.
"Securities Act" means the Securities Act of 1933, or any successor Federal
statute, and the rules and regulations of the Commission thereunder, all as
the same shall be in effect at the time. Reference to a particular section of
the Securities Act shall include a reference to the comparable section, if
any, of any such successor Federal statute.
A-5
<PAGE>
"Series D Stock Purchase Agreement" means an agreement between the Company,
ACO, CVI and RGC in the form of Exhibit I.
"Series E Stock" means the Series E Convertible Preferred Stock of the
Company, having the rights, preferences, and privileges set forth in the
Certificate of Designation for Series E Stock.
"Shareholders' Voting Agreement" means an agreement among ACO and each of
the Company's directors substantially in the form of Exhibit D.
"Subsidiary" means, as to any Person, any corporation or other entity of
which securities or other ownership interests having ordinary voting power to
elect a majority of the board of directors or other persons performing similar
functions are at the time directly or indirectly owned by such Person.
"Tax" means any and all federal, state, local and foreign taxes, assessments
and other governmental charges, duties, impositions and liabilities, including
taxes based upon or measured by gross receipts, income, profits, sales, use
and occupation, and value added, ad valorem, transfer, gains, franchise,
withholding, payroll, recapture, employment, excise, unemployment insurance,
social security, business license, occupation, business organization, stamp,
environmental and property taxes, together with all interest, penalties and
additions imposed with respect to such amounts. For purposes of this
Agreement, "Tax" also includes any obligations under any agreements or
arrangements with any other Person with respect to Taxes of such other Person
(including pursuant to Treas. Reg. (S) 1.1502.5 or comparable provisions of
state, local or foreign tax law) and including any liability for Taxes of any
predecessor entity.
"TMC" means Temporary Media Co., LLC, a Delaware limited liability company.
"TMC Option" means an option in the form of Exhibit A to the Consulting
Agreement.
"TMC Warrant" means a warrant in the form of Exhibit B to the Consulting
Agreement.
"Transaction Initiation Fee" means cash in the amount of (i) ACO's
reasonable expense arising directly out of the negotiating of this Agreement,
and its investigations regarding the Company and its legal and accounting
advice with respect to the transactions contemplated hereby, up to a maximum
of $500,000 in aggregate; (ii) plus 4.9% of the difference, if any, between
the aggregate equity value attributed to the Company for the purposes of the
Acquisition Proposal and the aggregate equity value attributed to the Company
for the purposes of this Agreement up to a maximum amount of $2,500,000 for
both (i) and (ii). For the purposes of this Agreement, such difference between
the "aggregate equity values" shall be calculated by: (a) determining the
final price per share of Common Stock contemplated by the Acquisition
Proposal; (b) subtracting the mean price per share of Common Stock on July 10,
1998 and (c) multiplying that difference by the total number of shares of
Common Stock issued or issuable on that day on a fully diluted basis, but
excluding therefrom all shares of Common Stock issuable pursuant to the TMC
Option or the TMC Warrant the exercise price of which is less than the
purchase price of a share of Common Stock on that day.
"Verratti Waiver Agreement" means an agreement between the Company and
Robert Verratti substantially in the form of Exhibit K.
"VVI" means ValueVision International, Inc., a Minnesota corporation.
"VVI Agreement" means an agreement between the Company, VVI and ACO in the
form of Exhibit J.
"Wholly-Owned Subsidiary" means as to any Person or Subsidiary, all of the
shares of capital stock or other equity interests of which (except directors'
qualifying shares) are at the time directly or indirectly owned by such
Person.
A-6
<PAGE>
Section 1.2 Accounting Terms and Determinations. Unless otherwise specified
herein (a) all accounting terms used herein shall be interpreted, all
accounting determinations hereunder shall be made, and all financial
statements required to be delivered hereunder shall be prepared, in accordance
with GAAP and (b) references to fiscal periods are to those of the Company.
When used herein, the term "financial statements" shall include the notes and
schedules thereto.
Section 1.3 Computation of Time Periods. In this Agreement, with respect to
the computation of periods of time from a specified date to a later specified
date, the word "from" means "from and including" and the words "to" and
"until" each mean "to but excluding." Periods of days referred to in this
Agreement shall be counted in calendar days unless otherwise stated.
Section 1.4 Construction. Unless the context of this Agreement clearly
requires otherwise, references to the plural include the singular and to the
singular include the plural, references to any gender include any other
gender, the part includes the whole, the term "including" is not limiting, and
the term "or" has, except where otherwise indicated, the inclusive meaning
represented by the phrase "and/or." The words "hereof," "herein," "hereby,"
"hereunder," and similar terms in this Agreement refer to this Agreement as a
whole and not to any particular provision of this Agreement. Article, section,
subsection, clause, exhibit and schedule references are to this Agreement,
unless otherwise specified. Any reference to this Agreement or the other
Investment Documents includes any and all permitted alterations, amendments,
changes, extensions, modifications, renewals, or supplements thereto or
thereof, as applicable.
Section 1.5 Exhibits and Schedules. Any reference to an exhibit or schedule
shall be deemed to be a reference to an exhibit or schedule hereto.
Section 1.6 No Presumption Against Any Party. Neither this Agreement nor any
other Investment Document nor any uncertainty or ambiguity herein or therein
shall be construed or resolved using any presumption against any party hereto
or thereto, whether under any rule of construction or otherwise. On the
contrary, this Agreement and the other Investment Documents have been reviewed
by each of the parties and their counsel and, in the case of any ambiguity or
uncertainty, shall be construed and interpreted according to the ordinary
meaning of the words used so as to fairly accomplish the purposes and
intentions of all parties hereto.
ARTICLE II
The Purchases
Section 2.1 Initial Purchase. Subject to the terms and conditions of this
Agreement:
(a) The Company hereby agrees to sell to ACO and ACO hereby agrees to
purchase from the Company, 20,000 shares of Series E Stock, at a purchase
price equal to $1,000 per share (the "Initial Purchase"), provided that ACO
shall be entitled to set off against the purchase price any amounts payable
by the Company pursuant to Section 8.4, as reasonably substantiated by ACO
to the Company on or before the Closing Date; and
(b) Contemporaneously with the execution of the Consulting Agreement, the
Company shall issue the TMC Option and the TMC Warrant to TMC, without any
additional consideration to be paid therefor by TMC.
The closing of the Initial Purchase shall be held at the office of
Buchalter, Nemer, Fields & Younger, 601 South Figueroa Street, Suite 2400, Los
Angeles, California, as soon as practicable after all conditions to Closing
have been satisfied or waived (the "Closing Date"). On the Closing Date, the
Company will deliver to ACO one or more Series E Stock certificates,
registered in ACO's name in any denominations as ACO may specify by timely
notice to the Company (or, in the absence of such notice, one such share
certificate registered in ACO's name), duly executed and dated as of the
Closing Date, against payment of the purchase price therefor by wire transfer
of immediately available funds to the account of the Company at such bank or
other financial institution
A-7
<PAGE>
as the Company shall notify ACO. Contemporaneously with the execution of the
Consulting Agreement, the Company shall deliver to TMC the TMC Warrant and the
TMC Option, registered in its name, as duly executed and dated the Closing
Date.
Section 2.2 Further Purchase. Subject to the terms and conditions of this
Agreement, the Company shall have the right to sell to ACO and ACO hereby
agrees to purchase from the Company at the request of the Company, up to 2,000
shares of Series E Stock, at a purchase price equal to $1,000 per share (the
"Further Purchase"), provided that: (a) such request is made prior to the date
on which the Proxy Statement is first mailed to the Company's Stockholders;
(b) the Initial Purchase has been consummated; and (c) ACO shall be entitled
to set off against the purchase price any amounts payable by the Company
pursuant to Section 8.4, as reasonably substantiated by ACO to the Company on
or before the Closing Date.
The closing of the Further Purchase shall be held at the office of
Buchalter, Nemer, Fields & Younger, 601 South Figueroa Street, Suite 2400, Los
Angeles, California, on the date requested by the Company, provided that such
date is 60 days or more after such request is made (the "Further Closing
Date"). On the Further Closing Date, the Company will deliver to ACO one or
more Series E Stock certificates, registered in ACO's name in any
denominations as ACO may specify by timely notice to the Company (or, in the
absence of such notice, one such share certificate registered in ACO's name),
duly executed and dated as of the Further Closing Date, against payment of the
purchase price therefor by wire transfer of immediately available funds to the
account of the Company at such bank or other financial institution as the
Company shall notify ACO.
Section 2.3 Transaction Initiation Fee. If the Company enters into any
understanding or agreement with any Person pursuant to an Acquisition
Proposal, during the term hereof or within four months after the termination
of this Agreement pursuant to Section 7.1(d) or (e), the Company shall
promptly pay the Transaction Initiation Fee to ACO. The Company acknowledges
and agrees that (a) ACO has expended and will expend a considerable amount of
time and effort in connection with the transactions contemplated by this
Agreement, (b) ACO has incurred and will incur significant expenses in
connection with the transactions contemplated by this Agreement, (c) the
relationship of the parties is not marked by any self-dealing, (d) the
Transaction Initiation Fee provides ACO with a reasonable incentive to make
the offer contained in the transactions contemplated by this Agreement, and
(e) ACO's costs described above are and will be difficult to predict and
ascertain and that the Transaction Initiation Fee is a good faith attempt by
ACO to estimate the amount of such costs.
Section 2.4 Register of Securities. The Company or its duly appointed agent
shall maintain a separate register for the shares of Series E Stock and Common
Stock, in which it shall register any issuance or subsequent sale of any such
shares accomplished in accordance with the terms of the Investment Documents.
All transfers of the Series E Stock shall be recorded on the register
maintained by the Company or its agent, and the Company shall be entitled to
regard the registered holder of the Series E Stock as the actual holder of the
Securities so registered until the Company or its agent is required to record
a transfer of such Series E Stock on its register. Subject to Section 2.4(c),
the Company or its agent shall be required to record any such transfer when it
receives the Security to be transferred duly and properly endorsed by the
registered holder thereof or by its attorney duly authorized in writing.
Section 2.5 Restrictions on Transfer.
(a) ACO understands and agrees that the Series E Stock it will be acquiring
have not been registered under the Securities Act of 1933, as amended (the
"Securities Act"), and that accordingly they will not be fully transferable
except as permitted under various exemptions contained in the Securities Act,
or upon satisfaction of the registration and prospectus delivery requirements
of the Securities Act. ACO acknowledges that it must bear the economic risk of
its investment in the Series E Stock for an indefinite period of time
(subject, however, to the Company's obligation to effect the registration of
the Conversion Stock under the Securities Act in accordance with the
Registration Rights Agreement) since they have not been registered under the
Securities Act and therefore cannot be sold unless they are subsequently
registered or an exemption from registration is available.
A-8
<PAGE>
(b) ACO hereby represents and warrants to the Company that it is acquiring
the Series E Stock it has agreed to purchase for investment purposes only, for
its own account, and not as nominee or agent for any other Person, and not
with the view to, or for resale in connection with, any distribution thereof
within the meaning of the Securities Act.
(c) ACO hereby agrees with the Company as follows:
(i) The certificates evidencing the Series E Stock it has agreed to
purchase, and each certificate issued in transfer thereof, will bear the
following legend:
"The securities evidenced by this certificate have not been registered
under the Securities Act of 1933 and have been acquired for investment
purposes only and not with a view to the distribution thereof, and such
securities may not be sold, pledged or transferred unless there is an
effective registration statement or Regulation A notification under
such Act covering such securities or the Company receives an opinion of
counsel (which may be counsel for the Company), reasonably satisfactory
in form and content to the Company, stating that such sale or transfer
is exempt from the registration and prospectus delivery requirements of
such Act."
(ii) The certificates representing such Securities, and each certificate
issued in transfer thereof, will also bear any legend required under any
applicable state securities law.
(iii) Absent an effective Conversion Stock registration statement under
the Securities Act, covering the disposition of the Conversion Stock which
ACO acquires, ACO will not sell, transfer, assign, pledge, hypothecate or
otherwise dispose of any or all of the Conversion Stock without first
providing the Company with an opinion of counsel (which may be counsel for
the Company), reasonably satisfactory in form and content to the Company,
to the effect that such sale, transfer, assignment, pledge, hypothecation
or other disposition will be exempt from the registration and the
prospectus delivery requirements of the Securities Act and the registration
or qualification requirements of any applicable state securities laws,
except that no such opinion shall be required with respect to a sale or
transfer effected in accordance with Rule 144(k) under the Securities Act.
(iv) ACO consents to the Company's making a notation on its records or
giving instructions to any transfer agent of the Common Stock or Series E
Stock in order to implement the restrictions on transfer of the Series E
Stock mentioned in this subsection (c).
Section 2.6 Removal of Transfer Restrictions. Any legend endorsed on a
certificate evidencing a Security pursuant to Section 2.4(c)(i) hereof and the
stop transfer instructions and record notations with respect to such Security
shall be removed and the Company shall issue a certificate without such legend
to the holder of such Security (a) if such Security is registered under the
Securities Act, or (b) if such Security may be sold under Rule 144(k) of the
Commission under the Securities Act or (c) if such holder provides the Company
with an opinion of counsel (which may be counsel for the Company) reasonably
acceptable to the Company to the effect that a public sale or transfer of such
Security may be made without registration under the Securities Act.
Section 2.7 Additional Representations and Warranties by ACO. ACO represents
and warrants to the Company as follows:
(a) ACO is a limited liability company duly organized, validly existing
and in good standing under the laws of Delaware, and is qualified to do
business as a foreign corporation in each jurisdiction in which the failure
to be so qualified would be a Material Adverse Change (if ACO were the
Company) with respect to ACO's business, condition or results of
operations. ACO has all required legal power and authority to carry on its
business as presently conducted, to enter into and perform this Agreement
and the agreements contemplated hereby to which it is a party and to carry
out the transactions contemplated hereby and thereby.
(b) This Agreement constitutes the legal, valid and binding obligation of
ACO and is enforceable against ACO in accordance with its terms, except as
such enforcement is limited by bankruptcy, insolvency, and other similar
laws affecting the enforcement of creditors' rights generally.
A-9
<PAGE>
(c) ACO is an Accredited Investor and is experienced in evaluating
companies such as the Company, is able to fend for itself in the
transactions contemplated by this Agreement and has such knowledge and
experience in financial and business matters as to be capable of evaluating
the merits and risks of its investment. It has had access, during the
course of the transaction and prior to its purchase of Series E Stock, to
such information as is sufficient to make an informed decision with respect
to its purchase of the Series E Stock and it has had, during the course of
the transaction and prior to its purchase of Series E Stock, the
opportunity to ask questions of and receive answers from the Company
concerning the terms and conditions of the offering and to obtain
additional information necessary to verify the accuracy of any information
furnished to it or to which it had access.
(d) ACO knows of no public solicitation or advertisement of an offer in
connection with the Series E Stock; ACO's jurisdiction of formation or
incorporation and the principal place of business as set forth in the
signature page hereof are accurate.
(e) Stephen Lehman, Daniel Yukelson and a Nevada corporation controlled
by Eric Weiss are the only members of TMC. TMC is the only Manager of ACO.
The provisions of ACO's Operating Agreement regarding the management of ACO
shall be substantially as disclosed in the draft operating agreement
delivered to the Company on August 10, 1998.
(f) Stephen Lehman, Jacor Communications and Gruber McBain are and
through the Closing will be the only members of ACO holding a membership
interest of 10% or greater therein.
(g) ACO has or has arranged for sufficient funds to consummate the
transactions contemplated by the Investment Documents.
(h) ACO will hold and will not transfer, encumber or otherwise dispose of
any shares of the Company's Series D Preferred Stock (or Common Stock
received in connection with the conversion thereof) until after the Closing
Date.
Section 2.8 No Brokers or Finders. ACO represents and warrants to the
Company that, as a result of ACO's actions, no person other than BT Alex.
Brown Incorporated has, or as a result of the transaction as contemplated
herein will have, any right or valid claim against the Company for any
commission, fee or other compensation as a finder or broker, or in any similar
capacity.
Section 2.9 Information in Proxy Statement. The information to be supplied
by ACO or about ACO by ACO's agents for inclusion in the Proxy Statement shall
not, on the date the Proxy Statement is first mailed to stockholders of the
Company, at the time of the Company stockholders' meeting to approve the
transactions contemplated by this Agreement (the "Stockholders' Meeting") and
as of the Closing Date, contain any statement which, at such time and in light
of the circumstances under which it shall be made, is false or misleading with
respect to any material fact, omit to state any material fact necessary in
order to make the statements made in such proxy statement not false or
misleading, or omit to state any material fact necessary to correct any
statement in any earlier communication with respect to the solicitation of
proxies for the Stockholders' Meeting which has become false or misleading. If
at any time prior to the Closing Date any event relating to ACO or any of its
Affiliates, officers or directors should be discovered by ACO which should be
set forth in a supplement to the Proxy Statement, then ACO shall promptly
inform the Company. Such information shall include all necessary information
regarding the ACO Board Nominees.
ARTICLE III
Conditions
Section 3.1 Conditions to Each Party's Obligation to Effect the
Purchase. The respective obligations of each party to this Agreement to effect
the Initial Purchase and (if applicable) the Further Purchase (collectively,
the "Purchases") shall be subject to the satisfaction or waiver in writing by
each of the Company and ACO prior to the Closing Date of the following
conditions:
A-10
<PAGE>
(a) Receipt by each party hereto of counterparts hereof signed by each of
the other parties hereto;
(b) The transactions contemplated by this Agreement (and other matters
contained in the Proxy Statement) shall have been approved in the manner
required under the rules of the New York Stock Exchange and the DGCL, as
the case may be, by the holders of the issued and outstanding shares of
capital stock of the Company.
(c) The waiting period applicable to the consummation of the transactions
contemplated by this Agreement under the Hart-Scott-Rodino Antitrust
Improvements Act of 1976 as amended (the "HSR Act") shall have expired or
been terminated, provided that ACO and the Company shall use best efforts
to make any necessary filings under the HSR Act within 45 days after the
date of this Agreement.
(d) All authorizations, consents, orders or approvals of, or declarations
or filings with, or expiration of waiting periods imposed by, any court,
administrative agency or commission or other governmental authority or
instrumentality ("Governmental Entity") the failure to which to file,
obtain or occur is reasonably likely to cause a Material Adverse Change,
shall have been filed or obtained or have occurred.
(e) No Governmental Entity shall have enacted, issued, promulgated,
enforced or entered any order, executive order, stay, decree, judgment or
injunction or statute, rule, regulation which is in effect and which has
the effect of making the transactions contemplated by this Agreement
illegal or otherwise prohibiting consummation of the transactions
contemplated by this Agreement.
(f) The Company shall have received, on or prior to the date of the Proxy
Statement, an opinion, from an investment banking firm chosen by the
Company, and reasonably acceptable to ACO, to the effect that the
transactions contemplated by this Agreement are fair to the holders of
Common Stock from a financial point of view (the "Fairness Opinion") and
such opinion shall be confirmed as of the Closing Date.
Section 3.2 Further Conditions to ACO's Obligation to Purchase. The
obligation of ACO to purchase and pay for the Series E Stock in the Purchases
is subject to the following conditions having been satisfied on or before the
Closing Date or Further Closing Date (as applicable):
(a) Receipt by ACO of an opinion of Klehr, Harrison, Harvey, Branzburg &
Ellers LLP, counsel to the Company, dated as of the Closing Date or the
Further Closing Date (as applicable), and substantially to the effect of
Exhibit L;
(b) Receipt by ACO of a fully completed and duly executed Compliance
Certificate;
(c) On the Closing Date or the Further Closing Date (as applicable), the
Company shall have duly issued and delivered to ACO a certificate
evidencing the Series E Stock purchased by ACO as provided by Section 2.1;
(d) The Certificate of Designation for Series E Stock shall have been
filed with the Delaware Secretary of State and a copy of the Certificate
certified by such Secretary of State shall have been delivered to ACO;
(e) The Company shall have obtained all material registrations,
qualifications, permits and approvals required under applicable state
securities laws for the lawful execution, delivery and performance of this
Agreement and the performance of the Certificate, including without
limitation the offer, sale, issue and delivery of the Securities;
(f) Receipt by ACO from the Company of a payment in such amount as ACO
may reasonably request on account of expenses incurred by ACO and its
attorneys in connection with the negotiation and preparation of this
Agreement and related matters and for which ACO is entitled to
reimbursement pursuant to Section 7.3;
(g) Receipt by ACO on the Closing Date or the Further Closing Date (as
applicable) of all documents it may reasonably request relating to the
existence, status, and capacity of the Company and the corporate authority
for, and the validity, force, and effect of the Investment Documents and
any other matters relevant hereto or thereto, all in form and substance
satisfactory to ACO;
(h) Receipt by ACO of evidence reasonably satisfactory to ACO that the
purchase price for the Series E Stock will be applied pursuant to Section
5.17;
A-11
<PAGE>
(i) The fact that, immediately before and after giving effect to the
consummation of such Purchase, no material Default shall have occurred and
be continuing;
(j) The representations and warranties of the Company contained in this
Agreement shall be true and correct in all material respects on and as of
the Closing Date or the Further Closing Date (as applicable) unless
expressly made as of another date;
(k) The Company shall have performed in all material respects all
material obligations required to be performed by it under this Agreement on
or prior to the Closing Date or the Further Closing Date (as applicable);
(l) Each of the following shall have been executed by all of the parties
named therein (other than ACO or TMC (as appropriate)) and shall not have
been terminated or purported to have been terminated by any of the parties
named therein (other than ACO or TMC (as appropriate)):
(i) the Amendment No. 7 to Rights Agreement;
(ii) the Stockholders Voting Agreement;
(iii) the Consulting Agreement;
(iv) the Costalas Waiver Agreement;
(v) the Hammer Waiver Agreement;
(vi) the Series D Stock Purchase Agreement;
(vii) the VVI Agreement;
(viii) the Verratti Waiver Agreement;
(ix) the Registration Rights Agreement;
(x) the Series B Consent Agreement; and
(xi) the First Union National Bank Consent Agreement.
(m) The Company's Common Stock shall not have been delisted by the New
York Stock Exchange, Inc.; and
(n) The ACO Board Nominees shall constitute a majority of the Company's
directors and Stephen Lehman shall be the Company's acting Chief Executive
Officer and Jack Kirby shall not have been removed by the Company as a
Company director without cause.
Section 3.3 Conditions to the Company's Obligations to Effect the
Purchase. The obligation of the Company to sell and issue the Series E Stock
in the Purchase is subject to the following conditions having been satisfied
on or before the Closing Date or the Further Closing Date (as applicable):
(a) The Company shall have received the Purchase Price for the Series E
Stock as provided by Sections 2.1 and/or 2.2, as the case may be;
(b) The representations and warranties of ACO contained in this Agreement
shall be true and correct in all material respects on and as of the Closing
Date or the Further Closing Date (as applicable), unless expressly made as
of another date;
(c) ACO shall have performed in all material respect all material
obligations required to be performed by it under this Agreement at or prior
to the Closing Date or the Further Closing Date (as applicable); and
(d) Each of the following shall have been executed by all of the parties
named therein (other than the Company) and shall not have been terminated
or purported to have been terminated by any of the parties named therein
(other than the Company):
(i) the Amendment No. 7 to Rights Agreement;
(ii) the Stockholders Voting Agreement;
(iii) the Consulting Agreement;
A-12
<PAGE>
(iv) the Costalas Waiver Agreement;
(v) the Hammer Waiver Agreement;
(vi) the Series D Stock Purchase Agreement;
(vii) the VVI Agreement;
(viii) the Verratti Waiver Agreement;
(ix) the Registration Rights Agreement;
(x) the Series B Consent Agreement; and
(xi) the First Union Bank Consent Agreement.
ARTICLE IV
Representations and Warranties by the Company
The Company represents and warrants to ACO that the statements contained in
this Article IV are true and correct, except as set forth on the disclosure
schedule delivered by the Company to ACO on or before the date of this
Agreement (the "Company Disclosure Schedule") or as disclosed in the Company
SEC Reports (as defined in Section 4.4). The Company Disclosure Schedule shall
be arranged in paragraphs corresponding to the numbered and lettered
paragraphs contained in this Article IV and the disclosure in any paragraph
shall qualify other paragraphs in this Article IV only to the extent that it
is reasonably apparent from a reading of such document that it also qualifies
or applies to such other paragraphs.
Section 4.1 Organization of the Company. Each of the Company and the
Company's Material Subsidiaries (as defined below) is a corporation duly
organized, validly existing and in good standing under the laws of the
jurisdiction of its incorporation, has all requisite corporate power to own,
lease and operate its property and to carry on its business as now being
conducted and as proposed to be conducted, and is duly qualified to do
business and is in good standing as a foreign corporation in each jurisdiction
in which the failure to be so qualified would cause a Material Adverse Change.
Except as set forth on the Company Disclosure Schedule or in the Company SEC
Reports (as defined in Section 4.4) filed prior to the date hereof, neither
the Company nor any of its Subsidiaries directly or indirectly owns (other
than ownership interests in the Company or in one or more of its Subsidiaries)
any equity or similar interest in, or any interest that is mandatorily
convertible into or exchangeable or exercisable for, any corporation,
partnership, joint venture or other business association or entity, excluding
securities in any publicly traded company held for investment by the Company
and comprising less than five percent (5%) of the outstanding stock of such
company. A true, correct and complete copy of the Certificate of Incorporation
and other similar organizational documents of the Company and each of the
Company's Material Subsidiaries (as defined below) has been delivered to ACO.
"The Company's Material Subsidiaries" shall mean those subsidiaries of the
Company set forth on the Company Disclosure Schedule, which Subsidiaries
constitute all of the Company's "significant subsidiaries" as defined in Rule
1-02 of Regulation S-X under the Securities Act.
Section 4.2 The Company Capital Structure.
(a) The authorized capital stock of the Company consists of 75,000,000
shares of Common Stock, $.01 par value, and 10,000,000 shares of Preferred
Stock, $.01 par value. As of the date of this Agreement, (i) 25,453,752 shares
of Common Stock are issued and outstanding, all of which are validly issued,
fully paid and nonassessable, and (ii) 887,229 shares of Common Stock which
are held in the treasury of the Company or by Subsidiaries of the Company. The
Company Disclosure Schedule shows the number of shares of Common Stock
reserved for future issuance pursuant to stock options granted and outstanding
as of the date hereof, the plans under which such options were granted and
award agreements pursuant to which "non-plan" options were granted
(collectively, the "Company Stock Plans"), and the entities or persons to whom
such options were granted. The Company Disclosure Schedule also shows the
agreements under which the warrants to purchase an
A-13
<PAGE>
aggregate of 7,093,413 shares of Common Stock granted and outstanding as of
the date hereof were issued and to whom such warrants were granted. As of the
date hereof, the only convertible securities of the Company which are issued
and outstanding are: (i) the TMC Warrant and the TMC Option, (ii) an aggregate
number of 81,250 shares of Series B Convertible Preferred Stock, par value
$.01 per share, of the Company, which are currently convertible into 812,500
shares of Common Stock and which are currently entitled to vote on all matters
submitted to the stockholders of the Company (with the exception of the
election of directors) on an "as converted" basis (the "Series B Convertible
Preferred Stock") (iii) 19,900 shares of Series D Convertible Preferred Stock,
par value $.01 per share, of the Company which are currently convertible into
a minimum of 18,543,972 shares of Common Stock, plus the number of shares of
Common Stock equal to the quotient of the Accrued Premium (as defined in the
Certificate of Designations (as defined below)) divided by $1.073125 (the
"Series D Convertible Preferred Stock" and, together with the Series B
Convertible Preferred Stock the "Company Convertible Preferred Stock") and
(iv) such other convertible securities as are disclosed on the Company
Disclosure Schedule. Based on the Certificate of Designations, the amount of
the Accrued Premium (as defined in the Certificate of Designations) is
$392,547.94 as at the date of this Agreement. All shares of Common Stock, into
which Series D Convertible Preferred Stock is convertible, or which are
issuable upon exercise of the Revised National Media Stock Purchase Warrant--C
or the National Media Stock Purchase Warrant--D are duly registered with the
Commission. All shares of Common Stock subject to issuance as specified above
shall be, when issued, validly issued, fully paid and nonassessable. Except as
set forth on the Company Disclosure Schedule and with respect to the Series D
Preferred Stock, there are no obligations, contingent or otherwise, of the
Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire
any shares of Common Stock or the capital stock of any Subsidiary or to
provide funds to or make any material investment (in the form of a loan,
capital contribution or otherwise) in any such Subsidiary or any other entity
other than guarantees of bank obligations of Subsidiaries entered into in the
ordinary course of business. Except as set forth on the Company Disclosure
Schedule, all of the outstanding shares of capital stock of each of the
Company's Subsidiaries are duly authorized, validly issued, fully paid for and
nonassessable and all such shares (other than directors' qualifying shares in
the case of foreign Subsidiaries) are beneficially owned by the Company or
another Subsidiary free and clear of all security interests, liens, claims,
pledges, agreements, limitations of the Company's voting rights, charges or
other encumbrances of any nature other than Permitted Liens.
(b) Except as set forth in this Section 4.2 or as reserved for future grants
of options under the Company Stock Plans, the TMC Warrant or the TMC Option,
and except for the Series A Junior Participating Preferred Stock issued and
issuable under the Company Rights Plan, or as disclosed on the Company
Disclosure Schedule, (i) there are no equity securities of any class of the
Company or any of its Subsidiaries, or any security exchangeable into or
exercisable for such equity securities, issued, reserved for issuance or
outstanding; (ii) except as set forth in the Certificate of Designations,
Preferences and Rights of the Series D Convertible Preferred Stock (the
"Certificate of Designations") and the Registration Rights Agreement dated as
of September 4, 1997, as amended, by Amendment No. 1 thereto, dated April 14,
1998 among the Company and the holders of the Series D Convertible Preferred
Stock, there are no options, warrants, equity securities, stock appreciation
rights, calls, rights, commitments or agreements of any character to which the
Company or any of its Subsidiaries is a party or by which it is bound
obligating the Company or any of its Subsidiaries to issue, deliver or sell,
or cause to be issued, delivered or sold, additional shares of capital stock
of the Company or any of its Subsidiaries or obligating the Company or any of
its Subsidiaries to grant, extend, accelerate the vesting of or enter into any
such option, warrant, equity security, call, right, commitment or agreement;
and (iii) to the best knowledge of the Company, there are no voting trusts,
proxies or other voting agreements or understandings with respect to the
shares of capital stock of the Company.
Section 4.3 Authority; No Conflict; Required Filings and Consents.
(a) The Company has all requisite corporate power and authority to enter
into this Agreement and each of the Investment Documents to which it is a
party and to consummate the transactions contemplated by this Agreement and
each of the Investment Documents to which it is a party. The execution and
delivery of this
A-14
<PAGE>
Agreement and each of the Investment Documents to which it is a party and the
consummation of the transactions contemplated by this Agreement and each of
the Investment Documents to which it is a party by the Company have been duly
authorized by all necessary corporate action on the part of the Company,
subject only to the approval and adoption of this Agreement by the Company's
stockholders under the DGCL and the rules of the New York Stock Exchange. This
Agreement and each of the Investment Documents to which it is a party have
been duly executed and delivered by the Company and constitute the valid and
binding obligations of the Company, enforceable in accordance with their
terms, subject to the Bankruptcy and Equity Exception.
(b) Except as set forth on the Company Disclosure Schedule, the execution
and delivery of this Agreement and each of the Investment Documents to which
it is a party by the Company does not, and the consummation of the
transactions contemplated by this Agreement and each of the Investment
Documents to which it is a party will not, (i) conflict with, or result in any
violation or breach of, any provision of the Certificate of Designation for
Series E Stock, the Certificate of Incorporation or Bylaws of the Company or
any of its Subsidiaries, (ii) result in any violation or breach of, or
constitute (with or without notice or lapse of time, or both) a default (or
give rise to a right of termination, cancellation or acceleration of any
obligation or loss of any material benefit) under, or require a consent or
waiver under, any of the terms, conditions or provisions of any note, bond,
mortgage, indenture, lease, contract or other agreement, instrument or
obligation to which the Company or any of its Subsidiaries is a party or by
which any of them or any of their properties or assets may be bound (including
the Series D Convertible Preferred Stock), or (iii) conflict with or violate
any permit, concession, franchise, license, judgment, order, decree, statute,
law, ordinance, rule or regulation applicable to the Company or any of its
Subsidiaries or any of its or their properties or assets, except in the case
of (ii) and (iii) for any such conflicts, violations, defaults, terminations,
cancellations or accelerations which are not, individually or in the
aggregate, reasonably likely to cause a Material Adverse Change.
(c) Except as set forth on the Company Disclosure Schedule, no consent,
approval, order or authorization of, or registration, declaration or filing
with, any Governmental Entity (as defined above) is required by or with
respect to the Company or any of its Subsidiaries in connection with the
execution and delivery of this Agreement and each of the Investment Documents
to which it is a party or the consummation of the transactions contemplated
hereby or thereby, except for (i) the filing of the pre-merger notification
report under the Hart-Scott-Rodino Antitrust Improvements Act, (ii) the Proxy
Statement requirements imposed pursuant to the Exchange Act or by the
Commission, (iii) such consents, approvals, orders, authorizations,
registrations, declarations and filings as may be required under applicable
state or foreign securities laws, and (iv) such other consents,
authorizations, filings, approvals and registrations which, if not obtained or
made, would not be reasonably likely to cause a Material Adverse Change.
Section 4.4 SEC Filings; Financial Statements.
(a) The Company has filed and made available to ACO all forms, reports and
documents filed or required to be filed by the Company with the SEC since
January 1, 1995 (collectively, the "Company SEC Reports"). The Company SEC
Reports (i) except as set forth on the Company Disclosure Schedule, at the
time filed, complied in all material respects with the applicable requirements
of the Securities Act and the Exchange Act, as the case may be, and (ii) did
not at the time they were filed (or if amended or superseded by a filing prior
to the date of this Agreement, then on the date of such filing) contain any
untrue statement of a material fact or omit to state a material fact required
to be stated in such Company SEC Reports or omit to state a material fact
necessary in order to make the statements in such Company SEC Reports, in the
light of the circumstances under which they were made, not misleading. None of
the Company's Subsidiaries is required to file any forms, reports or other
documents with the SEC.
(b) Except as disclosed on the Company Disclosure Schedule, each of the
consolidated financial statements (including, in each case, any related notes)
contained in the Company SEC Reports complied as to form in all material
respects with the applicable published rules and regulations of the SEC with
respect thereto, was prepared in accordance with GAAP applied on a consistent
basis throughout the periods involved (except as may be indicated in the notes
to such financial statements or, in the case of unaudited statements, in
conformity with
A-15
<PAGE>
the requirements of Form 10-Q under the Exchange Act) and fairly present in
all material respects the consolidated financial position of the Company and
its Subsidiaries as of the applicable dates and the consolidated results of
its operations and cash flows for the periods indicated, except that the
unaudited financial statements were or are subject to normal and recurring
year-end adjustments which were not or are not expected to be material in
amount.
Section 4.5 No Undisclosed Liabilities. Except as disclosed in the Company
SEC Reports filed prior to the date hereof or on the Company Disclosure
Schedule, and except for normal or recurring liabilities incurred since March
31, 1998 in the ordinary course of business consistent with past practices,
the Company and its Subsidiaries do not have any liabilities, either accrued,
contingent or otherwise (whether or not required to be reflected in financial
statements in accordance with GAAP, and whether due) or to become due, which
individually or in the aggregate, are reasonably likely to cause a Material
Adverse Change.
Section 4.6 Absence of Certain Changes or Events. Except as disclosed in the
Company SEC Reports filed prior to the date hereof or on the Company
Disclosure Schedule, since the date of the Base Financials, the Company and
its Subsidiaries have conducted their businesses only in the ordinary course
and in a manner consistent with past practice and, since such date, there has
not been (i) any Material Adverse Change (other than changes that are the
effect or result of economic factors affecting the economy as a whole or the
industry (as described in the Company's Form 10-K for the fiscal year ended
March 31, 1998 as amended (the "Company 10-K") in which the Company competes)
or any development or combination of developments of which the management of
the Company is aware that, individually or in the aggregate has caused or is
reasonably likely to cause a Material Adverse Change (other than changes that
are the effect or result of economic factors affecting the economy as a whole
or the industry (as described in the Company 10-K) in which the Company
competes); (ii) any damage, destruction or loss (whether or not covered by
insurance) with respect to the Company or any of its Subsidiaries having a
Material Adverse Change; (iii) any material change by the Company or its
Subsidiaries in their respective accounting methods, principles or practices
to which ACO has not previously consented in writing; or (iv) any revaluation
by the Company or its Subsidiaries of any of their assets having a Material
Adverse Change.
Section 4.7 Taxes.
(a) Except as set forth on the Company Disclosure Schedule or the Company
SEC Reports, the Company and each of its Subsidiaries have (i) filed all
federal, state, local and foreign Tax returns and reports required to be filed
by them prior to the date of this Agreement (taking into account all
applicable extensions), (ii) paid or accrued all Taxes due and payable, and
(iii) paid or accrued all Taxes for which a notice of assessment or collection
has been received (other than amounts being contested in good faith by
appropriate proceedings), except in the case of clauses (i), (ii) or (iii) for
any such filings, payments or accruals that are not reasonably likely,
individually or in the aggregate, to cause a Material Adverse Change. There
are no audits in process or known by the Company to be pending or contemplated
with respect to the Company's Tax returns. Neither the Internal Revenue
Service ("IRS") nor any other taxing authority has asserted any claim for
Taxes, or to the actual knowledge of the executive officers of the Company, is
threatening to assert any claims for Taxes, which claims, individually or in
the aggregate, are reasonably likely to cause a Material Adverse Change. The
Company and each of its Subsidiaries have withheld or collected and paid over
to the appropriate governmental authorities (or are properly holding for such
payment) all Taxes required by law to be withheld or collected, except for
amounts that are not reasonably likely, individually or in the aggregate, to
cause a Material Adverse Change. Neither the Company nor any of its
Subsidiaries has made an election under Section 341(f) of the IRC, except for
any such elections that are not reasonably likely, individually or in the
aggregate, to cause a Material Adverse Change. There are no liens for Taxes
upon the assets of the Company or any of its Subsidiaries (other than liens
for Taxes that are not yet due or that are being contested in good faith by
appropriate proceedings), except for liens that are not reasonably likely,
individually or in the aggregate, to cause a Material Adverse Change. No
extension of a statute of limitations relating to any Taxes is in effect with
respect to the Company and its Subsidiaries.
A-16
<PAGE>
(b) Neither the Company nor any of its Subsidiaries has been a member of an
affiliated group of corporations filing a consolidated federal income tax
return (or a group of corporations filing a consolidated, combined or unitary
income tax return under comparable provisions of state, local or foreign tax
law) for any taxable period beginning on or after April 1, 1991, other than a
group the common parent of which was the Company or any Subsidiary of the
Company.
(c) Neither the Company nor any of its Subsidiaries has any obligation under
any agreement or arrangement with any other person with respect to Taxes of
such other person (including pursuant to Treas. Reg. Section 1.1502-6 or
comparable provisions of state, local or foreign tax law) and including any
liability for Taxes of any predecessor entity, except for obligations that are
not reasonably likely, individually or in the aggregate, to cause a Material
Adverse Change.
(d) Neither the Company nor any of its Subsidiaries has been a United States
real property holding corporation within the meaning of section 897(c)(2) of
the IRC during the applicable period specified in Section 897(c)(1)(A)(ii) of
the IRC.
Section 4.8 Properties.
(a) Neither the Company nor any of its Subsidiaries is in default under any
of their respective leases for real property, except where the existence of
such defaults, individually or in the aggregate, is not reasonably likely to
cause a Material Adverse Change.
(b) Neither the Company nor any of its Subsidiaries owns any real property.
Section 4.9 Intellectual Property. Other than as set forth on the Company
Disclosure Schedule, each of the Company and its Subsidiaries owns, or is
licensed or otherwise possesses legally enforceable rights to use, all
trademarks, trade names, service marks, copyrights, and any applications for
such trademarks, trade names, service marks and copyrights, know-how, computer
software programs or applications, and tangible or intangible proprietary
information or materials that are necessary to conduct the business of each of
the Company and its Subsidiaries as currently conducted, subject to such
exceptions that would not be reasonably likely to cause a Material Adverse
Change. Other than as set forth on the Company Disclosure Schedule, neither
the Company nor any of its Subsidiaries has any knowledge of any assertion or
claim challenging the validity of any of such intellectual property, except
such assertions or claims that, individually or in the aggregate, are not
reasonably likely to cause a Material Adverse Change.
Section 4.10 Agreements, Contracts and Commitments. Except as set forth on
the Company Disclosure Schedule or the Company SEC Reports, neither the
Company nor any of its Subsidiaries has breached, or received in writing any
claim or notice that it has breached, any of the terms or conditions of any
material agreement, contract or commitment filed or required to be filed as an
exhibit to the Company SEC Reports (the "Company Material Contracts") in such
a manner as, individually or in the aggregate, is reasonably likely to cause a
Material Adverse Change. To the Company's knowledge, each Company Material
Contract that has not expired by its terms is in full force and effect.
Section 4.11 Litigation and Regulatory Matters. Except as described in the
Company SEC Reports filed prior to the date hereof or as set forth on the
Company Disclosure Schedule, there is no action, suit or proceeding, claim,
arbitration or investigation against the Company or any of its Subsidiaries
pending or as to which the Company or any of its Subsidiaries has received any
written notice of assertion, which, individually or in the aggregate, is
reasonably likely to cause a Material Adverse Change or a material adverse
effect on the ability of the Company to consummate the transactions
contemplated by this Agreement.
Section 4.12 Environmental Matters. To the knowledge of the Company and its
Subsidiaries, except as disclosed in the Company SEC Reports filed prior to
the date hereof and except for such matters that, individually or in the
aggregate, are not reasonably likely to cause a Material Adverse Change: (i)
the Company and its
A-17
<PAGE>
Subsidiaries are in material compliance with all applicable Environmental
Laws; (ii) the properties currently owned or operated by the Company and its
Subsidiaries (including soils, groundwater, surface water, buildings,
equipment or other structures) are not contaminated with any hazardous
substances; (iii) the properties formerly owned or operated by the Company or
any of its Subsidiaries were not contaminated with Hazardous Substances during
the period of ownership or operation by the Company or any of its
Subsidiaries; (iv) neither the Company nor its Subsidiaries are subject to
liability for any Hazardous Substance disposal or contamination on any third
party property; (v) neither the Company nor any of its Subsidiaries has been
associated with any release or threat of release of any hazardous substance;
(vi) neither the Company nor any of its Subsidiaries has received any written
notice, demand, letter, claim or request for information alleging that the
Company or any of its Subsidiaries may be in violation of or liable under any
Environmental Law; (vii) neither the Company nor any of its Subsidiaries is
subject to any orders, decrees, injunctions or other arrangements with any
Governmental Entity (as defined above) or is subject to any indemnity or other
agreement with any third party relating to liability under any Environmental
Law or relating to hazardous substances; and (viii) there are no circumstances
or conditions involving the Company or any of its Subsidiaries that could
reasonably be expected to result in any claims, liability, investigations,
costs or restrictions on the ownership, use or transfer of any property of the
Company pursuant to any Environmental Law.
Section 4.13 Employee Benefit Plans.
(a) The Company has listed on the Company Disclosure Schedule all employee
benefit plans and all benefit arrangements, (i) which are maintained,
contributed to or required to be contributed to by the Company or any entity
that, together with the Company as of the relevant measuring date under ERISA,
is or was required to be treated as a single employer under Section 414 of the
IRC ("Company ERISA Affiliate") or under which the Company or any the Company
ERISA Affiliate may incur any liability, and (ii) which cover the employees,
former employees, directors or former directors of the Company or any Company
ERISA Affiliate ("Company Employee Plans").
(b) A true and complete copy of each written Company Employee Plan that
covers employees or former employees of the Company or any Subsidiary of the
Company, including each amendment thereto and any trust agreement, insurance
contract, collective bargaining agreement, or other funding or investment
arrangements for the benefits under such Company Employee Plan, has been
delivered to ACO. In addition, with respect to each such Company Employee Plan
to the extent applicable, the Company has delivered to ACO the most recently
filed Federal Forms 5500 (solely with respect to the Company 401(k) Plan), the
most recent summary plan description (including any summaries of material
modifications), the most recent IRS determination letter, if applicable, the
most recent actuarial report or valuation, if applicable, and all material
employee communications with respect to each such Company Employee Plan.
(c) Except as set forth on the Company Disclosure Schedule:
(i) Neither the Company nor any Company ERISA Affiliate sponsors,
maintains, contributes to, or has any obligation to contribute to any
Employee Benefit Plan regulated under Title IV of ERISA, other than a
"multiemployer plan," as defined in Sections 3(37) and 4001(a)(3) of ERISA,
("Pension Plan"); with respect to any Pension Plan previously sponsored,
maintained or contributed to by the Company or any Company ERISA Affiliate
or with respect to which the Company or any Company ERISA Affiliate
previously incurred an obligation to contribute:
(A) As of the last day of the last plan year of each such Pension
Plan and as of the Closing Date, the "amount of unfunded benefit
liabilities" as defined in Section 4001(a)(18) of ERISA (but excluding
from the definition of "current value" of "assets" of such Pension
Plan, accrued but unpaid contributions) did not and will not exceed
zero.
(B) No such Pension Plan has been terminated so as to subject,
directly or indirectly, the Company or any Company ERISA Affiliate to
any liability, contingent or otherwise, or the imposition of any lien
under Title IV of ERISA;
A-18
<PAGE>
(C) No proceeding has been initiated by any person, including the
Pension Benefit Guarantee Corporation ("PBGC"), to terminate any such
Pension Plan;
(D) No liability to PBGC exists or is reasonably expected to be
incurred with respect to any such Pension Plan that could subject,
directly or indirectly, the Company or any Company ERISA Affiliate to
any liability, contingent or otherwise, or the imposition of any lien
under Title IV of ERISA, whether to the PBGC or to any other person;
(E) No "reportable event," as defined in Section 4043 of ERISA (to
the extent the reporting of such event to PBGC has not been waived) has
occurred and is continuing with respect to any such Pension Plan;
(F) No such Pension Plan which is subject to Section 302 of ERISA or
Section 412 of the IRC has incurred an "accumulated funding
deficiency," within the meaning of Section 302 of ERISA and 412 of the
IRC, whether or not such deficiency has been waived;
(G) Neither the Company nor any Company ERISA Affiliate has, at any
time, (i) ceased operations at a facility so as to become subject to
the provisions of Section 4068(e) of ERISA, (ii) withdrawn as a
substantial employer so as to become subject to the provisions of
Section 4063 of ERISA, or (iii) ceased making contributions on or
before the Closing Date to any Pension Plan subject to Section 4064(a)
of ERISA to which the Company or any Company ERISA Affiliate made
contributions during the five years prior to the Closing Date.
(ii) neither the Company nor any Company ERISA Affiliate sponsors has
previously sponsored, maintained, contributed to or incurred an obligation
to contribute to any "multiemployer plan," as defined in Sections 3(37) and
4001(a)(3) of ERISA;
(iii) neither the Company nor any Company ERISA Affiliate sponsors has
previously sponsored, maintained, contributed to or incurred an obligation
to contribute to any employee benefit plan that provides or will provide
benefits described in Section 3(1) of ERISA to any former employee or
retiree of the Company or any Company ERISA Affiliate, except as required
under Part 6 of Title I of ERISA and Section 4980B of the IRC;
(iv) all Company Employee Plans that cover or have covered employees or
former employees of the Company have been maintained and operated, and
currently are, in compliance in all material respects with their terms, the
requirements prescribed by any and all applicable laws (including ERISA and
the IRC), orders, or governmental rules and regulations in effect with
respect thereto, and the Company and the Company ERISA Affiliates have
performed all material obligations required to be performed by them
thereunder, are not in any material respect in default under or in
violation of, and have no knowledge of any default or violation by any
other party to, any of the Company Employee Plans;
(v) each Company Employee Plan that covers or has covered employees or
former employees of the Company and is intended to qualify under Section
401(a) of the IRC and each trust established pursuant to each such Company
Employee Plan that is intended to qualify under Section 501(a) of the IRC
is the subject of a favorable determination letter from the IRS, a copy of
which has been delivered to ACO, and, to the Company's knowledge, nothing
has occurred which may reasonably be expected to impair such determination
or otherwise adversely affect the tax-qualified status of such Company
Employee Plan;
(vi) the Company and the Company ERISA Affiliates have made full and
timely payment of all amounts required to be contributed under the terms of
each Company Employee Plan and applicable law or required to be paid as
expenses under such Company Employee Plan; and
(vii) other than claims for benefits in the ordinary course, there is no
claim, suit, action, dispute, arbitration or legal, administrative or other
proceeding or governmental investigation or audit pending, or, to the
knowledge of the Company, threatened, alleging any breach of the terms of
any Company Employee Plan or of any fiduciary duty thereunder or violation
of any applicable law with respect to any such Company Employee Plan.
A-19
<PAGE>
(d) With respect to the Company Employee Plans, individually and in the
aggregate, no event has occurred, and to the knowledge of the Company, there
exists no condition or set of circumstances in connection with which the
Company could be subject to any liability that is reasonably likely to cause a
Material Adverse Change under ERISA, the IRC or any other applicable law.
(e) Except as disclosed in the Company SEC Reports filed prior to the date
of this Agreement or on the Company Disclosure Schedule, and except as
provided for in this Agreement, neither the Company nor any of its
Subsidiaries is a party to any oral or written (i) agreement with any officer
or other key employee of the Company or any of its Subsidiaries, the benefits
of which are contingent, or the terms of which are materially altered, upon
the occurrence of a transaction involving the Company of the nature
contemplated by this Agreement, (ii) agreement with any officer of the Company
providing any term of employment or compensation guarantee extending for a
period longer than one year from the date hereof and for the payment of
compensation in excess of $100,000 per annum, or (iii) agreement or plan,
including any stock option plan, stock appreciation right plan, restricted
stock plan or stock purchase plan, any of the benefits of which will be
increased, or the vesting of the benefits of which will be accelerated, by the
occurrence of any of the transactions contemplated by this Agreement or the
value of any of the benefits of which will be calculated on the basis of any
of the transactions contemplated by this Agreement. None of the execution or
delivery of this Agreement or any of the Transaction Documents to which it is
a party or the consummation of the transactions contemplated hereunder or
thereunder will trigger any "change in control" or similar provisions
resulting in an acceleration of benefits or compensation thereunder with
respect to any agreements with any officer or other key employee of the
Company or any of its Subsidiaries except for such applicable agreements as
set forth on the Company Disclosure Schedule (the" Company Parachute
Agreements"). Except as set forth on the Company Disclosure Schedule or
pursuant to the Costalas Waiver Agreement, the Hammer Waiver Agreement and the
Verratti Waiver Agreement, there are no amounts payable under the Company
Parachute Agreements as a result of the transactions contemplated by this
Agreement.
Section 4.14 Compliance With Laws. Except as disclosed on the Company
Disclosure Schedule, each of the Company and its Subsidiaries has complied
with, is not in violation of, and has not received any notices of violation
with respect to, any federal, state or local statute, foreign law or
regulation with respect to the conduct of its business, or the ownership or
operation of its business, except for failures to comply or violations which,
individually or in the aggregate, have not caused and are not reasonably
likely to cause a Material Adverse Change.
Section 4.15 Registration Statement; Proxy Statement. The information to be
supplied by the Company or its Subsidiaries or about the Company or its
Subsidiaries by the Company's agents for inclusion in the Registration
Statement (as defined in the Registration Rights Agreement) shall not at the
time the Registration Statement is declared effective by the SEC contain any
untrue statement of a material fact or omit to state any material fact
required to be stated in the Registration Statement or necessary in order to
make the statements in the Registration Statement, in light of the
circumstances under which they were made, not misleading. The information to
be supplied by the Company or its Subsidiaries or about the Company or its
Subsidiaries by the Company's agents for inclusion in the Proxy Statement
shall not, on the date the Proxy Statement is first mailed to stockholders of
the Company, at the time of the Company stockholders' meeting to approve the
transactions contemplated by this Agreement (the "Stockholders' Meeting") and
as of the Closing Date, contain any statement which, at such time and in light
of the circumstances under which it shall be made, is false or misleading with
respect to any material fact, omit to state any material fact necessary in
order to make the statements made in such proxy statement not false or
misleading, or omit to state any material fact necessary to correct any
statement in any earlier communication with respect to the solicitation of
proxies for the Stockholders' Meeting which has become false or misleading. If
at any time prior to the Closing Date any event relating to the Company or any
of its Affiliates, officers or directors should be discovered by the Company
which should be set forth in a supplement to the Proxy Statement, the Company
shall promptly inform ACO.
Section 4.16 Labor Matters. Except as disclosed in the Company Disclosure
Schedule or the Company SEC Reports filed prior to the date hereof, neither
the Company nor any of its Subsidiaries is a party to or
A-20
<PAGE>
otherwise bound by any collective bargaining agreement, contract or other
agreement or understanding with a labor union or labor organization, nor, as
of the date hereof, is the Company or any of its Subsidiaries the subject of
any material proceeding asserting that the Company or any of its Subsidiaries
has committed an unfair labor practice or is seeking to compel it to bargain
with any labor union or labor organization nor, as of the date of this
Agreement, is there pending or, to the knowledge of the executive officers of
the Company, threatened, any material labor strike, dispute, walkout, work
stoppage, slow-down or lockout involving the Company or any of its
Subsidiaries.
Section 4.17 Insurance. All material fire and casualty, general liability,
business interruption, product liability, and sprinkler and water damage
insurance policies maintained by the Company or any of its Subsidiaries are
with reputable insurance carriers, provide full and adequate coverage for all
normal risks incident to the business of the Company and its Subsidiaries and
their respective properties and assets, and are in character and amount at
least equivalent to that carried by persons engaged in similar businesses and
subject to the same or similar perils or hazards, except for any such failures
to maintain insurance policies that, individually or in the aggregate, are not
reasonably likely to cause a Material Adverse Change.
Section 4.18 Broker Fees, etc. Other than (i) any amounts claimed by Lehman
Brothers pursuant to arrangements previously disclosed to ACO and (ii) amounts
paid in respect of the Fairness Opinion (as defined in Section 3.1(f)), no
broker, investment banker, financial advisor or other person is entitled to
any broker's, finder's, financial advisor's or other similar fee or commission
in connection with the transactions contemplated by this Agreement.
Section 4.19 No Existing Discussions. As of the date hereof, neither the
Company nor any of its Affiliates is engaged, directly or indirectly, in any
discussions or negotiations with any other party with respect to an
Acquisition Proposal.
Section 4.20 Section 203 of the DGCL and Sections 2538, 2555 and 2564 of the
Pennsylvania Business Corporation Law Not Applicable. The Board of Directors
of the Company has taken all actions necessary under the DGCL and the
Pennsylvania Business Corporation Law ("PBCL"), including approving the
transactions contemplated by this Agreement and each of the Investment
Documents to which it is a party, to ensure that Section 203 of the DGCL
applicable to a "business combination" (as defined in Section 203 of the DGCL)
and Sections 2538, 2555 and 2564 of the PBCL applicable to a "business
combination", "control share transactions" and "transactions with interested
shareholders" do not, and will not, apply to the transactions contemplated
hereunder and thereunder. No other "fair price," "moratorium," "control share
acquisition" or other similar anti-takeover statute or regulation is
applicable to the Company or (by reason of the Company's participation
therein) the transactions contemplated by this Agreement or the other
Investment Documents to which it is a party.
Section 4.21 The Company Rights Plan. Under the terms of the Company Rights
Plan, the transactions contemplated by this Agreement will not cause a
Distribution Date to occur or in any other way cause the rights issued
pursuant to the Company Rights Plan to become exercisable.
Section 4.22 Board Recommendation. The Board of Directors of the Company, at
a meeting duly called and held, has (i) determined that this Agreement and the
transactions contemplated hereby, taken together, are fair to and in the best
interests of the stockholders of the Company, and (ii) resolved to recommend
that the stockholders of the Company approve and adopt this Agreement and the
transactions contemplated herein.
Section 4.23 Required Company Vote. Assuming the execution of all Investment
Documents, the affirmative vote of the majority of the outstanding shares of
Common Stock is the only vote of the holders of any class or series of the
Company's securities necessary to approve and adopt this Agreement and the
transactions contemplated hereby.
A-21
<PAGE>
Section 4.24 Full Disclosure. All written information heretofore furnished
by the Company or any Subsidiary of the Company to ACO for purposes of or in
connection with this Agreement or any transaction contemplated hereby was, as
of the time such information was furnished, or the date of such information,
as the case may be, and all such information hereafter furnished by the
Company or any Subsidiary of the Company to ACO will be as of the time such
information is furnished, or the date of such information, as the case may be,
true and accurate in all material respects or, in the case of forecasts or
projections, based on reasonable expectations and estimates believed by the
Company to be accurate. Other than as disclosed in the Company SEC Reports,
the Company has disclosed to ACO any and all facts known to any executive
officer of the Company which will or are likely to (to the extent the Company
can now reasonably foresee) cause a Material Adverse Change.
ARTICLE V
Covenants
The Company agrees that, so long as ACO or TMC continues to be the
beneficial owner (within the meaning of Rule 13d-3 under the Securities Act)
of at least 1,000 shares of Series E Stock or 100,000 shares of Restricted
Stock, unless ACO otherwise consents in writing (which consent shall not, in
the case of Sections 5.2, 5.6(a), 5.7, 5.8, 5.9, 5.10, 5.11, and 5.12 be
unreasonably withheld or delayed):
Section 5.1 Information. The Company will deliver the following information
to ACO:
(a) As soon as available and in any event within 105 days after the end
of each fiscal year, an audited consolidated balance sheet of the Company
and its Subsidiaries as of the end of such fiscal year and the related
consolidated statements of income, of cash flows, and of changes in
stockholders' equity for such fiscal year, setting forth in each case in
comparative form the figures for the previous fiscal year, all in
reasonable detail and reported on without Qualification by Ernst & Young
LLP or other public accountants of nationally recognized standing
reasonably acceptable to ACO;
(b) Simultaneously with the delivery of each set of financial statements
referenced in subsection (a) of this Section 5.1, a consolidating balance
sheet in reasonable detail of the Company and its Subsidiaries as of the
end of such fiscal year and the related consolidating statement of income
for such fiscal year, setting forth, in each case, in comparative form the
figures for the previous fiscal year, all certified by the chief financial
officer, the treasurer, or chief accounting officer of the Company.
(c) As soon as available and in any event within 50 days after the end of
each of the first three fiscal quarters of each fiscal year, a consolidated
and/or consolidating balance sheet of the Company and its Subsidiaries as
of the end of such fiscal quarter, and the related consolidated and
consolidating statements of income, cash flows, changes in stockholders'
equity for such fiscal quarter and/or for the portion of the fiscal year
ended at the end of such fiscal quarter, setting forth in each case in
comparative form the figures for the corresponding fiscal quarter and the
corresponding portion of the previous fiscal year, all certified (subject
to normal year-end audit adjustments) as to fairness of presentation and
consistency by the chief financial officer, the treasurer, or the chief
accounting officer of the Company;
(d) Within 60 days after the beginning of each fiscal year, a financial
forecast, budget, cash flow projection and general business plan for the
Company and its Subsidiaries for such fiscal year, as approved by the
Company's board of directors and certified by the chief financial officer,
the treasurer, or chief accounting officer of the Company;
(e) Simultaneously with the delivery of each set of financial statements
referenced in subsections (a) and (c) of this Section 5.1, a fully
completed Compliance Certificate of the chief financial officer, the
treasurer, or chief accounting officer of the Company;
(f) Simultaneously with the delivery of each set of financial statements
referenced in subsection (a) of this Section 5.1, a statement of the firm
of independent public accountants that reported on such statements;
A-22
<PAGE>
(g) Forthwith upon an executive officer of the Company learning of the
occurrence of any Default, a certificate of the chief financial officer,
the treasurer, or the chief accounting officer of the Company setting forth
the details thereof and the action that the Company is taking or proposes
to take with respect thereto;
(h) Promptly upon the filing thereof, copies of all registration
statements (other than the exhibits thereto and any registration statements
on Form S-8 or its equivalent) and reports on Forms 10-K, 10-Q and 8-K (or
their equivalents) that the Company or any of its Subsidiaries shall have
filed with the Commission;
(i) Within 14 days after any member of the ERISA Group (i) gives or is
required to give notice to PBGC of any "reportable event" (as defined in
Section 4043 of ERISA) with respect to any ERISA Material Plan which might
constitute grounds for a termination of such ERISA Plan under Title IV of
ERISA, or knows that the plan administrator of any such ERISA Plan has
given or is required to give notice of any such reportable event, a copy of
the notice of such reportable event given or required to be given to PBGC,
(ii) receives notice of complete or partial withdrawal liability in a
material amount under Title IV of ERISA, a copy of such notice, or (iii)
receives notice from PBGC under Title IV of ERISA of an intent to terminate
or appoint a trustee to administer any ERISA Material Plan, a copy of such
notice;
(j) As soon as reasonably practicable after an executive officer of the
Company obtains knowledge of the commencement of, or of a threat (with
respect to which there is a reasonable possibility of assertion) of the
commencement of, an action, suit, or proceeding against the Company or any
of its Subsidiaries before any court or arbitrator or any governmental
body, agency, or official in which there is a reasonable possibility of an
adverse decision which could reasonably be expected to cause a Material
Adverse Change, or which in any manner questions the validity of any
Investment Document or any of the transactions contemplated hereby,
information as to the nature of such pending or threatened action, suit, or
proceeding;
(k) Promptly upon receipt thereof, copies of each report submitted to the
Board of Directors (or the Audit Committee thereof) of the Company by
independent public accountants in connection with any annual, interim, or
special audit made by them of the consolidated financial statements of the
Company and its Subsidiaries including each report submitted to the Board
of Directors (or the Audit Committee thereof) of the Company concerning its
accounting practices and systems and any final "management letter"
submitted by such accountants to management in connection with the annual
audit of the Company and its Subsidiaries; and
(l) From time to time, such additional information regarding the
business, properties, financial position, results of operations, or
prospects of the Company or any of its Subsidiaries as ACO may reasonably
request.
Section 5.2 Fiscal Plans. On or before the earlier of the Closing Date and
termination of this Agreement, the Board of Directors of the Company will not
adopt any budget or other fiscal plan for the Company without the prior
written approval of such budget or other fiscal plan by ACO.
Section 5.3 Payment of Obligations. Except where failure to do so will not
cause a Material Adverse Change, the Company will, and will cause each of its
Subsidiaries to, pay and discharge, as the same shall become due and payable,
all their respective material obligations and liabilities, including: (i) all
claims or demands of materialmen, mechanics, carriers, warehousemen,
landlords, and other like Persons which, in any such case, if unpaid, might by
law give rise to a Lien upon any of its material assets, (ii) all material
lawful taxes, assessments, and governmental charges or levies upon it or its
assets, except to the extent that any such obligation or liability may be
diligently contested in good faith by appropriate proceedings, and the Company
will maintain, and will cause each of its Subsidiaries to maintain, in
accordance with GAAP, appropriate reserves for the accrual of any such
obligation or liability; and (iii) all Debts as and when due.
Section 5.4 Maintenance of Property; Insurance.
(a) Except where failure to do so will not cause a Material Adverse Change,
the Company will keep, and will cause each of its Subsidiaries to keep, all
material property useful and necessary in its business in good working order
and condition, reasonable wear and tear excepted.
A-23
<PAGE>
(b) Except where failure to do so will not cause a Material Adverse Change,
maintain adequate reserves (consistent with past practices) in order to
provide for any potential patent infringement actions involving the Company.
(c) Except where failure to do so will not cause a Material Adverse Change,
the Company will, and will cause each Subsidiary of the Company to, maintain
or cause to be maintained with financially sound and reputable insurance
companies insurance (including insurance against claims and liabilities
arising out of the manufacture or distribution of any products) with respect
to its properties and business against such casualties and contingencies and
of such types and in such amounts as is customary in the case of similar
businesses.
Section 5.5 Books and Records; Inspection. The Company will keep, and will
cause each of its Subsidiaries to keep, proper books of record and account in
which full, true, and correct entries in conformity with GAAP shall be made of
all dealings and transactions in relation to its business and activities. The
Company will permit ACO and its representatives to have access to and to
examine its properties, books and records (and to copy and make extracts
therefrom) at such reasonable times and intervals as ACO may request and to
discuss its affairs, finances and accounts with its officers and auditors, all
to such reasonable extent and at such reasonable times and intervals as ACO
may request.
Section 5.6 Conduct of Business; Maintenance of Subsidiaries; Compliance
with Law.
(a) On or before the earlier of the Closing Date and termination of this
Agreement, subject to this Section 5, the Company will, and will cause each of
its Subsidiaries to, engage in its business in the same general manner as now
conducted by the Company and its Subsidiaries, will conduct its operations so
as to implement the most recent Annual Operating Plan adopted by the Company
and provided to ACO.
(b) On or before the earlier of the Closing Date and termination of this
Agreement, the Company will preserve, renew, and keep in full force and
effect, and will cause each of its Subsidiaries to preserve, renew, and keep
in full force and effect, its corporate existence and all material rights,
privileges, and franchises necessary or desirable in the normal conduct of
business.
(c) On or before the earlier of the Closing Date and termination of this
Agreement, except for any minority interest existing on the Closing Date and
disclosed on the Company Disclosure Schedule, the Company will cause each of
its Subsidiaries to be a Wholly-Owned Subsidiary.
(d) The Company will comply, and will cause each Subsidiary of the Company
to comply, in all material respects with all material applicable laws,
ordinances, rules, regulations and requirements of governmental authorities
(including environmental laws and ERISA and the rules and regulations
thereunder).
Section 5.7 Debt. On or before the earlier of the Closing Date and
termination of this Agreement, the Company will not, and will not permit any
of its Subsidiaries to, incur or at any time be liable with respect to any
Debt except:
(a) Debt identified in the Company Disclosure Schedule including any
extension, renewal, refunding, or refinancing thereof, provided that (x)
such extension, renewal, refunding, or refinancing is on terms no less
favorable, in the reasonable opinion of the management of the Company, than
the Debt so extended, renewed, refunded or refinanced and (y) the amount of
such Debt shall not be increased;
(b) Debt of a Subsidiary of the Company owing to the Company or to a
Wholly-Owned Subsidiary; and
(c) Additional Debt, not otherwise permitted under this Section, in an
aggregate principal amount outstanding at any time not in excess of
$2,000,000.
A-24
<PAGE>
Section 5.8 Consolidations, Mergers and Sales of Assets.
(a) On or before the earlier of the Closing Date and termination of this
Agreement, the Company will not, and will not permit any Subsidiary of the
Company to, consolidate with or merge with or into any other Person, unless:
(i) (A) the Company is the surviving corporation, (B) immediately after giving
effect thereto, no Default shall have occurred and be continuing, and (C) ACO
consents in writing, which consent shall not unreasonably be withheld; or (ii)
the Company pays the Transaction Initiation Fee to ACO.
(b) On or before the earlier of the Closing Date and termination of this
Agreement, neither the Company nor any of its Subsidiaries will make any
Disposition of any material part of their consolidated assets.
Section 5.9 Restricted Payments. On or before the earlier of the Closing
Date and termination of this Agreement, the Company will not declare or make,
or permit any of its Subsidiaries to declare or make, any Restricted Payment.
Section 5.10 Limitations on Investments. On or before the earlier of the
Closing Date and termination of this Agreement, the Company will not, and will
not permit any of its Subsidiaries to, make or acquire any Investment in any
Person other than:
(a) Investments in Persons which immediately before and after giving
effect to such Investment are Wholly-Owned Subsidiaries; and
(b) Investments made by the Company or any Subsidiary of the Company in
connection with its cash management policies and practices conducted in the
ordinary course of business, consistent with reasonable business practice,
provided that, in each case, such Investment matures within one year from
the date of acquisition thereof by the Company or such Subsidiary.
Section 5.11 Transactions with Affiliates. Except as set forth on the
Company Disclosure Schedule, pursuant to any Investment Document, or as
required under any contract or obligation entered into before the date of this
Agreement, the Company will not, and will not permit any of its Subsidiaries
to, directly or indirectly: (i) make any Investment in an Affiliate of the
Company; (ii) sell, lease, or otherwise transfer any assets to an Affiliate of
the Company; (iii) purchase or acquire assets from an Affiliate of the
Company; or (iv) enter into any other transaction directly or indirectly with
or for the benefit of an Affiliate of the Company (including Guarantees and
assumptions of obligations of an Affiliate); provided that the Company and any
Wholly-Owned Subsidiary may enter into any such transaction with each other.
Section 5.12 Replacement of Certificates. Upon receipt of evidence
reasonably satisfactory to the Company of the loss, theft, destruction, or
mutilation of any certificate representing any of the Securities, and in the
case of loss, theft or destruction, upon receipt of indemnity in reasonable
form and scope, the Company will issue a new certificate representing such
Securities in lieu of such lost, stolen, destroyed, or mutilated certificate.
Section 5.13 Compensation of Board. The Company shall compensate the ACO
Board Nominees consistently with other Company directors providing similar
services.
Section 5.14 Organizational Documents. On or before the earlier of the
Closing Date and termination of this Agreement, other than pursuant to this
Agreement, the Company will not make any change in its Certificate of
Incorporation, the Certificate or its bylaws, including without limiting the
foregoing, any change in the authorized number of directors.
Section 5.15 Securities Law Filings. The Company will make any filings
necessary to perfect in a timely fashion exemptions from (i) the registration
and prospectus delivery requirements of the Securities Act and (ii) the
registration or qualification requirements of all applicable securities or
blue sky laws of any state or other jurisdiction, for the issuance of the
Securities to ACO.
A-25
<PAGE>
Section 5.16 Compliance With Certificate and Bylaws. The Company will
perform and observe all of its obligations to the holders of Securities set
forth in the Certificate and the Company's Bylaws.
Section 5.17 Use of Proceeds. Concurrently with the Closing, the Company
will apply the proceeds received by it from the Purchase as follows:
(a) Approximately $16.5 million (as specified in First Union National
Bank Consent Agreement) to First Union National Bank, in repayment of the
Company's line of credit, including interest and fees, pursuant to the
First Union National Bank Consent Agreement;
(b) all payments to be made pursuant to Section 8.4;
(c) payment of costs and fees payable by the Company in connection with
the transactions contemplated by the Investment Documents as provided
herein and therein; and
(d) the balance to be used for working capital and for general corporate
purposes not inconsistent with the provisions of this Agreement.
Section 5.18 Employees.
(a) On or before the earlier of the Closing Date and termination of this
Agreement, without the written consent of ACO (which consent will not be
unreasonably withheld), neither the Company nor any of its Subsidiaries shall
(except as set forth in any Investment Document) adopt or amend (except as may
be required by law) any bonus, profit sharing, compensation, stock option
(including by accelerating of altering the vesting thereof) pension,
retirement, deferred compensation, severance, change-in-control, fringe
benefits, employment or other employee benefit plan, agreement, trust, fund or
other arrangement for the benefit or welfare of any employee, director or
former director or employee, increase the compensation, bonus or fringe
benefits of any director, employee or former director or employee or pay any
benefit not required by any existing plan, arrangement or agreement, except
that the Company will be permitted to (i) provide for any payment deemed
necessary by management to certain employees on terms reasonably acceptable to
ACO and (ii) grant merit increases in salaries of employees (other than
officers) at regular scheduled times in customary amounts consistent with past
practices.
(b) On or before the earlier of the Closing Date and termination of this
Agreement, neither the Company nor any of its Subsidiaries shall grant any new
or modified severance or termination arrangement or increase or accelerate any
benefits payable under its severance or termination pay policies in effect on
the date of this Agreement.
Section 5.19 Transition. On or before the earlier of the Closing Date and
termination of this Agreement, in order to permit the coordination of their
related operations on a timely basis, the Company shall consult with ACO on
all strategic and material operational matters. The Company shall make
available to ACO at the Company's facilities office space in order to assist
it in observing all operations and reviewing all matters concerning the
Company's affairs. Without in any way limiting the foregoing sentence, ACO,
its officers, employees, counsel, financial advisors and other representatives
shall, upon reasonable notice to the Company, be entitled to review the
operations and visit the facilities of the Company and its Subsidiaries at all
times as may be deemed reasonably necessary by ACO.
Section 5.20 Exclusivity. On or before the earlier of the Closing Date and
termination of this Agreement, the Company agrees that, the Company and its
officers, directors, employees, representatives and agents shall not, and each
of them shall cause their Affiliates and representatives to not, directly or
indirectly, (x) take any action to encourage, solicit or initiate any
Acquisition Proposal or (y) respond to, continue, initiate or engage in
discussions or negotiations concerning any Acquisition Proposal with, or
disclose in connection with any Acquisition Proposal any non-public
information relating to the Company or its assets or afford access to the
properties, books or records of the Company or any of its Subsidiaries to any
Person (except ACO and its representatives), except that the Company may
engage in negotiations with, or disclose such non-public information to, or
provide such access to any person who has made an unsolicited Acquisition
Proposal if the
A-26
<PAGE>
Board of Directors of the Company, after consultation with outside counsel to
the Company, determines that its fiduciary duties under applicable law require
such actions. Subject to such fiduciary duties, the Company shall, and shall
cause its Affiliates and representatives to, immediately discontinue and not
resume or otherwise continue any discussions with respect to any Acquisition
Proposal existing on or commenced prior to the date hereof (other than, in
each case, with ACO and its representatives). In addition, the Company shall
provide ACO with notice of any Acquisition Proposal received by the Company
not later than 24 hours after receipt.
Section 5.21 Registration. The Company shall use best efforts to ensure that
all Conversion Stock held by ACO is continuously registered with the
Commission in accordance with the terms and conditions of the Registration
Rights Agreement.
Section 5.22 Reasonable Best Efforts. Upon the terms and subject to the
conditions set forth in this Agreement, each of the parties agrees to use its
reasonable best efforts to take, or cause to be taken, all actions, and to do,
or cause to be done, and to assist and cooperate with the other party in
doing, all things necessary, proper or advisable to consummate and make
effective, in the most expeditious manner practicable, the transactions
contemplated by this Agreement. The parties shall use their reasonable best
efforts and cooperate with one another (i) in promptly determining whether any
filings are required to be made or consents, approvals, waivers, permits or
authorizations are required to be obtained (or, which if not obtained, would
result in an event of default, termination or acceleration of any agreement or
any put right under any agreement) under any applicable law or regulation or
from any governmental authorities or third parties, including parties to loan
agreements or other debt instruments, in connection with the transactions
contemplated by this Agreement, and (ii) in promptly making any such filings,
in furnishing information required in connection therewith and in timely
seeking to obtain any such consents, approvals, permits or authorizations. ACO
and the Company shall mutually cooperate in order to facilitate the
achievement of the benefits reasonably anticipated from the transactions
contemplated by this Agreement. Following the execution of this Agreement, ACO
and the Company shall cooperate to prepare, file, cause to be approved by the
SEC and mail to the Company's stockholders, in as expeditious manner as
possible, the Proxy Statement in accordance with Regulation 14A of the
Securities Exchange Act of 1934, as amended, which Proxy Statement shall
contain proposals related to, at a minimum, (i) an increase in the number of
authorized shares of Common Stock of the Company; (ii) approval of the
transactions contemplated by this Agreement pursuant to the rules of the New
York Stock Exchange, Inc. and (iii) such other matters as the Company shall
determine.
Section 5.23 Public Announcements. ACO and the Company shall consult with
each other before holding any press conferences or analyst calls and before
issuing any press releases. The parties will provide each other the
opportunity to review and comment upon any press release with respect to the
transactions contemplated by this Agreement, and shall not issue any such
press release prior to such consultation, except as may be required by
applicable law, court process or by obligations pursuant to any listing
agreement with any national securities exchange.
ARTICLE VI
Defaults
Section 6.1 Defaults. If one or more of the following events ("Events of
Default") shall have occurred and be continuing other than as a result of any
action caused or taken by ACO, its affiliates (including TMC) or the ACO Board
Nominees:
(a) The Company shall fail to observe or perform any of its material
covenants or agreements contained in this Agreement or any other Investment
Document;
(b) Any material representation, warranty, certification, or statement
made by or on behalf of the Company in any Investment Document, or in any
certificate, financial statement or other document delivered pursuant
thereto, shall have been incorrect or misleading in any material adverse
respect when made (or deemed made);
A-27
<PAGE>
(c) The Company or any Subsidiary of the Company shall commence a
voluntary case or other proceeding seeking liquidation, reorganization, or
other relief with respect to itself or its debts under any bankruptcy,
insolvency, or other similar law now or hereafter in effect or seeking the
appointment of a trustee, receiver, liquidator, custodian, or other similar
official of it or any substantial part of its property, or shall consent to
any such relief or to the appointment of or taking possession by any such
official in an involuntary case or other proceeding commenced against it,
or shall make a general assignment for the benefit of creditors, or shall
fail generally to pay its debts as they become due, or shall take any
corporate action to authorize any of the foregoing;
(d) An involuntary case or other proceeding shall be commenced against
the Company or any Subsidiary of the Company seeking liquidation,
reorganization, or other relief with respect to it or its debts under any
bankruptcy, insolvency, or other similar law now or hereafter in effect or
seeking the appointment of a trustee, receiver, liquidator, custodian, or
other similar official of it or any substantial part of its property, and
such involuntary case or other proceeding shall remain undismissed for a
period of 60 days; or an order for relief shall be entered against the
Company or any Subsidiary of the Company under the Federal bankruptcy laws
as now or hereafter in effect;
then, and in every such event, (x) ACO may, by notice to the Company,
terminate any outstanding obligation of ACO to Purchase, and any such
obligation to Purchase shall thereupon terminate, and (y) ACO may proceed to
protect and enforce its rights by suit in equity or action at law, whether for
the specific performance of any term contained in this Agreement or the
Certificate or for an injunction against the breach of any such term or in aid
of the exercise of any power granted in this Agreement or the Certificate, or
to enforce any other legal or equitable right of ACO or to take any one or
more of such actions.
ARTICLE VII
Termination
Section 7.1 Termination. This Agreement may be terminated at any time prior
to the Closing Date (with respect to Sections 7.1(b) through 7.1(f), by
written notice by the terminating party to the other party), whether before or
after approval of the matters presented in connection with the transactions
contemplated by this Agreement by the stockholders of the Company:
(a) by mutual written consent of ACO and the Company; or
(b) by either ACO or the Company if the transactions contemplated by this
Agreement shall not have been consummated by November 15, 1998 or, upon
receipt of a letter from NMC to ACO extending the termination date of the
Transaction because NMC is awaiting regulatory or shareholder approval, by
December 31, 1998 (the "Outside Date"); provided, however, that the right
to terminate this Agreement under this Section 7.1(b) shall not be
available to any party whose failure to fulfill any obligation under this
Agreement has been the cause of or resulting in the failure of the Purchase
to occur on or before such date;
(c) by either ACO or the Company if a court of competent jurisdiction or
other Governmental Entity shall have issued a nonappealable final order,
decree or ruling or taken any other nonappealable final action, in each
case having the effect of permanently restraining, enjoining or otherwise
prohibiting the transactions contemplated by this Agreement;
(d) by ACO, if there has been a material breach of any representation,
warranty, covenant or agreement under this Agreement by the Company, which
breach shall not have been cured within 20 business days following receipt
by the Company of written notice of such breach from ACO; provided that
such breach was not caused by Steve Lehman, as acting CEO of the Company,
TMC or an ACO Board Nominee;
(e) by the Company if the Company accepts an Acquisition Proposal (and
pays to ACO the Transaction Initiation Fee pursuant to Section 2.2); or
A-28
<PAGE>
(f) by the Company, if there has been a material breach of any
representation, warranty, covenant or agreement under this Agreement by the
ACO, which breach shall not have been cured within 20 business days
following receipt by the ACO of written notice of such breach from the
Company.
Section 7.2 Effect of Termination.
(a) In the event of a termination of this Agreement pursuant to Section
7.1(d) or (e), there shall be no liability or obligation on the part of ACO,
the Company or their respective officers, directors, or stockholders or
members, except as set forth in Sections 8.4 (Expenses; Documentary Taxes;
Indemnification) and 2.2 (Transaction Initiation Fee), provided that any such
termination shall not limit liability for a wilful breach of this Agreement.
(b) In the event of a termination of this Agreement by the Company pursuant
to Section 7.1(f), (i) TMC shall forfeit the TMC Option and the TMC Warrant
and such shall be cancelled and of no further force and effect; and (ii) the
fixed "floor" conversion price of $1.073125 per share shall remain in full
force and effect with respect to all shares of Series D Preferred Stock and
warrants over shares of Series D Stock purchased by ACO.
(c) Other than as set forth in Section 7.2(a) and in Section 8.8, neither
party hereto shall be limited in pursuing any and all remedies available to
such party at law or in equity.
ARTICLE VIII
Miscellaneous
Section 8.1 Notices. All notices, requests, and other communications to any
party under this Agreement shall be in writing and shall be given to such
party at its address or facsimile number set forth on the signature pages
hereof or such other address facsimile number as such party may hereafter
specify for the purpose by notice to the other parties. Each such notice,
request or other communication shall be effective: (a) if given by facsimile,
when such facsimile is transmitted to the facsimile number specified in
accordance with this Section 8.1 and the party sending the facsimile has
telephonically confirmed its receipt, (b) if given by registered or certified
mail, return receipt requested, 72 hours after such communication is deposited
in the mails with postage prepaid, addressed as aforesaid or (c) if given by
any other means, when delivered at the address specified in accordance with
this Section 8.1.
Section 8.2 No Waivers. No failure or delay by ACO or the Company in
exercising any right, power, or privilege under this Agreement shall operate
as a waiver thereof nor shall any single or partial exercise thereof preclude
any other or further exercise thereof or the exercise of any other right,
power, or privilege.
Section 8.3 Cumulative Remedies. None of the rights, powers or remedies
conferred upon ACO or the Company pursuant to this Agreement shall be mutually
exclusive, and each such right, power or remedy shall be cumulative and in
addition to every other right, power or remedy, whether conferred hereby or by
the Certificate of Designation for Series E Stock (as to ACO) or now or
hereafter available at law, in equity, by statute or otherwise.
Section 8.4 Expenses; Documentary Taxes; Indemnification.
(a) Subject to Section 7.4(c), the Company shall pay: (i) all reasonable
fees and disbursements of ACO's counsel in connection with the negotiation and
preparation of this Agreement and all related documents, (ii) all other
reasonable out-of-pocket expenses of ACO, and (iii) upon any Event of Default,
all out-of-pocket expenses incurred by ACO, including reasonable fees and
disbursements of counsel, in connection with the such Event of Default and
enforcement proceedings resulting therefrom.
A-29
<PAGE>
(b) Subject to Section 7.4(c), the Company shall indemnify ACO against any
transfer taxes, documentary taxes, assessments, or charges made by any
governmental authority by reason of the execution and delivery of the
Investment Documents.
(c) The Company shall not be required to make any payment to ACO pursuant to
this Section 8.4 if the Company has paid the Transaction Initiation Fee to ACO
pursuant to Section 2.2.
Section 8.5 Amendments and Waivers. Any provision of this Agreement and the
obligations or rights of the Company or ACO in respect of the Common Stock,
Series E Stock or Series D Stock of the Company may be amended or waived if,
but only if, such amendment or waiver is in writing and is signed by the party
or parties whose performance is conditional with respect such right or
obligation, whereupon such amendment or waiver shall be binding on the Company
and ACO.
Section 8.6 Successors and Assigns. This Agreement shall be binding upon and
inure to the benefit of the parties hereto and their respective successors and
assigns, except that the Company may not assign or transfer any of its rights
or obligations hereunder without the consent of ACO. ACO may not assign its
rights or obligations under this Agreement except (a) with the consent of the
Company or (b) to TMC only after the Closing Date. Upon any such assignment,
ACO shall notify the Company, which notice shall specify the precise nature of
the rights which have been so assigned.
Section 8.7 Survival of Representations and Warranties. All representations
and warranties made in, pursuant to or in connection with this Agreement shall
survive the execution and delivery of this Agreement and the Purchase.
Section 8.8 Governing Law; Submission to Jurisdiction; Waiver of Jury Trial.
(a) GOVERNING LAW. THIS AGREEMENT AND THE OTHER INVESTMENT DOCUMENTS (EXCEPT
TO THE EXTENT OTHERWISE EXPRESSLY SET FORTH THEREIN) SHALL BE DEEMED TO HAVE
BEEN MADE IN THE STATE OF DELAWARE AND THE VALIDITY, CONSTRUCTION,
INTERPRETATION, AND ENFORCEMENT HEREOF AND THEREOF, AND THE RIGHTS OF THE
PARTIES HERETO AND THERETO, SHALL BE DETERMINED UNDER, GOVERNED BY, AND
CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF DELAWARE,
WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW.
(b) JURISDICTION AND VENUE. TO THE MAXIMUM EXTENT PERMITTED BY LAW, THE
PARTIES HERETO AGREE THAT ALL ACTIONS OR PROCEEDINGS ARISING IN CONNECTION
WITH THIS AGREEMENT OR THE OTHER INVESTMENT DOCUMENTS SHALL BE TRIED AND
LITIGATED ONLY IN THE DELAWARE COURT OF CHANCERY, COUNTY OF NEW CASTLE,
DELAWARE, OR, IF JURISDICTION IS NOT AVAILABLE IN SUCH COURT, IN ANY OTHER
DELAWARE STATE COURT. TO THE EXTENT THEY MAY LEGALLY DO SO, THE PARTIES HERETO
HEREBY WAIVE ANY RIGHT EACH MAY HAVE TO ASSERT THE DOCTRINE OF FORUM NON
CONVENIENS OR TO OBJECT TO VENUE TO THE EXTENT ANY PROCEEDING IS BROUGHT IN
ACCORDANCE WITH THIS SUBSECTION (b) AND STIPULATE THAT SUCH COURTS SHALL HAVE
IN PERSONAM JURISDICTION AND VENUE OVER EACH SUCH PARTY FOR THE PURPOSE OF
LITIGATING ANY SUCH DISPUTE, CONTROVERSY, OR PROCEEDING ARISING OUT OF OR
RELATED TO THIS AGREEMENT, OR THE OTHER INVESTMENT DOCUMENTS. TO THE MAXIMUM
EXTENT PERMITTED BY LAW, SERVICE OF PROCESS SUFFICIENT FOR PERSONAL
JURISDICTION IN ANY ACTION AGAINST THE COMPANY MAY BE MADE BY REGISTERED OR
CERTIFIED MAIL, RETURN RECEIPT REQUESTED, TO ITS ADDRESS SPECIFIED FOR NOTICES
PURSUANT TO SECTION 8.1.
(c) WAIVER OF TRIAL BY JURY. TO THE MAXIMUM EXTENT THEY MAY LEGALLY DO SO,
THE PARTIES TO THIS AGREEMENT HEREBY EXPRESSLY WAIVE ANY RIGHT TO TRIAL BY
JURY OF ANY CLAIM, DEMAND, ACTION, CAUSE OF ACTION, OR PROCEEDING ARISING
UNDER OR
A-30
<PAGE>
WITH RESPECT TO THIS AGREEMENT, OR THE OTHER INVESTMENT DOCUMENTS, OR IN ANY
WAY CONNECTED WITH, OR RELATED TO, OR INCIDENTAL TO, THE DEALINGS OF THE
PARTIES HERETO WITH RESPECT TO THIS AGREEMENT, THE OTHER INVESTMENT DOCUMENTS,
OR THE TRANSACTIONS RELATED HERETO OR THERETO, IN EACH CASE WHETHER NOW
EXISTING OR HEREAFTER ARISING, AND IRRESPECTIVE OF WHETHER SOUNDING IN
CONTRACT, TORT, OR OTHERWISE. TO THE EXTENT THEY MAY LEGALLY DO SO, THE
PARTIES TO THIS AGREEMENT HEREBY AGREE THAT ANY SUCH CLAIM, DEMAND, ACTION,
CAUSE OF ACTION, OR PROCEEDING SHALL BE DECIDED BY A COURT TRIAL WITHOUT A
JURY AND THAT ANY PARTY HERETO MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF
THIS SUBSECTION (c) WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENT OF THE
OTHER PARTY OR PARTIES HERETO TO WAIVER OF ITS OR THEIR RIGHT TO TRIAL BY
JURY.
Section 8.9 Counterparts; Facsimile Signatures. This Agreement may be signed
in any number of counterparts, each of which shall be an original, with the
same effect as if the signatures thereto and hereto were upon the same
instrument. Delivery of an executed counterpart of the signature page to this
Agreement by facsimile shall be effective as delivery of a manually executed
counterpart of this Agreement, and any party delivering an executed
counterpart of the signature page to this Agreement by facsimile to any other
party shall thereafter also promptly deliver a manually executed counterpart
of this Agreement to such other party, but the failure to deliver such
manually executed counterpart shall not affect the validity, enforceability,
and binding effect of this Agreement.
Section 8.10 Entire Agreement. This Agreement and the other Investment
Documents (a) integrate all the terms and conditions set forth in or
incidental to the Investment Documents, (b) supersede all oral negotiations
and prior writings (including, without limiting the foregoing, the letter of
intent dated July 10, 1998 between ACO and the Company together with the
Annexes thereto) with respect to the subject matter hereof, and (c) are
intended by the parties as the final expression of the agreement with respect
to the terms and conditions set forth in the Investment Documents and as the
complete and exclusive statement of the terms agreed to by the parties.
Section 8.11 Confidentiality. Each of the Company and ACO agree to maintain
confidentiality of the terms of this Agreement and all information disclosed
in connection herewith including, without limitation, pursuant to Article 5
hereof, subject to the applicable rules and regulations under the Securities
Act of 1933 and the Securities Exchange Act of 1934; provided, however, that
the Company and ACO may disclose such information to its legal and financial
advisors and lenders and to the parties to the Investment Documents, provided
that such advisors, lenders and parties to the Investment Documents are, prior
to receipt of such information, informed of the confidential nature of such
information and agree to be bound by the nondisclosure provisions hereof.
A-31
<PAGE>
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly
executed by their respective authorized signatories as of the day and year
first above written.
COMPANY: National Media Corporation, a
Delaware corporation
By /s/ Robert N. Verratti
-----------------------------------
Name: Robert N. Verratti
Title: Chief Executive Officer
Address for Notices:
Attn: General Counsel
Eleven Penn Center
Suite 1100
1835 Market Street
Philadelphia, PA 19103
Telephone: (215) 988-4600
Facsimile: (215) 988-4869
ACO: NM Acquisition Co., LLC, a Delaware
limited liability company
By its Manager,
Temporary Media, Co., LLC, a
Delaware limited liability company
By /s/ Eric R. Weiss
-----------------------------------
Name: Eric Weiss
Title: Managing Member
Address for Notice:
Attn: Stuart D. Buchalter, Esq.
Buchalter, Nemer, Fields & Younger
601 S. Figueroa Street, Suite 2400
Los Angeles, California 90017
Telephone: (213) 891-0700
Facsimile: (213) 896-0400
A-32
<PAGE>
ANNEX B
JANNEY MONTGOMERY SCOTT INC.
1801 MARKET STREET
PHILADELPHIA, PA 19103-1675
August 28, 1998
Board of Directors
National Media Corporation
Eleven Penn Centre, Suite 1100
1835 Market Street
Philadelphia, PA 19103
Gentlemen:
It is our understanding that on August 11, 1998, National Media Corporation
("National Media" or the "Company") executed definitive agreements with NM
Acquisition Co., LLC ("ACO"), pursuant to which ACO agreed to acquire a
substantial equity interest in, and operational control of, the Company. In
connection therewith, ACO entered into a stock purchase agreement (the "Series
D Stock Purchase Agreement"), pursuant to which for an aggregate amount of $10
million, ACO acquired 10,000 shares of the Company's outstanding Series D
Convertible Preferred Stock (the "Series D Preferred Stock"), along with
warrants to purchase 992,942 shares of the Company's common stock ("Common
Stock") which had been issued to the original holders of the Series D
Preferred Stock. In addition, the Company and ACO entered into a stock
purchase agreement (the "Series E Stock Purchase Agreement") pursuant to which
ACO agreed to invest a minimum of $20,000,000, and a maximum of $22,000,000,
directly into the Company in exchange for shares of the Company's newly-
created Series E Convertible Preferred Stock (the "Series E Preferred Stock"),
which will be convertible into shares of Common Stock at a fixed conversion
price of $1.50 per share. The Company also entered into a consulting agreement
(the "Consulting Agreement") with Temporary Media Co., LLC ("TMC"), pursuant
to which TMC is providing executive management consulting services to the
Company. In connection with the Consulting Agreement, the Company granted to
TMC (i) a five-year option to purchase up to 212,500 shares of Common Stock,
subject to certain vesting requirements, at an exercise price of $1.32 per
share and (ii) contingent warrants to purchase up to 3,762,500 shares of
Common Stock, at exercise prices ranging from $1.32 per share to $3.00 per
share. The Company also executed agreements with First Union National Bank
(the "First Union Agreement") and ValueVision International, Inc.
("ValueVision") (the "ValueVision Agreement") providing for modifications to
the Company's two primary credit facilities. First Union Bank agreed to waive
all outstanding financial covenant violations, to modify certain financial
covenants and to accept payment of 75% of all outstanding principal
obligations in full satisfaction of the Company's indebtedness, provided such
payment is made by November 15, 1998. ValueVision agreed to waive its right to
prepayment of its $10,000,000 demand note, and also agreed to certain
standstill provisions, until January 1, 1999. In consideration thereof, the
Company agreed to re-price certain warrants held by ValueVision to $2.74 per
share.
The various transactions contemplated by the agreements summarized above
will be described in greater detail in the Company's related Proxy Statement,
and are hereinafter collectively referred to as the "Transactions". You have
requested our opinion with respect to the fairness, from a financial point of
view, of the Transactions to the holders of the Common Stock of the Company.
In rendering our opinion, we have reviewed:
Certain publicly available business and financial information relating to
the Company that we deemed relevant;
1) Certain information, including financial forecasts, relating to the
business and prospects of the Company;
2) Selected financial and stock market data for certain other publicly
traded companies that we deemed relevant;
B-1
<PAGE>
3) The financial terms of certain other business combinations that we
deemed relevant;
4) The recent trading history of the Company's Common Stock;
5) Various agreements, including, among others, the Series D Stock
Purchase Agreement, the Series E Stock Purchase Agreement, the
Consulting Agreement, the First Union Agreement and the ValueVision
Agreement; and
6) Other financial studies and analyses as we deemed necessary.
In addition, we held discussions with members of management of the Company
regarding the Company's business, financial condition and prospects.
In preparing our opinion, we have assumed and relied on the accuracy and
completeness of all information supplied or otherwise made available to us,
discussed with or reviewed by or for us, or publicly available, and we have
not assumed any responsibility for independently verifying such information or
undertaken any independent evaluation or appraisal of any of the assets or
liabilities of the Company or been furnished with any such evaluation or
appraisal. With respect to the financial forecast information furnished to or
discussed with us by the Company, we have assumed that they have been
reasonably prepared and reflect the best currently available estimates and
judgment of the Company's management as to the expected future financial
performance of the Company. We express no view with respect to the
obtainability of such projections or the assumptions on which they were based.
Further, we have relied upon the assurances of management of the Company that
they are not aware of any facts or circumstances that would make such
information inaccurate or misleading.
Our opinion is necessarily based upon market, economic and other conditions
as they exist and can be evaluated on, and on the information made available
to us as of, the date hereof.
This opinion is for the use and benefit of the Board of Directors of the
Company. Our opinion does not address the merits of the underlying decision by
the Company to proceed with the Transactions and does not constitute a
recommendation to any shareholder as to how such shareholder should vote or as
to any other action such shareholder should take in connection with the
proposed Transactions. In addition, we express no opinion as the price or
range of prices at which shares of Common Stock of the Company may trade
following consummation of the Transaction.
Based upon and subject to the foregoing, we are of the opinion as of the
date hereof that, from a financial point of view, the Transactions are fair to
the holders of the Company's Common Stock.
We have acted as financial advisor to the Company in connection with the
Transactions and will receive a fee for our services, a significant portion of
which is contingent upon the consummation of the Transactions. In addition,
the Company has agreed to indemnify us for certain liabilities that may arise
out of the rendering of this opinion. In the ordinary course of our business,
we may trade in the equity securities of the Company for our own account and
for the accounts of our customers and, accordingly, may at any time hold a
long or short position in such securities.
Very Truly Yours,
/s/ Janney Montgomery Scott Inc.
JANNEY MONTGOMERY SCOTT INC.
B-2
<PAGE>
ANNEX C
NATIONAL MEDIA CORPORATION
AMENDED AND RESTATED STOCK OPTION PLAN
(as last amended effective August 11, 1998, to eliminate Section 2(b) hereof)
The purpose of the Amended and Restated Stock Option Plan (the "Plan") of
National Media Corporation (the "Company") is to promote the interests of the
Company by providing incentives to (i) designated officers and other employees
of the Company or a Subsidiary Corporation (as defined herein), (ii) non-
employee members of the Company's Board of Directors (the "Board") and (iii)
independent contractors and consultants (who may be individuals or entities)
who perform services for the Company, to enable the Company to attract and
retain them and to encourage them to acquire a proprietary interest, or to
increase their proprietary interest, in the Company. The Company believes that
the Plan will cause participants to contribute materially to the growth of the
Company, thereby benefiting the Company's stockholders. For purposes of the
Plan, the terms "Parent Corporation" and "Subsidiary Corporation" shall have
the meanings set forth in subsections (e) and (f) of Section 424 of the
Internal Revenue Code of 1986, as amended (the "Code").
1. ADMINISTRATION
(a) The Plan shall be administered and interpreted by a committee of the
Board (the "Committee") consisting of not less than two persons, all of whom
shall be "disinterested persons" as defined under Rule 16b-3 under the
Securities Exchange Act of 1934 (the "Exchange Act") or any successor
provisions and "outside directors" for purposes of Section 162(m) of the Code.
The Committee shall have the sole authority to determine (i) who is eligible
to receive Grants (as defined in Section 2 below) under the Plan, (ii) the
type, size and terms of each Grant under the Plan (subject to Section 4
below), (iii) the time when each Grant will be made and the duration of any
exercise or restriction period; (iv) any restrictions on resale applicable to
the shares to be issued or transferred pursuant to the Grant; and (v) any
other matters arising under the Plan. The Committee may, if it so desires,
base any of the foregoing determinations upon the recommendations of
management of the Company. The Committee shall have full power and authority
to administer and interpret the Plan and to adopt or amend such rules,
regulations, agreements and instruments as it may deem appropriate for the
proper administration of the Plan. The Committee's interpretations of the Plan
and all determinations made by the Committee pursuant to the powers vested in
it hereunder shall be conclusive and binding on all persons having any
interests in the Plan or in any Grants under the Plan. No person acting under
this subsection shall be held liable for any action or determination made in
good faith with respect to the Plan or any Grant under the Plan.
(b) Each member of the Committee shall be indemnified and held harmless by
the Company against any cost or expense (including counsel fees) reasonably
incurred by him or her, or liability (including any sum paid in settlement of
a claim with the approval of the Company) arising out of any act or omission
to act in connection with the Plan, unless arising out of such member's own
fraud or bad faith, to the extent permitted by applicable law. Such
indemnification shall be in addition to any rights of indemnification the
members may have as directors or otherwise under the Certificate of
Incorporation or By-Laws of the Company, any agreement of stockholders or
disinterested directors or otherwise.
2. GRANTS
Incentives under the Plan shall consist of Incentive Stock Options (as
defined in Section 5(b) below), Nonqualified Stock Options (as defined in
Section 5(b) below), Restricted Stock Grants (as defined in Section 6 below)
or SARs (as defined in Section 7 below) (hereinafter collectively referred to
as "Grants"). All Grants shall be subject to the terms and conditions set
forth herein and to such other terms and conditions of any nature as long as
they are not inconsistent with the Plan as the Committee deems appropriate and
specifies in writing to the participant (the "Grant Letter"). The Committee
shall approve the form and provisions of each Grant Letter. Grants under any
section of the Plan need not be uniform as among the participants receiving
the same type of Grant, and Grants under two or more sections of the Plan may
be combined in one Grant Letter.
C-1
<PAGE>
3. SHARES SUBJECT TO THE PLAN
(a) The aggregate number of shares of the Common Stock, par value $.01
("Common Stock"), of the Company that may be issued or transferred under the
Plan is 6,565,000, subject to adjustment pursuant to Section 3(b) below. Such
shares may be authorized but unissued shares or reacquired shares. If and to
the extent that options granted under the Plan terminate, expire or are
canceled without having been exercised (including shares cancelled as part of
an exchange of Grants), or if any shares of restricted stock are forfeited,
the shares subject to such Grant shall again be available for subsequent
Grants under the Plan.
(b) If any change is made to the Common Stock (whether by reason of merger,
consolidation, reorganization, recapitalization, stock dividend, stock split,
combination of shares, or exchange of shares or any other change in capital
structure made without receipt of consideration), then unless such event or
change results in the termination of all outstanding Grants under the Plan,
the Committee shall preserve the value of the outstanding Grants by adjusting
the maximum number and class of shares issuable under the Plan to reflect the
effect of such event or change in the Company's capital structure, and by
making appropriate adjustments to the number and class of shares, the exercise
price of each outstanding option and otherwise, except that any fractional
shares resulting from such adjustments shall be eliminated by rounding any
portion of a share equal to .500 or greater up, and any portion of a share
equal to less than .500 down, in each case to the nearest whole number.
4. ELIGIBILITY FOR PARTICIPATION
Officers and other employees of the Company or a Subsidiary Corporation,
non-employee members of the Board, and independent contractors and consultants
who perform services for the Company shall be eligible to participate in the
Plan (hereinafter referred to individually as an "Eligible Participant", and
collectively as the "Eligible Participants"). Only Eligible Participants who
are officers or other employees of the Company or a Subsidiary Corporation
shall be eligible to receive Incentive Stock Options. All Eligible
Participants shall be eligible to receive Nonqualified Stock Options,
Restricted Stock Grants and SARs. The Committee shall select from among the
Eligible Participants those who will receive Grants (the "Grantees") and shall
determine the number of shares of Common Stock subject to each Grant. The
maximum number of shares of Common Stock for which any Grantee may be granted
options under this Plan in any one taxable year of the Company shall not
exceed 1,000,000 shares. The Committee may, if it so desires, base any such
selections or determinations upon the recommendations of management of the
Company. Nothing contained in the Plan shall be construed to limit in any
manner whatsoever the right of the Company to grant rights or options to
acquire Common Stock or awards of Common Stock otherwise than pursuant to the
Plan.
5. STOCK OPTIONS
(a) Number of Shares. The Committee, in its sole discretion, shall determine
the number of shares of Common Stock that will be subject to each option.
(b) Type of Option and Option Price.
(1) The Committee may grant options qualifying as incentive stock options
within the meaning of Section 422 of the Code ("Incentive Stock Options")
and other stock options ("Nonqualified Stock Options") in accordance with
the terms and conditions set forth herein, or may grant any combination of
Incentive Stock Options and Nonqualified Stock Options (hereinafter
referred to collectively as "Stock Options"). The option price per share of
an Incentive Stock Option shall be the fair market value (as defined
herein) of a share of Common Stock on the date of grant. If the Grantee of
an Incentive Stock Option is the owner of Common Stock (as determined under
section 424(d) of the Code) who possesses more than 10% of the total
combined voting power of all classes of stock of the Company or a Parent
Corporation or Subsidiary Corporation, the option price per share in the
case of an Incentive Stock Option shall not be less than 110% of the fair
market value of a share of Common Stock on the date of grant.
C-2
<PAGE>
(2) For all valuation purposes under the Plan, the fair market value of a
share of Common Stock shall be determined in accordance with the following
provisions.
(A) If the Common Stock is not at the time listed or admitted to
trading on any stock exchange but is traded in the over-the-counter
market (but not on the Nasdaq National Market segment of The Nasdaq
Stock Market), the fair market value shall be the mean between the last
reported bid and asked prices of one share of Common Stock on the date
in question in the over-the-counter market, as such prices are reported
by the National Association of Securities Dealers through its Nasdaq
system or any successor system. If there are no reported bid and asked
prices on the date in questions, then the mean between the last
reported bid and asked prices on the next preceding date for which such
quotations exist shall be determinative of fair market value. If the
Common Stock is traded over-the-counter on the Nasdaq National Market
segment of The Nasdaq Stock Market, the fair market value shall be the
closing selling price of one share of Common Stock on the date in
question as such price is reported by the National Association of
Securities Dealers through such system or any successor system. If
there is no reported closing selling price for the Common Stock on the
date in question, then the closing selling price on the next preceding
date for which such quotation exists shall be determinative of fair
market value.
(B) If the Common Stock is at the time listed or admitted to trading
on any stock exchange, then the fair market value shall be the closing
selling price of one share of Common Stock on the date in question on
the stock exchange determined by the Committee to be the primary market
for the Common Stock, as such prices are officially quoted on such
exchange. If there is no reported closing selling price of Common Stock
on such exchange on the date in question, then the fair market value
shall be the closing selling price on the next preceding date for which
such quotation exists.
(C) If the Common Stock is at the time neither listed nor admitted to
trading on any stock exchange nor traded in the over-the-counter market
(or, if the Committee determines that the value as determined pursuant
to Section 5(b)(2)(A) or (B) above does not reflect fair market value),
then the Committee shall determine fair market value after taking into
account such factors as it deems appropriate.
(c) Exercise Period. The Committee shall determine the option exercise
period of each Stock Option. The exercise period shall not exceed ten years
from the date of grant. Notwithstanding any determinations by the Committee
regarding the exercise period of any Stock Option, all outstanding Stock
Options shall become immediately exercisable upon a Change of Control of the
Company (as defined in Section 9 below).
(d) Vesting of Options and Restrictions on Shares. The vesting period for
Stock Options shall commence on the date of grant and shall end on the date or
dates, or upon the happening of the events or events, as determined by the
Committee, that shall be specified in the Grant Letter. The Committee may
impose upon the shares of Common Stock issuable upon the exercise of a Stock
Option such restrictions as it deems appropriate and specifies in the Grant
Letter. During any period in which such restrictions apply, the provisions of
Section 6(d) below shall be applicable to such shares, and the Committee, in
such circumstances as it deems equitable, may determine that all such
restrictions shall lapse. Notwithstanding any other provision of the Plan, all
outstanding Stock Options shall become immediately exercisable upon a Change
of Control of the Company (as defined in Section 9 below).
(e) Manner of Exercise. A Grantee may exercise a Stock Option by delivering
a duly completed notice of exercise to the Committee, together with payment of
the option price. Such notice may include instructions authorizing the Company
to deliver the certificates representing the shares of Common Stock issuable
upon the exercise of such Stock Option to any designated registered broker or
dealer ("Designated Broker"). Such instructions shall designate the account
into which the shares are to be deposited. The Grantee may tender such notice
of exercise, which has been properly executed by the Grantee, and the
aforementioned delivery instructions to any Designated Broker.
C-3
<PAGE>
(f) Termination of Employment, Disability or Death.
(1) If a Grantee ceases to be an Eligible Participant for any reason
(other than, in the case of an individual, the death of such individual)
any Stock Option which is otherwise exercisable by the Grantee shall
terminate unless exercised within three months after the date on which the
Grantee ceases to be an Eligible Participant (or within such other period
of time, which may be longer or shorter than three months, as may be
specified in the Grant Letter), but in any event no later than the date of
expiration of the option exercise period, except that in the case of an
individual Grantee who is disabled within the meaning of section 105(d)(4)
of the Code, such period shall be one year rather than three months (except
as otherwise provided in the Grant Letter).
(2) Except to the extent more liberal terms are set forth in a Grant
Letter, in the event of the death of an individual Grantee while he or she
is an Eligible Participant or within not more than three months after the
date on which the Grantee ceases to be an Eligible Participant (or within
such other period of time, which may be longer or shorter than three
months, as may be specified in the Grant Letter), any Stock Option which
was otherwise exercisable by the Grantee at the date of death may be
exercised by the Grantee's personal representative at any time prior to the
expiration of one year from the date of death, but in any event no later
than the date of expiration of the option exercise period.
(g) Satisfaction of Option Price. The Grantee shall pay the option price in
full at the time of exercise in cash, or, with the consent of the Committee in
its sole discretion, by delivering shares of Common Stock already owned by the
Grantee and having a fair market value on the date of exercise equal to the
option price or a combination of cash and shares of Common Stock; provided,
however, that in lieu of payment in full in such manner, a Grantee may with
the approval of the Board in its sole discretion, be entitled to pay for the
shares purchased upon exercise of the Stock Option by payment to the Company
in cash or by certified or bank check a sum equal at least to the par value of
the Common Stock, with the remainder of the purchase price satisfied by the
issuance of an interest bearing promissory note or notes, in a form and having
terms, including rate of interest, satisfactory to the Board in its sole
discretion. The Grantee shall also pay the amount of withholding tax due, if
any, at the time of exercise. Shares of Common Stock shall not be issued or
transferred upon any purported exercise of a Stock Option until the option
price and the withholding obligation are fully paid.
(h) Limits on Incentive Stock Options. Each Grant of an Incentive Stock
Option shall provide that:
(1) the Stock Option is not transferable by the Grantee, except, in the
case of an individual Grantee, by will or the laws of descent and
distribution;
(2) the Stock Option is exercisable only by the Grantee, except as
otherwise provided herein or in the Grant Letter in the event of the death
of an individual Grantee;
(3) the aggregate fair market value of the Common Stock on the date of
the Grant with respect to which Incentive Stock Options are exercisable for
the first time by a Grantee during any calendar year under the Plan and
under any other stock option plan of the Company shall not exceed $100,000;
and
(4) unless the Grantee could otherwise transfer Common Stock issued
pursuant to the Stock Option without incurring liability under Section
16(b) of the Exchange Act, at least six months must elapse from the date of
acquisition of the Stock Option until the date of disposition of the Common
Stock issued upon exercise thereof.
6. RESTRICTED STOCK GRANTS
The Committee may issue shares of Common Stock to an Eligible Participant
pursuant to an incentive or long range compensation plan, program or contract
approved by the Committee (a "Restricted Stock Grant"). The following
provisions are applicable to Restricted Stock Grants:
(a) General Requirements. Shares of Common Stock issued pursuant to
Restricted Stock Grants will be issued in consideration for cash or
services rendered having a value, as determined by the Board, at least
equal to the par value thereof. All conditions and restrictions imposed
under each Restricted Stock Grant,
C-4
<PAGE>
and the period of years during which the Restricted Stock Grant will remain
subject to such restrictions, shall be set forth in the Grant Letter and
designated therein as the "Restriction Period." All restrictions imposed
under any Restricted Stock Grant shall lapse on such date or dates as the
Committee may approve until the restrictions have lapsed as to 100% of the
shares, except that upon a Change of Control of the Company, all
restrictions on the transfer of the shares which have not been forfeited
prior to such date shall immediately lapse. In addition, the Committee, in
circumstances that it deems equitable, may determine as to any or all
Restricted Stock Grants, that all the restrictions shall lapse,
notwithstanding any Restriction Period.
(b) Number of Shares. The Committee, in its sole discretion, shall
determine the number of shares of Common Stock that will be granted in each
Restricted Stock Grant.
(c) Requirement of Relationship with Company. If the Grantee's
relationship with the Company (as an employee, non-employee member of the
Board, independent contractor or consultant, as the case may be) terminates
during the period designated in the Grant Letter as the Restriction Period,
the Restricted Stock Grant shall terminate as to all shares covered by the
Grant as to which restrictions on transfer have not lapsed, and such shares
shall be immediately returned to the Company. The Committee may, in its
sole discretion, provide for complete or partial exceptions to the
provisions of this Section 6(c).
(d) Restrictions on Transfer and Legend on Stock Certificate. During the
Restriction Period, a Grantee may not sell, assign, transfer, pledge or
otherwise dispose of the shares of Common Stock to which such Restriction
Period applies except to a Successor Grantee pursuant to Section 8 below.
Each certificate representing a share of Common Stock issued or transferred
under a Restricted Stock Grant shall contain a legend giving appropriate
notice of the restrictions in the Grant. The Grantee shall be entitled to have
the legend removed from the stock certificate or certificates representing any
such shares as to which all restrictions have lapsed.
7. STOCK APPRECIATION RIGHTS
(a) General Provisions. The Committee may grant stock appreciation rights
("SARs") to any Grantee in tandem with any Stock Option, for all or a portion
of the applicable Stock Option, either at the time the Stock Option is granted
or at any time thereafter while the Stock Option remains outstanding.
(b) Number of SARs. The number of SARs granted to a Grantee which shall be
exercisable during any given period of time shall not exceed the number of
shares of Common Stock which the Grantee may purchase upon the exercise of the
related Stock Option during such period. Upon the exercise of a Stock Option,
the SARs relating to the Common Stock covered by the Stock Option shall
terminate. Upon the exercise of any SARs, the related Stock Option shall
terminate to the extent of an equal number of shares of Common Stock.
(c) Settlement Amount. Upon a Grantee's exercise of some or all of the
Grantee's SARs, the Grantee shall receive in settlement of such SARs an amount
equal to the stock appreciation (as defined herein) for the number of SARs
exercised, payable in cash, Common Stock or a combination thereof. The "stock
appreciation" for an SAR is the difference between the option price specified
for the related Stock Option and the fair market value of the underlying
Common Stock on the date of exercise of the SAR.
(d) Settlement Election. Upon the exercise of any SARs, the Grantee shall
have the right to elect the portions of the settlement amount that the Grantee
desires to receive in cash and shares of Common Stock, respectively. For
purposes of calculating the number of shares of Common Stock to be received
upon settlement, shares of Common Stock shall be valued at their fair market
value on the date of exercise of the SARs. Notwithstanding the foregoing, the
Committee shall have the right (i) to disapprove a Grantee's election to
receive such settlement in whole or in part in cash, and to require that
shares of Common Stock be delivered in lieu of cash or (ii) to require that
settlement be made in cash if the Company does not or may not in the future
have sufficient shares authorized for issuance. If shares of Common Stock are
to be received upon exercise of an SAR, cash shall be delivered in lieu of any
fractional share.
C-5
<PAGE>
(e) Exercise. An SAR is exercisable only during the period when the Stock
Option to which it is related is also exercisable. No SAR may be exercised, in
whole or in part, by any person who is subject to Section 16 of the Exchange
Act except in accordance with Rule 16b-3(e) under the Exchange Act.
8. TRANSFERABILITY OF OPTIONS AND GRANTS
Only a Grantee (or, in the case of an individual Grantee, his or her
authorized legal representative) may exercise rights under a Grant. No
individual Grantee may transfer those rights except by will or by the laws of
descent and distribution or, if permitted under Rule 16b-3 of the Exchange Act
and by the Committee in its sole discretion, pursuant to a qualified domestic
relations order as defined under the Code or Title I of ERISA or the rules
thereunder. Upon the death of an individual Grantee, the personal
representative or other person entitled to succeed to the rights of the
Grantee ("Successor Grantee") may exercise such rights. A Successor Grantee
shall furnish proof satisfactory to the Company of such person's right to
receive the Grant under the Grantee's will or under the applicable laws of
descent and distribution.
9. CHANGE OF CONTROL OF THE COMPANY
As used herein, a "Change of Control" shall be deemed to have taken place
if: (i) any Person (including any individual, firm, corporation, partnership
or other entity except the Company or any employee benefit plan of the Company
or of any Affiliate or Associate (each as defined in Rule 12b-2 under the
Exchange Act), any Person or entity organized, appointed or established by the
Company for or pursuant to the terms of any such employee benefit plan),
together with all Affiliates and Associates of such Person, shall become the
beneficial owner in the aggregate of 20% or more of the Common Stock of the
Company then outstanding, except that no "Change of Control" shall be deemed
to occur during any period in which any such Person, and its Affiliates and
Associates, are bound by the terms of a standstill agreement under which such
parties have agreed not to acquire more than 30% of the Common Stock of the
Company then outstanding or to solicit proxies; or (ii) during any 24 month
period, individuals who at the beginning of such period constituted the Board
cease for any reason to constitute a majority thereof, unless the election, or
the nomination for election by the Company's stockholders, of at least 75% of
the directors who were not directors at the beginning of such period was
approved by a vote of at least 75% of the directors in office at the time of
such election or nomination who were directors at the beginning of such
period.
10. CERTAIN CORPORATE CHANGES
(a) Sale or Exchange of Assets, Dissolution or Liquidation or Merger or
Consolidation Where the Company Does Not Survive. If all or substantially all
of the assets of the Company are to be sold or exchanged, the Company is to be
dissolved or liquidated, or the Company is a party to a merger or
consolidation with another corporation in which the Company will not be the
surviving corporation, then, at least ten days prior to the effective date of
such event, the Company shall give each Grantee with any outstanding Grants
written notice of such event. Each such Grantee shall thereupon have the right
to exercise in full any installments of such Grants not previously exercised
(whether or not the right to exercise such installments has accrued pursuant
to such Grants), within ten days after such written notice is sent by the
Company. Any installments of such Grants not so exercised shall thereafter
lapse and be of no further force or effect.
(b) Merger or Consolidation Where the Company Survives. If the Company is a
party to a merger or consolidation in which the Company will be the surviving
corporation, then the Committee may, in its sole discretion, elect to give
each Grantee with any outstanding Grants written notice of such event. If such
notice is given, each such Grantee shall thereupon have the right to exercise
in full any installments of such Grants not previously exercised (whether or
not the right to exercise such installments has accrued pursuant to such
Grants), within ten days after such written notice is sent by the Company. Any
installments of such Grants not so exercised shall thereafter lapse and be of
no further force or effect.
C-6
<PAGE>
11. STOCKHOLDER APPROVAL
This Plan is subject to and no Options shall be exercisable hereunder until
after approval by holders of a majority of the shares of the stock of the
Company present or represented by a proxy in a separate vote at a duly held
meeting of the stockholders of the Company within twelve months after the date
of the adoption of the Plan by the Board. If the Plan, as herein amended, is
not so approved by stockholders, the Plan as previously approved shall
continue in effect.
12. APPROVAL BY OUTSIDE DIRECTORS
This Plan is subject to and no Options shall be exercisable hereunder until
after approval by a compensation committee (the "Compensation Committee") of
the Board of Directors which is comprised solely of two or more directors
("Outside Directors") who are (i) not presently employees of the Company (or
related entities); (ii) not former employees still receiving compensation for
prior services (other than benefits under a tax-qualified pension plan); (iii)
not officers of the Company (or related entities) at any time; and (iv) not
currently receiving compensation for personal services in any capacity other
than as a director.
13. AMENDMENT AND TERMINATION OF THE PLAN
(a) Amendment. The Board may amend or terminate the Plan at any time,
subject to the following limitations:
(1) the approval by the stockholders of the Company and approval by the
Compensation Committee shall be required in respect of any amendment that
(A) materially increases the benefits accruing to Eligible Participants
under the Plan, (B) increases the aggregate number of shares of Common
Stock that may be issued or transferred under the Plan (other than by
operation of Section 3(b) above), (C) increases the maximum number of
shares of Common Stock for which any Grantee may be granted options under
this Plan; (D) materially modifies the requirements as to eligibility for
participation in the Plan; or (E) modifies the provisions for determining
the fair market value of a share of Common Stock; and
(2) the Board shall not amend the Plan if such amendment would cause the
Plan, any Grant or the exercise of any right under the Plan to fail to
comply with the requirements of Rule 16b-3 under the Exchange Act, or if
such amendment would cause the Plan or the Grant or exercise of an
Incentive Stock Option to fail to comply with the requirements of Section
422 of the Code including, without limitation, a reduction of the option
price set forth in Section 5(b) above or an extension of the period during
which an Incentive Stock Option may be exercised as set forth in Section
5(c) above.
(b) Termination of Plan. The Plan shall terminate on the tenth anniversary
of its effective date (as set forth in Section 20 below) unless earlier
terminated by the Board or unless extended by the Board with the approval of
the stockholders.
(c) Termination and Amendment of Outstanding Grants. A termination or
amendment of the Plan that occurs after a Grant is made shall not result in
the termination or amendment of the Grant unless the Grantee consents or
unless the Committee acts under Section 21(b) below. The termination of the
Plan shall not impair the power and authority of the Committee with respect to
an outstanding Grant. Whether or not the Plan has terminated, an outstanding
Grant may be terminated or amended under Section 21(b) below or may be amended
by agreement of the Company and the Grantee which is consistent with the Plan.
(d) Employees in Foreign Countries. The Board shall have the authority to
adopt such modifications, procedures and subplans as may be necessary or
desirable to comply with provisions of the laws of foreign countries in which
the Company or its Subsidiaries may operate to assure the viability of
benefits from Grants made to participants employed in such countries and to
meet the objectives of the Plan.
C-7
<PAGE>
14. FUNDING OF THE PLAN
The Plan shall be unfunded. The Company shall not be required to establish
any special or separate fund or to make any other segregation of assets to
assure the payment of any Grants under the Plan. In no event shall interest be
paid or accrued on any Grant, including unpaid installments of Grants.
15. RIGHTS OF ELIGIBLE PARTICIPANTS
Nothing in the Plan shall entitle any Eligible Participant or other person
to any claim or right to any Grant under the Plan. Neither the Plan nor any
action taken hereunder shall be construed as giving any Eligible Participant
or Grantee any rights to be retained by the Company in any capacity, whether
as an employee, non-employee member of the Board, independent contractor,
consultant or otherwise.
16. WITHHOLDING OF TAXES
The Company shall have the right to deduct from all Grants paid in cash any
federal, state or local taxes required by law to be withheld with respect to
such Grants paid in cash. In the case of Grants paid in Common Stock, the
Company shall have the right to require the Grantee to pay to the Company the
amount of any taxes which the Company is required to withhold in respect of
such Grants or to take whatever action it deems necessary to protect the
interests of the Company in respect of such tax liabilities, including,
without limitation, withholding a portion of the shares of Common Stock
otherwise deliverable pursuant to the Plan. The Company's obligation to issue
or transfer shares of Common Stock upon the exercise of a Stock Option or SAR
or the acceptance of a Restricted Stock Grant shall be conditioned upon the
Grantee's compliance with the requirements of this section to the satisfaction
of the Committee.
17. AGREEMENTS WITH GRANTEES
Each Grant made under the Plan shall be evidenced by a Grant Letter
containing such terms and conditions as the Committee shall approve.
18. REQUIREMENTS FOR ISSUANCE OF SHARES
No Common Stock shall be issued or transferred under the Plan unless and
until all applicable legal requirements have been complied with to the
satisfaction of the Committee. The Committee shall have the right to condition
any Stock Option, Restricted Stock Grant or SAR on the Grantee's undertaking
in writing to comply with such restrictions on any subsequent disposition of
the shares of Common Stock issued or transferred thereunder as the Committee
shall deem necessary or advisable as a result of any applicable law,
regulation or official interpretation thereof, and certificates representing
such shares may be legended to reflect any such restrictions.
19. HEADINGS
The section headings of the Plan are for reference only. In the event of a
conflict between a section heading and the content of a section of the Plan,
the content of the section shall control.
20. EFFECTIVE DATES
(a) Effective Date of the Plan. The Plan shall be effective as of April 25,
1996, subject to the approval of the Company's stockholders within 12 months
after such effective date.
(b) Effectiveness of Section 16 Provisions. The provisions of the Plan that
refer to, or are applicable to persons subject to, Section 16 of the Exchange
Act shall be effective, if at all, upon the registration of the Common Stock
under the Exchange Act, and shall remain in effect thereafter for so long as
the Common Stock is registered under the Exchange Act.
C-8
<PAGE>
21. MISCELLANEOUS
(a) Substitute Grants. The Committee may make a Grant to an employee, a non-
employee director, or an independent contractor or consultant of another
corporation, if such person shall become an Eligible Participant by reason of
a corporate merger, consolidation, acquisition of stock or property,
reorganization or liquidation involving the Company or a Subsidiary
Corporation and such other corporation. Any such Grant shall be made in
substitution for a stock option or restricted stock grant granted by the other
corporation ("Substituted Stock Incentives"), but the terms and conditions of
the substitute Grant may vary from the terms and conditions required by the
Plan and from those of the Substituted Stock Incentives. The Committee shall
prescribe the provisions of the substitute Grants.
(b) Compliance with Law. The Plan, the exercise of Grants and the
obligations of the Company to issue or transfer shares of Common Stock under
Grants shall be subject to all applicable laws and required approvals by any
governmental or regulatory agencies. With respect to persons subject to
Section 16 of the Exchange Act, it is the intent of the Company that the Plan
and all transactions under the Plan shall comply with all applicable
conditions of Rule 16b-3 or any successor provisions under the Exchange Act.
The Committee may revoke any Grant if it is contrary to law or modify any
Grant to bring it into compliance with any valid and mandatory government
regulations. The Committee may also adopt rules regarding the withholding of
taxes on payments to Grantees. The Committee may, in its sole discretion,
agree to limit its authority under this section.
(c) Ownership of Stock. A Grantee or Successor Grantee shall have no rights
as a stockholder with respect to any shares of Common Stock covered by a Grant
until the shares are issued or transferred to the Grantee or Successor Grantee
on the stock transfer records of the Company.
C-9
<PAGE>
NATIONAL MEDIA CORPORATION
COMMON STOCK PROXY
This Proxy is solicited on behalf of the Board of Directors
I hereby constitute and appoint Brian J. Sisko, Esq. and James M.
Gallagher, and each of them acting individually, my true and lawful agents and
proxies, with full power of substitution in each, to vote all shares of Common
Stock held of record by me at the Meeting of Stockholders of National Media
Corporation to be held on October __, 1998 and any adjournments or postponements
thereof. I direct said proxies to vote as specified on the reverse side.
Unless otherwise specified, all shares will be voted for the election of
all nominees listed and for each of the proposal to be acted upon at the
Meeting. This Proxy also delegated discretionary authority to vote with respect
to any other business which may properly come before the Meeting or any
adjournment or postponement thereof.
Please mark, sign, date and return the Proxy Card promptly.
[Reverse Side]
1. Proposal I, to approve and adopt the Transactions contemplated by the Stock
Purchase Agreement, dated as of August 11, 1998, by and between National
Media and NM Acquisition Co., LLC ("ACO"), including among other things,
(i) the issuance of a minimum of 20,000 and, at the option of the Company,
a maximum of 22,000 shares of the Company's Series E Convertible Preferred
Stock; (ii) the amendment of National Media's Certificate of Incorporation
increasing the authorized number of shares of common stock of the Company
("Common Stock") to 150,000,000 shares; (iii) an agreement with ValueVision
International, Inc. ("ValueVision") amending, among other things, certain
terms of a $10,000,000 promissory note, payable to ValueVision and certain
warrants of the Company held by ValueVision; and (iv) the grant to
Temporary Media Co., LLC ("TMC"), an affiliate of ACO, of options to
purchase up to 212,500 shares of Common Stock and warrants to purchase up
to 3,762,500 shares of Common Stock, 2,612,500 of which may be exercised by
TMC.
FOR AGAINST ABSTAIN
/ / / / / /
2. Proposal II, Election of Directors
FOR all nominees listed WITHHOLD To withhold authority
(except through as indicated AUTHORITY to vote for any
to the contrary below) individual nominee,
strike a line the nominee's
name listed below:
/ / / /
Albert R. Dowden Andrew M. Schuon
William M. Goldstein, Esq. Robert N. Verratti
Frederick S. Hammer Eric R. Weiss
John W. Kirby Jon W. Yoskin, II
Stephen C. Lehman
3. Proposal III, to approve an amendment to the Company's 1991 Stock Option
Plan to increase the number of shares of Common Stock available for awards
by 800,000 shares.
FOR AGAINST ABSTAIN
/ / / / / /
<PAGE>
4. Proposal IV, to ratify the Board of Directors' appointment of Ernst & Young
LLP, independent certified public accountants, as auditors for the Company
for the fiscal year ending March 31, 1999.
FOR AGAINST ABSTAIN
/ / / / / /
The undersigned hereby revokes all previous proxies for the Meeting and
acknowledges receipt of the Notice of Meeting and Proxy Statement of National
Media Corporation.
Date: , 1998
----------------------------------
---------------------------------------------
---------------------------------------------
By:
------------------------------------------
NOTE: Please sign this proxy exactly as name(s) appear in address.
When signing as attorney-in-fact, executor, administrator,
trustee or guardian, please add your title as such.
<PAGE>
NATIONAL MEDIA CORPORATION
SERIES B CONVERTIBLE PREFERRED STOCK PROXY
This Proxy is Solicited on Behalf of the Board of Directors
I hereby constitute and appoint Brian J. Sisko, Esq. and James M.
Gallagher, and each of them acting individually, my true and lawful agents and
proxies, with full power of substitution in each, to vote all shares of Series B
Convertible Preferred Stock held of record by me at the Meeting of Stockholders
of National Media Corporation to be held on October ___, 1998 and any
adjournments or postponements thereof. I direct said proxies to vote as
specified on the reverse side.
Unless otherwise specified, all shares will be voted for the election of
all nominees listed and for each of the proposal to be acted upon at the
Meeting. This Proxy delegates discretionary authority to vote with respect to
any other business which may properly come before the Meeting or any adjournment
or postponement thereof.
Please mark, sign, date and return the Proxy Card promptly.
[Reverse Side]
1. Proposal I, to approve and adopt the Transactions contemplated by the Stock
Purchase Agreement dated as of August 11, 1998, by and between National
Media and NM Acquisition Co., LLC ("ACO"), including among other things,
(i) the issuance of a minimum of 20,000 and, at the option of the Company,
a maximum of 22,000 shares of the Company's Series E Convertible Preferred
Stock; (ii) the amendment of National Media's Certificate of Incorporation
increasing the authorized number of shares of common stock of the Company
("Common Stock") to 150,000,000 shares; (iii) an agreement with ValueVision
International, Inc. ("ValueVision") amending, among other things, certain
terms of a $10,000,000 promissory note, payable to ValueVision and certain
warrants of the Company held by ValueVision; and (iv) the grant to
Temporary Media Co., LLC ("TMC"), an affiliate of ACO, of options to
purchase up to 212,500 shares of Common Stock and warrants to purchase up
to 3,762,500 shares of Common Stock, 2,612,500 of which may be exercised by
TMC.
FOR AGAINST ABSTAIN
/ / / / / /
2. Proposal III, to approve an amendment to the Company's 1991 Stock Option
Plan to increase the number of shares of Common Stock available for awards
by 800,000 shares.
FOR AGAINST ABSTAIN
/ / / / / /
3. Proposal IV, to ratify the Board of Directors' appointment of Ernst & Young
LLP, independent certified public accountants, as auditors for the Company
for the fiscal year ending March 31, 1999.
FOR AGAINST ABSTAIN
/ / / / / /
The undersigned hereby revokes all previous proxies for the
Meeting and acknowledges receipt of the Notice of
Meeting and Proxy Statement of National Media Corporation
Date: , 1998
----------------------------------
---------------------------------------------
---------------------------------------------
By:
------------------------------------------
NOTE: Please sign this proxy exactly as name(s) appear in address.
When signing as attorney-in-fact, executor, administrator,
trustee or guardian, please add your title as such.
